,BARCODE,COMBI_ID,Tissue,CELL_LINE_NAME,SIDM,COSMIC_ID,ANCHOR_ID,ANCHOR_NAME,ANCHOR_TARGET,ANCHOR_PATHWAY,ANCHOR_DRUG_TYPE,ANCHOR_Clin_Rel,ANCHOR_CONC,LIBRARY_ID,LIBRARY_NAME,LIBRARY_TARGET,LIBRARY_PATHWAY,LIBRARY_DRUG_TYPE,LIBRARY_Clin_Rel,LIBRARY_CONC,ANCHOR_VIABILITY,LIBRARY_RMSE,LIBRARY_EMAX,LIBRARY_XMID,LIBRARY_XMID_uM,LIBRARY_AUC,LIBRARY_fAUC,SYNERGY_RMSE,SYNERGY_EXP_EMAX,SYNERGY_OBS_EMAX,SYNERGY_DELTA_EMAX,SYNERGY_XMID,SYNERGY_XMID_uM,SYNERGY_DELTA_XMID,SYNERGY_DELTA_XMID_uM,SYNERGY_EXP_AUC,SYNERGY_OBS_AUC,SYNERGY_EXP_fAUC,SYNERGY_OBS_fAUC,SYNERGY_DELTA_AUC,SYNERGY_DELTA_fAUC,Synergy,DAY1_NORM_MEAN,DAY1_NORM_SD,GROWTH_RATE,DOUBLING_TIME
2168,38107,1564:1011,Pancreas,PL4,SIDM00042,1298533,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.658917565930479,0.10156612677526,0.185289021347006,5.88970508543465,1.158,0.668657259808303,0.653686403489876,0.0792432289955204,0.12209019093961,0.0459427712873242,0.0761474196522857,3.55840502602194,0.2301,2.33130005941271,0.9279,0.440590014074631,0.292929557734914,0.430725453869399,0.305315628189177,0.147660456339717,0.125409825680222,True,0.369015225346918,0.0622468248261796,0.923654642499215,52.4604517987161
2169,38107,1561:1011,Pancreas,PL4,SIDM00042,1298533,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.771118686287883,0.10156612677526,0.185289021347006,5.88970508543465,1.158,0.668657259808303,0.653686403489876,0.0647489454191569,0.142879826724671,0.0436597642013355,0.0992200625233353,3.09172258358259,0.1665,2.79798250185206,0.9915,0.515614107760234,0.311058544334802,0.504069800703365,0.327660421395395,0.204555563425432,0.176409379307969,True,0.369015225346918,0.0622468248261796,0.923654642499215,52.4604517987161
2170,38112,1011:1083,Pancreas,PL4,SIDM00042,1298533,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.331590318189735,0.0756269295275551,0.53579208383472,9.30120448333484,9.8574,0.854559251698018,0.87049330660716,0.068125009761096,0.177663467562296,0.0591416038396921,0.118521863722604,5.79183507646319,0.8656,3.50936940687165,8.9918,0.283363574182528,0.178820790157866,0.288647152519903,0.214221136483351,0.104542784024661,0.0744260160365512,True,0.369015225346918,0.0622468248261796,0.923654642499215,52.4604517987161
2171,38112,1372:1085,Pancreas,PL4,SIDM00042,1298533,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.683639229212901,0.116697392446392,0.613972375599047,9.9746021028812,19.651,0.902452436337357,0.898675239548746,0.0494448758394862,0.419735601612547,0.526497388533444,-0.106761786920898,11.5394070492163,58.135,-1.56480494633511,-38.484,0.616951887978976,0.642817543414248,0.614369648077824,0.646504203552839,-0.0258656554352727,-0.032134555475015,True,0.369015225346918,0.0622468248261796,0.923654642499215,52.4604517987161
2172,38112,1558:1085,Pancreas,PL4,SIDM00042,1298533,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.811799384518815,0.116697392446392,0.613972375599047,9.9746021028812,19.651,0.902452436337357,0.898675239548746,0.0938038506837399,0.498422396622861,0.199790955084115,0.298631441538747,6.64882379972716,1.9599,3.32577830315404,17.6911,0.732610332376172,0.578895240893211,0.72954400634797,0.577174200254071,0.153715091482961,0.1523698060939,True,0.369015225346918,0.0622468248261796,0.923654642499215,52.4604517987161
2173,38415,1594:1168,Pancreas,PL4,SIDM00042,1298533,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.382238404571905,0.0350050810239685,0.925352937945857,14.2871777805654,390.4803,0.982202899213153,0.983851126618838,0.0471218505170678,0.35370543066635,0.271838271935577,0.0818671587307732,10.8925267732557,37.1285,3.39465100730969,353.3518,0.375435669161136,0.343067142380742,0.376065684975056,0.355154535230072,0.0323685267803941,0.020911149744984,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2174,38415,1079:1168,Pancreas,PL4,SIDM00042,1298533,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.68094885650096,0.0350050810239685,0.925352937945857,14.2871777805654,390.4803,0.982202899213153,0.983851126618838,0.0913365376825192,0.630118024954035,0.404723728397788,0.225394296556247,9.80227126660557,17.4384,4.48490651395981,373.0419,0.668829941071124,0.546543328630714,0.669952299638279,0.607372520114722,0.122286612440411,0.0625797795235564,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2175,38416,1011:1372,Pancreas,PL4,SIDM00042,1298533,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.645874211930469,0.102333639391726,0.301516587966998,7.23560857016401,0.2944,0.727391209915484,0.752315892361432,0.0993168572255812,0.194741788637149,0.0359555932264471,0.158786195410701,3.05410648057082,0.0162,4.18150208959319,0.2782,0.469803224469314,0.257892189414117,0.485901434101708,0.272454421202948,0.211911035055197,0.21344701289876,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2176,38416,1561:1372,Pancreas,PL4,SIDM00042,1298533,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.794566951022561,0.102333639391726,0.301516587966998,7.23560857016401,0.2944,0.727391209915484,0.752315892361432,0.0647130412308425,0.239575115983663,0.079957866707601,0.159617249276062,4.39995727179144,0.0412,2.83565129837257,0.2532,0.577961015863158,0.41543047384169,0.597765344799441,0.423657240768939,0.162530542021468,0.174108104030502,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2177,38417,1080:1510,Pancreas,PL4,SIDM00042,1298533,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.617099122737561,0.0716094509016992,0.865344605555427,12.9073238049859,150.045,0.94757532105539,0.969903996567565,0.0959851279279997,0.534003396953935,0.337872223348273,0.196131173605662,9.40039811389034,13.1987,3.50692569109555,136.8463,0.584747899351044,0.455106449640003,0.598526905421499,0.539942277575897,0.129641449711041,0.0585846278456019,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2178,38417,1085:1510,Pancreas,PL4,SIDM00042,1298533,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.724329834840943,0.0716094509016992,0.865344605555427,12.9073238049859,150.045,0.94757532105539,0.969903996567565,0.0758207944104475,0.626794915222464,0.438533125854364,0.188261789368099,9.89923168958129,18.6507,3.00809211540461,131.3943,0.686357075799405,0.597053962697916,0.702530401645355,0.648836298830201,0.0893031131014883,0.0536941028151546,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2179,38417,1011:1510,Pancreas,PL4,SIDM00042,1298533,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.643125148462948,0.0716094509016992,0.865344605555427,12.9073238049859,150.045,0.94757532105539,0.969903996567565,0.0628396098821465,0.556524877919445,0.314610263456821,0.241914614462624,8.90916936595604,9.3898,3.99815443902985,140.6552,0.609409519033573,0.507687410068996,0.623769651787322,0.54774891436162,0.101722108964577,0.0760207374257015,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2180,38417,1057:1510,Pancreas,PL4,SIDM00042,1298533,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.903721020715189,0.0716094509016992,0.865344605555427,12.9073238049859,150.045,0.94757532105539,0.969903996567565,0.117635781791402,0.782030110202933,0.373780741654218,0.408249368548715,8.26681335093277,6.0157,4.64051045405313,144.0293,0.8563437363487,0.650846348016262,0.876522629773781,0.738440387469611,0.205497388332438,0.13808224230417,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2181,38417,1594:1510,Pancreas,PL4,SIDM00042,1298533,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.416179075666274,0.0716094509016992,0.865344605555427,12.9073238049859,150.045,0.94757532105539,0.969903996567565,0.061155230230738,0.360138318072854,0.138602083444311,0.221536234628543,7.5413948259292,3.6384,5.3659289790567,146.4066,0.394361021241006,0.273470609114465,0.403653748776515,0.321557958125992,0.120890412126541,0.0820957906505228,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2182,38417,1079:1510,Pancreas,PL4,SIDM00042,1298533,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.87439513123442,0.0716094509016992,0.865344605555427,12.9073238049859,150.045,0.94757532105539,0.969903996567565,0.074628597452647,0.756653109937635,0.488254165076798,0.268398944860837,9.49278921143022,14.0716,3.41453459355568,135.9734,0.828555247208726,0.725536147144187,0.848079332363484,0.768624171686781,0.103019100064538,0.0794551606767039,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2183,38418,1510:1558,Pancreas,PL4,SIDM00042,1298533,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.848400738502939,0.0666817269002284,0.892185551649691,13.4383793926811,216.813,0.946376895153224,0.976257099656311,0.0806369916385812,0.756930880901249,0.501632053867514,0.255298827033736,9.77543108071538,17.117,3.66294831196567,199.696,0.802906856750114,0.719313329876113,0.828257244317152,0.75581735394327,0.0835935268740001,0.0724398903738815,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2184,38418,1053:1558,Pancreas,PL4,SIDM00042,1298533,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.87229989641082,0.0666817269002284,0.892185551649691,13.4383793926811,216.813,0.946376895153224,0.976257099656311,0.0788743918913566,0.778253364283255,0.696188063803197,0.0820653004800578,11.8867948930594,73.9625,1.55158449962163,142.8505,0.82552446760775,0.811189033052976,0.851588966900528,0.831380763641157,0.0143354345547745,0.0202082032593709,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2185,38418,1083:1558,Pancreas,PL4,SIDM00042,1298533,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.886132428510087,0.0666817269002284,0.892185551649691,13.4383793926811,216.813,0.946376895153224,0.976257099656311,0.0565340540736958,0.790594549564952,0.722435727089804,0.0681588224751483,12.1180586641087,86.8219,1.32032072857238,129.9911,0.838615256387962,0.846285531534815,0.865093074568661,0.848482096858286,-0.0076702751468523,0.0166109777103749,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2186,38418,1085:1558,Pancreas,PL4,SIDM00042,1298533,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.958797244247488,0.0666817269002284,0.892185551649691,13.4383793926811,216.813,0.946376895153224,0.976257099656311,0.0607822641095338,0.855425048279148,0.806295473033286,0.0491295752458624,12.4974917843881,112.9406,0.940887608292943,103.8724,0.907383559092405,0.919271091483389,0.936032616827516,0.924239347428209,-0.0118875323909846,0.0117932693993068,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2187,38418,1372:1558,Pancreas,PL4,SIDM00042,1298533,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.50694684588147,0.0666817269002284,0.892185551649691,13.4383793926811,216.813,0.946376895153224,0.976257099656311,0.116581823306077,0.45229065134983,0.231345920639104,0.220944730710727,8.63237263626806,7.7506,4.806006756413,209.0624,0.479762782013026,0.344857682736793,0.494910457440159,0.424500298402324,0.134905099276233,0.0704101590378353,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2188,38418,1594:1558,Pancreas,PL4,SIDM00042,1298533,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.380168979054089,0.0666817269002284,0.892185551649691,13.4383793926811,216.813,0.946376895153224,0.976257099656311,0.0392253166365668,0.339181270297472,0.298856964945184,0.0403243053522883,11.7338351066275,66.5222,1.70454428605353,150.2908,0.35978313803078,0.349303913836227,0.371142664870646,0.36113983651467,0.010479224194553,0.0100028283559759,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2189,38418,1372:1561,Pancreas,PL4,SIDM00042,1298533,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.470846335070862,0.107440613815064,0.420006283108773,8.3221493642692,6.251,0.763147225326217,0.820272735787967,0.0949788046368031,0.197758419108501,0.0668993746069633,0.130859044501538,5.22355320856442,0.7298,3.09859615570478,5.5212,0.359325074164347,0.242763346503897,0.386222411404314,0.282859296515159,0.11656172766045,0.103363114889156,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2190,38418,1011:1561,Pancreas,PL4,SIDM00042,1298533,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.604596403556944,0.107440613815064,0.420006283108773,8.3221493642692,6.251,0.763147225326217,0.820272735787967,0.0547269456224836,0.253934288238884,0.0634299695342866,0.190504318704597,4.49750424378368,0.4412,3.82464512048552,5.8098,0.461396067816691,0.321382182915812,0.49593394599322,0.327248021638361,0.140013884900879,0.16868592435486,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2191,38418,1057:1561,Pancreas,PL4,SIDM00042,1298533,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.924291216835217,0.107440613815064,0.420006283108773,8.3221493642692,6.251,0.763147225326217,0.820272735787967,0.0974871430279543,0.388208118493044,0.185735112479194,0.20247300601385,6.10086632131867,1.3405,2.22128304295053,4.9105,0.705370277521188,0.563741238559639,0.758170885098213,0.619272179473155,0.141629038961549,0.138898705625057,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2192,38418,1594:1561,Pancreas,PL4,SIDM00042,1298533,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.380168979054089,0.107440613815064,0.420006283108773,8.3221493642692,6.251,0.763147225326217,0.820272735787967,0.100948613590143,0.159673359845765,0.0586721073660721,0.101001252479693,5.42742571725129,0.8405,2.89472364701791,5.4105,0.290124901520229,0.177943659208161,0.311842248510416,0.234624034898689,0.112181242312068,0.0772182136117274,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2193,38418,1564:1561,Pancreas,PL4,SIDM00042,1298533,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.502298711442336,0.107440613815064,0.420006283108773,8.3221493642692,6.251,0.763147225326217,0.820272735787967,0.100127719430245,0.210968614803222,0.0711831503515041,0.139785464451718,5.21719769495201,0.7265,3.10495166931719,5.5245,0.383327867922153,0.256637543624041,0.412021938217576,0.301495966483886,0.126690324298111,0.110525971733689,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2194,38419,1053:1564,Pancreas,PL4,SIDM00042,1298533,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.906703438361959,0.105670953286101,0.362451719185826,7.81390749655602,4.3949,0.739245131131135,0.789989826613243,0.132172373946463,0.328636220025992,0.126302910684086,0.202333309341906,5.17518393602777,0.7057,2.63872356052825,3.6892,0.670276102188938,0.512947998045198,0.716286492061195,0.541148055125096,0.15732810414374,0.175138436936099,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2195,38419,1561:1564,Pancreas,PL4,SIDM00042,1298533,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.733438970954211,0.105670953286101,0.362451719185826,7.81390749655602,4.3949,0.739245131131135,0.789989826613243,0.123776042343588,0.265836215940237,0.0421803756972022,0.223655840243035,3.12652724879552,0.1706,4.6873802477605,4.2243,0.542191188259731,0.305810196485582,0.579409325495513,0.313740614805554,0.236380991774149,0.265668710689959,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2196,38419,1057:1564,Pancreas,PL4,SIDM00042,1298533,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.906858205500539,0.105670953286101,0.362451719185826,7.81390749655602,4.3949,0.739245131131135,0.789989826613243,0.119802202747663,0.328692315641443,0.14768121392586,0.181011101715584,5.56151496253147,0.9224,2.25239253402455,3.4725,0.670390513042592,0.53838745724198,0.716408756526168,0.569377840589018,0.132003055800612,0.14703091593715,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2197,38419,1011:1564,Pancreas,PL4,SIDM00042,1298533,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.609506757914302,0.105670953286101,0.362451719185826,7.81390749655602,4.3949,0.739245131131135,0.789989826613243,0.0844432985945066,0.220916772261418,0.0192956334981349,0.201621138763283,1.81588184201812,0.0688,5.9980256545379,4.3261,0.450574903179671,0.161855236077777,0.481504138004319,0.197264612529914,0.288719667101894,0.284239525474405,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2198,38419,1558:1564,Pancreas,PL4,SIDM00042,1298533,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.986351369941016,0.105670953286101,0.362451719185826,7.81390749655602,4.3949,0.739245131131135,0.789989826613243,0.131337318866303,0.357504749756416,0.252884120106538,0.104620629649878,6.76354548858633,2.1221,1.05036200796969,2.2728,0.729155447813422,0.674920178815571,0.779207547719438,0.709468878915032,0.0542352689978506,0.069738668804406,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2199,38419,1594:1564,Pancreas,PL4,SIDM00042,1298533,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.42217295024956,0.105670953286101,0.362451719185826,7.81390749655602,4.3949,0.739245131131135,0.789989826613243,0.0970977598789671,0.153017311611705,0.197075127758566,-0.0440578161468606,8.72077164256067,8.2403,-0.906864146004644,-3.8454,0.312089297967255,0.293477526679833,0.333512335768451,0.355485976944523,0.0186117712874211,-0.0219736411760712,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2200,38419,1561:1594,Pancreas,PL4,SIDM00042,1298533,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.695510765245005,0.0967699247927042,0.367462631668522,7.85931713454396,1.8142,0.805335919261529,0.792806942590156,0.0776421566673456,0.255574216150717,0.116497774021745,0.139076442128973,5.63234841519454,0.3875,2.22696871934942,1.4267,0.560119801484876,0.432150897567637,0.551405763332432,0.440590388957603,0.127968903917238,0.110815374374829,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2201,38419,1510:1594,Pancreas,PL4,SIDM00042,1298533,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.901030902209343,0.0967699247927042,0.367462631668522,7.85931713454396,1.8142,0.805335919261529,0.792806942590156,0.102478567080478,0.331095186540508,0.13073312254669,0.200362063993819,5.27495642806945,0.3025,2.58436070647451,1.5117,0.725632549913807,0.53804763805788,0.714343554759839,0.545032896414295,0.187584911855926,0.169310658345545,True,0.460000596625353,0.0739947369785051,0.724395516121771,66.6564022500615
2202,35944,1564:1053,Pancreas,SUIT-2,SIDM00371,1240219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.77655191184996,0.0707279289896904,0.896725689943733,13.7302828929806,265.4343,0.945359306055312,0.976404600791612,0.109309108314429,0.69635404893078,0.352748321418582,0.343605727512198,8.59836460735163,7.57,5.13191828562899,257.8643,0.734120576502404,0.552258488828523,0.758228859483824,0.644543685643741,0.181862087673881,0.113685173840083,True,0.424190196426818,0.0692014474387167,0.816391018500765,59.8351871830716
2203,35944,1372:1053,Pancreas,SUIT-2,SIDM00371,1240219,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.588888286818773,0.0707279289896904,0.896725689943733,13.7302828929806,265.4343,0.945359306055312,0.976404600791612,0.110475154257324,0.528071255297347,0.318616773632602,0.209454481664746,9.3601548372484,12.8356,4.37012805573222,252.5987,0.556711022171097,0.412553219713037,0.574993232602141,0.510851124475747,0.14415780245806,0.0641421081263942,True,0.424190196426818,0.0692014474387167,0.816391018500765,59.8351871830716
2204,35944,1558:1053,Pancreas,SUIT-2,SIDM00371,1240219,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.942100073757064,0.0707279289896904,0.896725689943733,13.7302828929806,265.4343,0.945359306055312,0.976404600791612,0.0294652726834468,0.844805338635845,0.734650124034321,0.110155214601523,11.7674515674374,68.0904,1.96283132554321,197.3439,0.890623071961636,0.880405649067848,0.919870846422514,0.891421030141928,0.010217422893788,0.0284498162805858,True,0.424190196426818,0.0692014474387167,0.816391018500765,59.8351871830716
2205,35944,1594:1053,Pancreas,SUIT-2,SIDM00371,1240219,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.655577840994508,0.0707279289896904,0.896725689943733,13.7302828929806,265.4343,0.945359306055312,0.976404600791612,0.0790497598231048,0.587873491777623,0.40907184974471,0.178801642032913,10.1085187733595,21.5624,3.62176411962111,243.8719,0.619756612827808,0.540227553505712,0.640109220124069,0.588803527568587,0.0795290593220954,0.0513056925554821,True,0.424190196426818,0.0692014474387167,0.816391018500765,59.8351871830716
2206,35944,1561:1054,Pancreas,SUIT-2,SIDM00371,1240219,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,0.90140965146319,0.0971666873862165,0.778950678209214,11.7566348355872,54.0654,0.885676523334683,0.94597082698413,0.123835377794645,0.702153659351583,0.535066411884339,0.167087247467244,9.82907309775813,14.2123,1.92756173782902,39.8531,0.798357366208246,0.68994351546226,0.85270723344611,0.799910030057109,0.108413850745987,0.052797203389001,True,0.424190196426818,0.0692014474387167,0.816391018500765,59.8351871830716
2207,38077,1561:1079,Pancreas,SUIT-2,SIDM00371,1240219,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.899780012950623,0.0569400947772104,0.862540972553397,13.0194264666962,32.4338,0.962342055482922,0.96799835013588,0.0780204764354099,0.776097127454539,0.470019438721719,0.306077688732819,9.19597693870148,2.291,3.82344952799467,30.1428,0.865896147145353,0.710395227391067,0.870985568021444,0.773760712215342,0.155500919754287,0.0972248558061021,True,0.25422191395617,0.0468775435389465,1.26936020626965,38.5142066827039
2208,38077,1510:1079,Pancreas,SUIT-2,SIDM00371,1240219,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,2.5,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.886190847219646,0.0569400947772104,0.862540972553397,13.0194264666962,32.4338,0.962342055482922,0.96799835013588,0.104729801835882,0.764375915228752,0.381040096708394,0.383335818520358,8.38292868393185,1.304,4.6364977827643,31.1298,0.852818721463506,0.636519036336885,0.857831278014135,0.725139950558281,0.216299685126621,0.132691327455854,True,0.25422191395617,0.0468775435389465,1.26936020626965,38.5142066827039
2209,38077,1053:1079,Pancreas,SUIT-2,SIDM00371,1240219,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.902742732646605,0.0569400947772104,0.862540972553397,13.0194264666962,32.4338,0.962342055482922,0.96799835013588,0.128241910734126,0.778652594582513,0.372404523157379,0.406248071425134,8.22626682593588,1.1698,4.79315964076027,31.264,0.868747296907404,0.629791342690418,0.873853475799069,0.730697229795451,0.238955954216986,0.143156246003618,True,0.25422191395617,0.0468775435389465,1.26936020626965,38.5142066827039
2210,38077,1564:1079,Pancreas,SUIT-2,SIDM00371,1240219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.605693662667245,0.0569400947772104,0.862540972553397,13.0194264666962,32.4338,0.962342055482922,0.96799835013588,0.133497946322957,0.522435600866435,0.279566772953135,0.2428688279133,8.66286147003985,1.5832,4.35656499665631,30.8506,0.582884484324176,0.405829925352058,0.586310466149651,0.504800455283044,0.177054558972118,0.081510010866607,True,0.25422191395617,0.0468775435389465,1.26936020626965,38.5142066827039
2211,38077,1372:1079,Pancreas,SUIT-2,SIDM00371,1240219,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.438655876941472,0.0569400947772104,0.862540972553397,13.0194264666962,32.4338,0.962342055482922,0.96799835013588,0.062709765514692,0.37835866671336,0.246981275511585,0.131377391201775,9.55483086322177,2.938,3.46459560347438,29.4958,0.42213699826552,0.332390706306871,0.424618165156752,0.384280881066542,0.0897462919586486,0.0403372840902103,True,0.25422191395617,0.0468775435389465,1.26936020626965,38.5142066827039
2212,38077,1510:1080,Pancreas,SUIT-2,SIDM00371,1240219,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.761534913210477,0.0740105730286569,0.70678980447993,10.9255961028356,0.3799,0.894795915016577,0.924991093813352,0.0410947806118604,0.538245112412673,0.27166843122434,0.266576681188334,7.70972946384155,0.0409,3.215866638994,0.339,0.681418329483239,0.573596463118391,0.704413012347616,0.592828921855583,0.107821866364847,0.111584090492032,True,0.25422191395617,0.0468775435389465,1.26936020626965,38.5142066827039
2213,38077,1011:1080,Pancreas,SUIT-2,SIDM00371,1240219,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.950011342685869,0.0740105730286569,0.70678980447993,10.9255961028356,0.3799,0.894795915016577,0.924991093813352,0.079880880400961,0.671458331150661,0.479067864951797,0.192390466198864,9.03743364689279,0.1026,1.88816245594276,0.2773,0.850066268654729,0.843113504377689,0.878752031006094,0.809773302548704,0.0069527642770405,0.0689787284573893,True,0.25422191395617,0.0468775435389465,1.26936020626965,38.5142066827039
2214,38077,1561:1080,Pancreas,SUIT-2,SIDM00371,1240219,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.87018622386146,0.0740105730286569,0.70678980447993,10.9255961028356,0.3799,0.894795915016577,0.924991093813352,0.0514917424898353,0.615038751024169,0.407123317433147,0.207915433591022,8.71822911755534,0.0823,2.20736698528021,0.2976,0.778639078414935,0.681213036004451,0.804914507030922,0.727757443704171,0.097426042410484,0.0771570633267512,True,0.25422191395617,0.0468775435389465,1.26936020626965,38.5142066827039
2215,35947,1558:1083,Pancreas,SUIT-2,SIDM00371,1240219,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.95345028394039,0.0944521401708753,0.761082937393934,11.5357296639484,46.3896,0.89435196871662,0.940960338199184,0.0545755880880296,0.725654742760432,0.521918970968388,0.203735771792044,9.41620464993003,10.6753,2.11952501401838,35.7143,0.852720138515508,0.832060659222103,0.897158901632657,0.82949249410949,0.0206594792934051,0.0676664075231674,True,0.424190196426818,0.0692014474387167,0.816391018500765,59.8351871830716
2216,37958,1564:1168,Pancreas,SUIT-2,SIDM00371,1240219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.550708917039812,0.0659368164056466,0.672113864161134,10.570868426098,29.7083,0.902858492391703,0.914146225135205,0.0415570315106679,0.370139098259621,0.293114672105196,0.0770244261544256,9.28271518505731,12.1648,1.28815324104069,17.5435,0.497212222585232,0.454554156785857,0.503428477660241,0.475792935980164,0.0426580657993752,0.0276355416800764,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2217,37958,1080:1168,Pancreas,SUIT-2,SIDM00371,1240219,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.967609271081451,0.0659368164056466,0.672113864161134,10.570868426098,29.7083,0.902858492391703,0.914146225135205,0.101966197336577,0.650343606184692,0.619913333050226,0.0304302731344664,10.2655414381261,24.0417,0.305326987971942,5.6666,0.873614247712833,0.896670373981713,0.884536362564936,0.874547669388117,-0.0230561262688802,0.0099886931768188,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2218,37960,1594:1510,Pancreas,SUIT-2,SIDM00371,1240219,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.638742875282002,0.0656224248541906,0.835545150836799,12.5574016360082,117.7293,0.94013660362033,0.961123914165742,0.0796901364758912,0.533698512073431,0.205971599674151,0.32772691239928,7.37505275988869,3.2422,5.18234887611955,114.4871,0.600505557354305,0.424894292156418,0.613911052436518,0.48354220620259,0.175611265197887,0.130368846233928,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2219,37960,1564:1510,Pancreas,SUIT-2,SIDM00371,1240219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.51314285332889,0.0656224248541906,0.835545150836799,12.5574016360082,117.7293,0.94013660362033,0.961123914165742,0.0827026851232565,0.428754022785513,0.296501477195901,0.132252545589612,9.68679153202466,16.097,2.87061010398358,101.6323,0.482424379300668,0.399448636637201,0.49319386771764,0.452390891793069,0.0829757426634666,0.0408029759245712,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2220,37961,1510:1558,Pancreas,SUIT-2,SIDM00371,1240219,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.79528568799247,0.065484857567791,0.801256860743659,12.0512300140997,82.8918,0.936869751455779,0.952069131540499,0.046325786525797,0.637228113755208,0.418151689343907,0.219076424411301,9.22595569868773,11.6955,2.82527431541193,71.1963,0.745079104845843,0.672721044043957,0.757166954293579,0.685013849635351,0.0723580608018857,0.0721531046582278,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2221,37961,1080:1558,Pancreas,SUIT-2,SIDM00371,1240219,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.994968554647889,0.065484857567791,0.801256860743659,12.0512300140997,82.8918,0.936869751455779,0.952069131540499,0.0496755619548473,0.797225380635823,0.70446228269102,0.0927630979448031,10.9386532064791,38.3348,1.11257680762054,44.557,0.932155942499283,0.926398756169342,0.947278847733721,0.92071162409918,0.005757186329941,0.0265672236345414,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2222,37961,1564:1558,Pancreas,SUIT-2,SIDM00371,1240219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.78696664356754,0.065484857567791,0.801256860743659,12.0512300140997,82.8918,0.936869751455779,0.952069131540499,0.0837732415338334,0.630562422334901,0.241807485716155,0.388754936618746,7.22083580792521,2.9135,4.83039420617445,79.9783,0.737285243763109,0.523379403336623,0.749246648892689,0.587703190492022,0.213905840426486,0.161543458400667,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2223,37961,1372:1561,Pancreas,SUIT-2,SIDM00371,1240219,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.448299157208695,0.0862128822586796,0.72625074270117,11.1353465362544,43.9343,0.87110291374507,0.930850019109827,0.0898623162018754,0.325577595875123,0.184814756738883,0.140762839136241,8.22384646049922,5.8392,2.91150007575514,38.0951,0.390514702073954,0.291042241596636,0.417299279054633,0.362799731136487,0.0994724604773175,0.0544995479181461,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2224,37961,1594:1561,Pancreas,SUIT-2,SIDM00371,1240219,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.666096845385236,0.0862128822586796,0.72625074270117,11.1353465362544,43.9343,0.87110291374507,0.930850019109827,0.152756324889215,0.483753328671934,0.192613670008463,0.291139658663471,7.03153790472483,2.5553,4.10380863152953,41.379,0.580238902851478,0.388888185133583,0.620036261255842,0.488889123694613,0.191350717717896,0.131147137561229,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2225,37961,1564:1561,Pancreas,SUIT-2,SIDM00371,1240219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.541902910204686,0.0862128822586796,0.72625074270117,11.1353465362544,43.9343,0.87110291374507,0.930850019109827,0.0998523229514183,0.393557391008079,0.226457689528345,0.167099701479734,8.27465018443799,6.0485,2.86069635181637,37.8858,0.472053204046235,0.35826029458866,0.504430334319703,0.440122118688571,0.113792909457575,0.0643082156311319,True,0.226934173653881,0.0382289244364478,1.33674838290432,36.3780405043498
2226,38227,1510:1564,Pancreas,SUIT-2,SIDM00371,1240219,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.897237982732244,0.0717053328517269,0.602781428496435,9.9127809570988,18.8267,0.892244747850788,0.890704580753406,0.11248714748074,0.540838392932602,0.285093491792349,0.255744901140253,7.32760437685302,3.1373,2.58517658024578,15.6894,0.800555877665081,0.623751912726749,0.799173981245555,0.676425830127152,0.176803964938332,0.122748151118403,True,0.525132045984711,0.071803460598143,0.606304264252823,79.6806170205275
2227,38227,1053:1564,Pancreas,SUIT-2,SIDM00371,1240219,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.934228043804635,0.0717053328517269,0.602781428496435,9.9127809570988,18.8267,0.892244747850788,0.890704580753406,0.0964802123509769,0.563135314785988,0.391931059688628,0.171204255097361,8.28931155998798,6.1103,1.62346939711082,12.7164,0.833560065379601,0.737608025940387,0.832121198085082,0.759537087217365,0.0959520394392139,0.0725841108677171,True,0.525132045984711,0.071803460598143,0.606304264252823,79.6806170205275
2228,38227,1558:1564,Pancreas,SUIT-2,SIDM00371,1240219,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.962684564143345,0.0717053328517269,0.602781428496435,9.9127809570988,18.8267,0.892244747850788,0.890704580753406,0.128219193137265,0.580288376765794,0.499670821398119,0.0806175553676747,9.16675297942503,11.2253,0.746027977673764,7.6014,0.858950246193925,0.777310971700675,0.857467551103074,0.826533293412038,0.0816392744932501,0.030934257691036,True,0.525132045984711,0.071803460598143,0.606304264252823,79.6806170205275
2229,38227,1053:1594,Pancreas,SUIT-2,SIDM00371,1240219,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.934228043804635,0.0903681058020536,0.73030082321416,11.1801390395455,18.1279,0.899319686334323,0.93204986820086,0.0346663391871167,0.682267509460279,0.540838509288837,0.141429000171442,9.69666539955174,6.483,1.4834736399938,11.6449,0.840169671319112,0.825930660443688,0.870747125097658,0.824005019340189,0.0142390108754238,0.0467421057574692,True,0.525132045984711,0.071803460598143,0.606304264252823,79.6806170205275
2230,38227,1564:1594,Pancreas,SUIT-2,SIDM00371,1240219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.705415875772236,0.0903681058020536,0.73030082321416,11.1801390395455,18.1279,0.899319686334323,0.93204986820086,0.070548923427507,0.515165794784801,0.274775109872634,0.240390684912167,8.01663055006853,2.0232,3.163508489477,16.1047,0.634394384134738,0.526731144200352,0.657482774040307,0.562344465212807,0.107663239934387,0.0951383088274995,True,0.525132045984711,0.071803460598143,0.606304264252823,79.6806170205275
2231,38227,1561:1594,Pancreas,SUIT-2,SIDM00371,1240219,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.954159155238075,0.0903681058020536,0.73030082321416,11.1801390395455,18.1279,0.899319686334323,0.93204986820086,0.0603575898086898,0.696823216547693,0.334873651071582,0.361949565476111,7.65444068899014,1.574,3.5256983505554,16.5539,0.858094112201728,0.699606014728665,0.889323914882292,0.739469588468148,0.158488097473062,0.149854326414144,True,0.525132045984711,0.071803460598143,0.606304264252823,79.6806170205275
2232,38227,1510:1594,Pancreas,SUIT-2,SIDM00371,1240219,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.897237982732244,0.0903681058020536,0.73030082321416,11.1801390395455,18.1279,0.899319686334323,0.93204986820086,0.0766246886213266,0.65525363740837,0.373635684981297,0.281617952427073,8.26146562463935,2.3974,2.91867341490618,15.7305,0.806903781198002,0.704795818773564,0.836270543550394,0.728045181343234,0.102107962424438,0.10822536220716,True,0.525132045984711,0.071803460598143,0.606304264252823,79.6806170205275
2233,34817,1080:1011,Pancreas,YAPC,SIDM00411,909904,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.874819091619307,0.173552914148548,0.620477122505218,10.7426614465886,33.4652,0.874376280920454,0.843490465338752,0.150930590435762,0.542805232680576,0.327021017521364,0.215784215159213,7.1711635368742,2.8149,3.57149790971439,30.6503,0.7649210638083,0.600622236326562,0.737901562677194,0.599146476932571,0.164298827481737,0.138755085744623,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2234,34817,1564:1011,Pancreas,YAPC,SIDM00411,909904,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.800778279709989,0.173552914148548,0.620477122505218,10.7426614465886,33.4652,0.874376280920454,0.843490465338752,0.140936301472055,0.496864602759133,0.272097765977265,0.224766836781868,6.64528651579622,1.9551,4.09737493079237,31.5101,0.7001815340547,0.559259348324287,0.675448843785744,0.525434990894512,0.140922185730413,0.150013852891233,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2235,34817,1558:1011,Pancreas,YAPC,SIDM00411,909904,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.702677185611596,0.173552914148548,0.620477122505218,10.7426614465886,33.4652,0.874376280920454,0.843490465338752,0.152435891464138,0.435995118178348,0.282020011407601,0.153975106770748,7.58254050869222,3.7437,3.16012093789637,29.7215,0.614404264242719,0.524371071065655,0.59270150627445,0.496466222305197,0.0900331931770648,0.0962352839692533,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2236,34819,1564:1053,Pancreas,YAPC,SIDM00411,909904,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.868663457798773,0.101908412375341,0.635280745803085,10.9672954815359,39.1034,0.805018129294409,0.851083238260269,0.0803189597922527,0.551845169322291,0.368064876935282,0.183780292387009,7.9097317219487,4.6967,3.05756375958719,34.4067,0.699289831783581,0.57042875523025,0.739304908621742,0.628216123330756,0.128861076553331,0.111088785290987,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2237,34819,1372:1053,Pancreas,YAPC,SIDM00411,909904,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.848697929283356,0.101908412375341,0.635280745803085,10.9672954815359,39.1034,0.805018129294409,0.851083238260269,0.0457713564133366,0.539161453476664,0.347484115165395,0.191677338311269,7.70139352370768,4.0652,3.2659019578282,35.0382,0.683217219367726,0.569579684446976,0.722312581959263,0.604822493250508,0.113637534920749,0.117490088708755,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2238,34819,1558:1053,Pancreas,YAPC,SIDM00411,909904,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.876939113978512,0.101908412375341,0.635280745803085,10.9672954815359,39.1034,0.805018129294409,0.851083238260269,0.0660654926613621,0.557102534352166,0.576895846533822,-0.0197933121816564,11.3175334853007,49.8479,-0.350238003764833,-10.7445,0.705951885040078,0.705825319341581,0.746348180881923,0.75623337762916,0.0001265656984972,-0.009885196747237,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2239,34821,1372:1079,Pancreas,YAPC,SIDM00411,909904,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.892074495910115,0.0811651471590103,0.638886214431699,11.0225777151559,8.1262,0.834008575485133,0.852908114012048,0.0760697874861598,0.56993409768308,0.446170349705109,0.123763747977971,9.00211576238893,2.0029,2.02046195276701,6.1233,0.743997779560613,0.643420797360744,0.760857575864944,0.691248167953101,0.100576982199869,0.0696094079118434,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2240,34821,1011:1080,Pancreas,YAPC,SIDM00411,909904,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.924858879689777,0.0839892202572684,0.814740253325887,14.2506334422879,3.8071,0.905202541249868,0.932135238067918,0.0931073561902169,0.753519757929145,0.446489359943333,0.307030397985812,8.75550422485126,0.0844,5.49512921743661,3.7227,0.837184608192692,0.708081775563149,0.862093551998859,0.706377352012481,0.129102832629542,0.155716199986378,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2241,34822,1011:1083,Pancreas,YAPC,SIDM00411,909904,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.973868357463014,0.0907643686871727,0.648652472484703,11.1735549054242,36.0907,0.853811028338152,0.857804546531478,0.0553620976679542,0.631702117943001,0.545483448889301,0.0862186690536997,9.85666629452089,14.4868,1.31688861090336,21.6039,0.831499543751483,0.798807265463248,0.835388704754916,0.789545824838526,0.0326922782882348,0.0458428799163899,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2242,34822,1558:1083,Pancreas,YAPC,SIDM00411,909904,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.796726484031142,0.0907643686871727,0.648652472484703,11.1735549054242,36.0907,0.853811028338152,0.857804546531478,0.1182398930679,0.516798603760845,0.325262563666593,0.191536040094252,7.68403687917011,3.2133,3.48951802625414,32.8774,0.680253858634869,0.596261078699224,0.683435600343953,0.567077328885657,0.0839927799356457,0.116358271458296,True,0.481711914238674,0.0535966179242956,0.701861854839167,69.7296936504019
2243,34871,1510:1168,Pancreas,YAPC,SIDM00411,909904,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.717002868006612,0.0626850102799574,0.771974488757258,13.3231858921013,200.1744,0.924844363998201,0.914434594919748,0.039538515552293,0.553507922466892,0.339146119341655,0.214361803125237,8.61683477702868,7.6675,4.70635111507262,192.5069,0.663116061446461,0.522517308557304,0.655652227161924,0.543039897155157,0.140598752889157,0.112612330006767,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2244,34872,1053:1372,Pancreas,YAPC,SIDM00411,909904,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.790103401707958,0.0874809385111934,0.864855803248615,15.5804228385698,95.6984,0.916111537003101,0.951812269537518,0.0432194832861475,0.683325512133599,0.523791689940312,0.159533822193287,11.3979764882543,5.2706,4.18244635031549,90.4278,0.723822841730056,0.66494467753516,0.752030111948965,0.683319683480742,0.0588781641948961,0.0687104284682228,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2245,34872,1561:1372,Pancreas,YAPC,SIDM00411,909904,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.700641131401582,0.0874809385111934,0.864855803248615,15.5804228385698,95.6984,0.916111537003101,0.951812269537518,0.0409743124481061,0.605953548487333,0.279654424160402,0.326299124326931,7.54990300841347,0.366,8.03051983015628,95.3324,0.641865423775895,0.456492203549191,0.666878825410674,0.49384356516213,0.185373220226704,0.173035260248543,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2246,34872,1011:1372,Pancreas,YAPC,SIDM00411,909904,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.933560196807334,0.0874809385111934,0.864855803248615,15.5804228385698,95.6984,0.916111537003101,0.951812269537518,0.0357743752425018,0.807394953890742,0.822406820034478,-0.0150118661437361,16.0948249669815,136.6958,-0.514402128411746,-40.9974,0.855245266782084,0.91168053283083,0.88857404967308,0.894258514668027,-0.0564352660487454,-0.0056844649949469,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2247,34873,1168:1510,Pancreas,YAPC,SIDM00411,909904,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.874621764290702,0.0954991780124467,0.688141546963134,11.8057247627313,69.9209,0.845006313750922,0.876940864831486,0.0578472470854358,0.60186357388663,0.426945808479735,0.174917765406895,8.83191935909783,8.9003,2.97380540363347,61.0206,0.739060912969614,0.636740953068802,0.766991566377529,0.671049931672528,0.102319959900812,0.0959416347050007,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2248,34873,1594:1510,Pancreas,YAPC,SIDM00411,909904,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.669444366438927,0.0954991780124467,0.688141546963134,11.8057247627313,69.9209,0.845006313750922,0.876940864831486,0.0687513599840537,0.460672481927039,0.389429334613944,0.0712431473130949,10.1693012938498,22.4903,1.63642346888155,47.4306,0.565684716345879,0.491902404297014,0.587063121661519,0.550822695781527,0.0737823120488657,0.0362404258799921,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2249,34873,1558:1510,Pancreas,YAPC,SIDM00411,909904,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.814038156751017,0.0954991780124467,0.688141546963134,11.8057247627313,69.9209,0.845006313750922,0.876940864831486,0.0741867241238968,0.560173476473664,0.321521858787345,0.238651617686319,7.4881642646352,3.5066,4.3175604980961,66.4143,0.687867382088773,0.518490710638612,0.713863325187066,0.571157491849699,0.169376671450161,0.142705833337367,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2250,34874,1083:1558,Pancreas,YAPC,SIDM00411,909904,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.914518566480768,0.0506148720249126,0.846460370732415,15.0517976571025,663.3957,0.952785705123115,0.944715845912998,0.0369914933677355,0.774103724824987,0.75686447464734,0.0172392501776476,14.5614306994755,472.2342,0.490366957626982,191.1615,0.871340217212558,0.850550623362185,0.863960181136021,0.857172201530763,0.0207895938503728,0.0067879796052575,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2251,34874,1564:1561,Pancreas,YAPC,SIDM00411,909904,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.81275233493577,0.0852419726996426,0.558700542776515,9.83624525940847,17.854,0.764282715061481,0.809923339970299,0.0891343801129848,0.454085170671495,0.282354566562037,0.171730604109458,6.76496525673193,2.1242,3.07128000267654,15.7298,0.621172561217269,0.48518434539335,0.658267085679838,0.538682949023781,0.135988215823918,0.119584136656057,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2252,34875,1510:1564,Pancreas,YAPC,SIDM00411,909904,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.650722723822014,0.0580235380594744,0.724517227031183,12.4280088652787,107.63,0.883747117162709,0.893698720636472,0.0662065369670403,0.471459823429703,0.329976994769718,0.141482828659985,9.10058857525071,10.7221,3.32742029002801,96.9079,0.57507433124997,0.478744463585873,0.581550065768814,0.507055610595661,0.096329867664097,0.0744944551731529,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2253,34875,1053:1564,Pancreas,YAPC,SIDM00411,909904,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.773393748169022,0.0580235380594744,0.724517227031183,12.4280088652787,107.63,0.883747117162709,0.893698720636472,0.074021476482671,0.560337093826673,0.428397558320098,0.131939535506575,9.76757140315383,17.024,2.6604374621249,90.606,0.683484495376035,0.611292301095097,0.691181003286901,0.624273972721068,0.0721921942809381,0.0669070305658332,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2254,34875,1561:1564,Pancreas,YAPC,SIDM00411,909904,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.734199222592477,0.0580235380594744,0.724517227031183,12.4280088652787,107.63,0.883747117162709,0.893698720636472,0.117846402595554,0.531939984841152,0.2016152766757,0.330324708165452,5.55639718325507,0.9191,6.87161168202366,106.7109,0.648846446389204,0.37437946366154,0.656152905923189,0.435839977940718,0.274466982727663,0.220312927982471,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2255,34875,1168:1564,Pancreas,YAPC,SIDM00411,909904,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.716539605929511,0.0580235380594744,0.724517227031183,12.4280088652787,107.63,0.883747117162709,0.893698720636472,0.0609947127456866,0.519145288346066,0.37795569659376,0.141189591752306,9.38997504385392,13.1037,3.03803382142481,94.5263,0.633239811073109,0.52649031719031,0.640370529104566,0.567258767396431,0.106749493882798,0.073111761708135,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2256,34875,1011:1564,Pancreas,YAPC,SIDM00411,909904,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.899174176734739,0.0580235380594744,0.724517227031183,12.4280088652787,107.63,0.883747117162709,0.893698720636472,0.129936797986187,0.6514671811459,0.32943609287121,0.32203108827469,7.05803315815126,2.6026,5.36997570712747,105.0274,0.794642586516478,0.635160800798865,0.80359081137719,0.61035540544651,0.159481785717612,0.193235405930679,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2257,34875,1558:1564,Pancreas,YAPC,SIDM00411,909904,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.940306348436591,0.0580235380594744,0.724517227031183,12.4280088652787,107.63,0.883747117162709,0.893698720636472,0.0833020805490627,0.681268148129096,0.479162639180789,0.202105508948307,9.13588359797724,10.9877,3.29212526730149,96.6423,0.83099302468063,0.686178268299784,0.840350580604134,0.734155691644626,0.144814756380846,0.106194888959508,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2258,34875,1079:1564,Pancreas,YAPC,SIDM00411,909904,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.723862105821657,0.0580235380594744,0.724517227031183,12.4280088652787,107.63,0.883747117162709,0.893698720636472,0.0785575946495088,0.52445056566286,0.333195244588333,0.191255321074527,8.43588601171357,6.7637,3.99212285356516,100.8663,0.639711049243217,0.491404277322482,0.646914637890038,0.542083835840405,0.148306771920735,0.104830802049633,True,0.360438605834855,0.0411792027929915,0.9861399348987,49.9747279774248
2259,36537,1510:1564,Pancreas,MZ1-PC,SIDM00053,753595,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.900972229260718,0.123790361145393,0.441300413074375,8.16658862600865,5.612,0.675478953184784,0.736429221238494,0.127714603941378,0.397599416941295,0.224143934281453,0.173455482659842,5.09545714329425,0.6678,3.0711314827144,4.9442,0.608587778269591,0.453019705861148,0.663502277151981,0.510307591755549,0.155568072408443,0.153194685396431,True,0.368817600545324,0.0559328613134607,0.962336596572033,51.1635766872659
2260,36537,1011:1564,Pancreas,MZ1-PC,SIDM00053,753595,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.992256262856751,0.123790361145393,0.441300413074375,8.16658862600865,5.612,0.675478953184784,0.736429221238494,0.0951066925778063,0.43788309867432,0.135343831605334,0.302539267068986,2.47958471864079,0.1089,5.68700390736786,5.5031,0.670248221725524,0.377533444213533,0.730726506924616,0.405111681838287,0.292714777511991,0.325614825086329,True,0.368817600545324,0.0559328613134607,0.962336596572033,51.1635766872659
2261,35914,1080:1011,Pancreas,DAN-G,SIDM00950,1290797,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.39891551117268,0.155799437645964,0.511811582852332,9.10297023833565,10.7398,0.864299142823575,0.8561507192315,0.0543539662930642,0.204169579197636,0.0144005820407245,0.189768997156912,1.84251609502154,0.07,7.26045414331411,10.6698,0.344782334365576,0.0968302737749789,0.341531801803091,0.131062619126263,0.247952060590597,0.210469182676828,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2262,35914,1372:1011,Pancreas,DAN-G,SIDM00950,1290797,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.663554756632884,0.155799437645964,0.511811582852332,9.10297023833565,10.7398,0.864299142823575,0.8561507192315,0.0475818085745741,0.33961501030147,0.122411220127036,0.217203790174434,5.76131382610897,1.0594,3.34165641222668,9.6804,0.573509807374308,0.429835979064055,0.568102882140727,0.425517482697301,0.143673828310253,0.142585399443426,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2263,35914,1083:1011,Pancreas,DAN-G,SIDM00950,1290797,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.938703893209529,0.155799437645964,0.511811582852332,9.10297023833565,10.7398,0.864299142823575,0.8561507192315,0.14935949667412,0.480439525413215,0.156835044062166,0.323604481351049,5.49940792741528,0.8835,3.60356231092037,9.8563,0.811320970266149,0.548212956723392,0.803672013316747,0.582815708569812,0.263108013542757,0.220856304746936,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2264,35914,1053:1011,Pancreas,DAN-G,SIDM00950,1290797,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.792212849329928,0.155799437645964,0.511811582852332,9.10297023833565,10.7398,0.864299142823575,0.8561507192315,0.0805275565281822,0.405463712371506,0.236924345259466,0.16853936711204,7.14401954355294,2.7624,1.95895069478271,7.9774,0.684708886609679,0.583508520540095,0.678253600738254,0.587901408404816,0.101200366069584,0.0903521923334374,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2265,35914,1564:1011,Pancreas,DAN-G,SIDM00950,1290797,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.670978725006999,0.155799437645964,0.511811582852332,9.10297023833565,10.7398,0.864299142823575,0.8561507192315,0.0916614236344396,0.343414683306072,0.0839984136323194,0.259416269673753,4.76354813297694,0.5305,4.33942210535871,10.2093,0.579926336876405,0.373467877442922,0.574458918003777,0.377196512298785,0.206458459433483,0.197262405704992,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2266,35914,1561:1011,Pancreas,DAN-G,SIDM00950,1290797,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.633102070826441,0.155799437645964,0.511811582852332,9.10297023833565,10.7398,0.864299142823575,0.8561507192315,0.0776795135557299,0.32402897297677,0.117363143024533,0.206665829952237,5.77432427535017,1.069,3.32864596298548,9.6708,0.547189577135124,0.402743900300749,0.54203079328501,0.406625164241243,0.144445676834374,0.135405629043767,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2267,35914,1558:1011,Pancreas,DAN-G,SIDM00950,1290797,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.296284554202753,0.155799437645964,0.511811582852332,9.10297023833565,10.7398,0.864299142823575,0.8561507192315,0.05962053434686,0.151641866661208,0.0275405988434654,0.124101267817743,4.03596089554448,0.3204,5.06700934279117,10.4194,0.256078486229304,0.115674539906732,0.253664234177871,0.14901260459278,0.140403946322573,0.104651629585091,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2268,35916,1564:1053,Pancreas,DAN-G,SIDM00950,1290797,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.7815632379095,0.0813316381417458,0.573864222702327,9.64855457853905,15.676,0.870500078219679,0.880622922997739,0.0758294117721034,0.44851118001565,0.198520111807225,0.249991068208424,6.65237893731275,1.9647,2.9961756412263,13.7113,0.680350859733846,0.563884907610736,0.688262503075442,0.553184463609099,0.11646595212311,0.135078039466342,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2269,35916,1507:1053,Pancreas,DAN-G,SIDM00950,1290797,1507,Ruxolitinib,"JAK1, JAK2","Other, kinases",Targeted,Advanced clinical trials,10.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.924734534622661,0.0813316381417458,0.573864222702327,9.64855457853905,15.676,0.870500078219679,0.880622922997739,0.0826930514754088,0.530672064917232,0.328016024406965,0.202656040510267,7.69610658954234,4.0503,1.95244798899671,11.6257,0.804981484721465,0.680914006740829,0.814342428876362,0.719579364828142,0.124067477980635,0.0947630640482199,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2270,35916,1372:1053,Pancreas,DAN-G,SIDM00950,1290797,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.705813891032078,0.0813316381417458,0.573864222702327,9.64855457853905,15.676,0.870500078219679,0.880622922997739,0.0574140008959441,0.405041339949629,0.109269472024104,0.295771867925525,5.30145583093987,0.7702,4.34709874759918,14.9058,0.614411047351961,0.40579420692057,0.621555891813077,0.427200261333512,0.20861684043139,0.194355630479565,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2271,35916,1011:1053,Pancreas,DAN-G,SIDM00950,1290797,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.832077084045519,0.0813316381417458,0.573864222702327,9.64855457853905,15.676,0.870500078219679,0.880622922997739,0.0497567273213698,0.477499269064201,0.183999552715918,0.293499716348283,6.25643588517934,1.4932,3.39211869335971,14.1828,0.724323166746427,0.556889446857675,0.7327461539116,0.564854364644098,0.167433719888752,0.167891789267502,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2272,35916,1558:1053,Pancreas,DAN-G,SIDM00950,1290797,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.882586733409951,0.0813316381417458,0.573864222702327,9.64855457853905,15.676,0.870500078219679,0.880622922997739,0.130027865308094,0.506484949735688,0.364914247770807,0.141570701964881,8.23803663029999,5.8969,1.41051794823907,9.7791,0.768291820469013,0.708925064294384,0.777226108974497,0.71548476658786,0.0593667561746291,0.0617413423866374,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2273,35916,1594:1053,Pancreas,DAN-G,SIDM00950,1290797,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.274546752583559,0.0813316381417458,0.573864222702327,9.64855457853905,15.676,0.870500078219679,0.880622922997739,0.0176699875580958,0.157552558766812,0.124064143660294,0.0334884151065183,8.5793412447523,7.4708,1.06921333378675,8.2052,0.238992969598947,0.222965717543805,0.241772163759671,0.227759589666113,0.0160272520551422,0.0140125740935577,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2274,35916,1168:1054,Pancreas,DAN-G,SIDM00950,1290797,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,0.905084373117423,0.0723894277114238,0.814956000424547,12.2304973105377,75.0873,0.935221076688014,0.955914631859997,0.0319377604865427,0.737603940762534,0.39546529881477,0.342138641947764,8.44739741963472,5.4543,3.78309989090302,69.633,0.846453981920373,0.724754798139202,0.865183395330777,0.744358382901813,0.121699183781171,0.120825012428964,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2275,35916,1079:1054,Pancreas,DAN-G,SIDM00950,1290797,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,0.793488333053287,0.0723894277114238,0.814956000424547,12.2304973105377,75.0873,0.935221076688014,0.955914631859997,0.0990262296248483,0.646658078288648,0.481291568444345,0.165366509844303,9.94316965581897,15.382,2.28732765471877,59.7053,0.742087013177473,0.631258838862919,0.758507107775836,0.70817849439129,0.110828174314554,0.050328613384546,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2276,35918,1510:1079,Pancreas,DAN-G,SIDM00950,1290797,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.673544179052433,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.0580312318148035,0.47668622643166,0.159618358423075,0.317067868008586,6.45207725654544,0.342,4.47500296369918,7.2637,0.576819780252665,0.451803946268464,0.623422060382469,0.466958206470968,0.125015833984202,0.156463853911501,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2277,35918,1053:1079,Pancreas,DAN-G,SIDM00950,1290797,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.82425114695219,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.127791238125814,0.583345801347978,0.296076266396012,0.287269534951966,7.73875598370783,0.8344,3.1883242365368,6.7713,0.705884454568135,0.557681983125258,0.762914095744186,0.643585868584984,0.148202471442877,0.119328227159202,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2278,35918,1083:1079,Pancreas,DAN-G,SIDM00950,1290797,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.954952753552995,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.129033673686035,0.67584701741779,0.150119391936649,0.525727625481141,5.34096667577475,0.1583,5.58611354446988,7.4474,0.817816640077051,0.535122101714628,0.883889478527548,0.580981687092127,0.282694538362423,0.302907791435421,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2279,35918,1561:1079,Pancreas,DAN-G,SIDM00950,1290797,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.450956663456473,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.0647677357547868,0.319154759068216,0.038664935179773,0.280489823888443,3.84268065998381,0.056,7.08439956026081,7.5497,0.386196973574006,0.199348113573031,0.417398503347993,0.219684036470501,0.186848860000975,0.197714466877492,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2280,35918,1080:1079,Pancreas,DAN-G,SIDM00950,1290797,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.718372754989439,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.0807554748850893,0.508412674917607,0.222221483476598,0.286191191441009,7.24979093483038,0.5945,3.67728928541424,7.0112,0.615210742754044,0.501754925626662,0.664914695971685,0.53821904995349,0.113455817127382,0.126695646018195,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2281,35918,1085:1079,Pancreas,DAN-G,SIDM00950,1290797,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,1.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.993645098563263,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.0812661388756352,0.703230682080565,0.575483863801584,0.127746818278982,9.69585975418208,3.2397,1.23122046606254,4.366,0.850952565886225,0.831308429280916,0.919702513807974,0.876982395919932,0.0196441366053094,0.042720117888042,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2282,35918,1054:1079,Pancreas,DAN-G,SIDM00950,1290797,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.846644128563308,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.154516488986599,0.599193946480454,0.375990572551708,0.223203373928746,8.51068137698894,1.4247,2.41639884325568,6.181,0.725061689163643,0.589408924800573,0.783640692704389,0.699225430271421,0.13565276436307,0.0844152624329682,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2283,35918,1564:1079,Pancreas,DAN-G,SIDM00950,1290797,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.752647581901985,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.0585254717804254,0.532669937337313,0.14589388497193,0.386776052365383,5.89435467035384,0.2323,5.03272554989078,7.3734,0.644563528722303,0.489853549497632,0.696638944918699,0.490351374620225,0.154709979224671,0.206287570298474,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2284,35918,1057:1079,Pancreas,DAN-G,SIDM00950,1290797,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.510003681888074,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.0565246521265638,0.360944000625909,0.165736963047912,0.195207037577998,7.40709840032399,0.663,3.51998181992063,6.9427,0.436764537299681,0.365544093079412,0.47205150909716,0.387411551843181,0.0712204442202686,0.0846399572539787,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2285,35918,1168:1079,Pancreas,DAN-G,SIDM00950,1290797,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.555485652784872,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.111633222135446,0.393132875167102,0.263199901755771,0.129932973411331,8.77159842704,1.7072,2.15548179320462,5.8985,0.475715063893284,0.388923559037433,0.514148916941478,0.466434135115637,0.0867915048558512,0.0477147818258414,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2286,35918,1372:1079,Pancreas,DAN-G,SIDM00950,1290797,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.712257830420085,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.0308677364890416,0.504084970204933,0.0829731873957185,0.421111782809215,4.58514498395326,0.0938,6.34193523629136,7.5119,0.609973952717021,0.383908752721033,0.6592548164973,0.390105360198807,0.226065199995988,0.269149456298493,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2287,35918,1011:1079,Pancreas,DAN-G,SIDM00950,1290797,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.871089622602467,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.100077227692654,0.61649471259082,0.347411557885428,0.269083154705392,8.10579881506543,1.0761,2.82128140517919,6.5296,0.745996684874946,0.635732496814059,0.806267063378989,0.69949223491883,0.110264188060888,0.106774828460159,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2288,35918,1558:1079,Pancreas,DAN-G,SIDM00950,1290797,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.884778209630527,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.147493457696253,0.626182511993625,0.396572225674255,0.22961028631937,8.54702532236921,1.4611,2.38005489787541,6.1446,0.757719520595393,0.643786935358167,0.818937007525435,0.732460464854467,0.113932585237226,0.0864765426709678,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2289,35918,1594:1079,Pancreas,DAN-G,SIDM00950,1290797,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.333551532148703,0.108386607985243,0.707728225195681,10.9270802202446,7.6057,0.856394870881605,0.925584512154084,0.0729645350361679,0.236063833858902,0.119135557680784,0.116928276178118,7.71948120574357,0.8233,3.20759901450105,6.7824,0.28565182130685,0.227496652525618,0.308730132162105,0.260040182320603,0.0581551687812327,0.0486899498415013,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2290,35919,1561:1083,Pancreas,DAN-G,SIDM00950,1290797,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.46747299090297,0.0982786961838115,0.464655015541091,8.69141445567249,6.4595,0.843384153331483,0.835522332470125,0.0405093737974031,0.21721366985306,0.0713144931523584,0.145899176700701,5.26358835878723,0.6002,3.42782609688526,5.8593,0.394259312638037,0.253922242081307,0.390584123726035,0.281537920212325,0.14033707055673,0.10904620351371,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2291,35919,1011:1083,Pancreas,DAN-G,SIDM00950,1290797,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.904074316225701,0.0982786961838115,0.464655015541091,8.69141445567249,6.4595,0.843384153331483,0.835522332470125,0.106113617894687,0.420082665456154,0.133941051906456,0.286141613549699,5.18852307142661,0.5698,3.50289138424588,5.8897,0.762481951738752,0.525965837401607,0.75537428141923,0.539085639965482,0.236516114337144,0.216288641453748,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2292,35919,1558:1083,Pancreas,DAN-G,SIDM00950,1290797,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.907801029757928,0.0982786961838115,0.464655015541091,8.69141445567249,6.4595,0.843384153331483,0.835522332470125,0.0930827997779843,0.421814301590389,0.206986756049736,0.214827545540652,6.34248333457254,1.2679,2.34893112109995,5.1916,0.765625002875838,0.642430629977405,0.758488033802125,0.622051923350006,0.123194372898433,0.136436110452119,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2293,35919,1079:1083,Pancreas,DAN-G,SIDM00950,1290797,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.742347330300014,0.0982786961838115,0.464655015541091,8.69141445567249,6.4595,0.843384153331483,0.835522332470125,0.0673231492956578,0.34493541029744,0.186505407837257,0.158430002460184,6.62044971742952,1.5374,2.07096473824297,4.9221,0.626083974642963,0.528598559243625,0.620247772915237,0.523725434801609,0.0974854153993385,0.0965223381136288,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2294,35919,1558:1085,Pancreas,DAN-G,SIDM00950,1290797,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.311749604020619,0.100903563284053,0.474877281147961,8.78084301168058,8.5907,0.841443541126368,0.840162746512567,0.0285612986867775,0.148042804356265,0.0464049678558036,0.101637836500461,5.20059663629499,0.7182,3.58024637538559,7.8725,0.262319690751852,0.16923008004853,0.261920403538168,0.186191279929143,0.0930896107033227,0.075729123609025,True,0.377976297584006,0.0690941151463686,0.937047615347088,52.4912835992931
2295,36967,1080:1372,Pancreas,DAN-G,SIDM00950,1290797,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.361206025133439,0.152372482291439,0.522780604253272,9.19869586425823,1.1477,0.76171637108109,0.860681503350883,0.0595886663199874,0.188831504079182,0.02685271624986,0.161978787829322,3.50485894814731,0.0222,5.69383691611091,1.1255,0.275136542677268,0.140588105578175,0.310883344731245,0.166014596001806,0.134548437099093,0.144868748729439,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2296,36967,1011:1372,Pancreas,DAN-G,SIDM00950,1290797,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.615824197055574,0.152372482291439,0.522780604253272,9.19869586425823,1.1477,0.76171637108109,0.860681503350883,0.0421081598879006,0.321940945850499,0.029322607254489,0.29261833859601,2.47203165080791,0.0108,6.72666421345031,1.1369,0.469083372605098,0.219679866869587,0.530028495721642,0.232096624514085,0.249403505735512,0.297931871207557,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2297,36967,1594:1372,Pancreas,DAN-G,SIDM00950,1290797,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.342494245362678,0.152372482291439,0.522780604253272,9.19869586425823,1.1477,0.76171637108109,0.860681503350883,0.0386955666244308,0.179049348543969,0.0634692013557079,0.115580147188261,5.77341125824411,0.1068,3.42528460601412,1.0409,0.260883473693815,0.205473573241785,0.294778461987776,0.219951100471253,0.0554099004520301,0.0748273615165227,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2298,36967,1053:1372,Pancreas,DAN-G,SIDM00950,1290797,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.831708122558235,0.152372482291439,0.522780604253272,9.19869586425823,1.1477,0.76171637108109,0.860681503350883,0.0424103861146364,0.434800874873349,0.218350483542461,0.216450391330887,6.7493980841915,0.2101,2.44929778006672,0.9376,0.633525692913726,0.591298399998898,0.715835797272562,0.594433065611192,0.0422272929148277,0.121402731661371,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2299,36967,1561:1372,Pancreas,DAN-G,SIDM00950,1290797,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.619764880629416,0.152372482291439,0.522780604253272,9.19869586425823,1.1477,0.76171637108109,0.860681503350883,0.035739211994918,0.324001058790403,0.0549456496818183,0.269055409108585,3.92251333969238,0.0296,5.27618252456585,1.1181,0.472085055796544,0.291782735301919,0.533420169184207,0.305959739825666,0.180302320494625,0.22746042935854,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2300,36967,1558:1372,Pancreas,DAN-G,SIDM00950,1290797,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.15109946942175,0.152372482291439,0.522780604253272,9.19869586425823,1.1477,0.76171637108109,0.860681503350883,0.0557905511951433,0.0789918719266512,0.0497188657149937,0.0292730062116575,7.44744832501318,0.3409,1.75124753924504,0.8068,0.115094939520214,0.0798985605120081,0.130048518497433,0.115176760946507,0.0351963790082055,0.0148717575509258,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2301,36967,1079:1372,Pancreas,DAN-G,SIDM00950,1290797,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.717160987777226,0.152372482291439,0.522780604253272,9.19869586425823,1.1477,0.76171637108109,0.860681503350883,0.0860576502693493,0.374917854537051,0.0958754043654313,0.27904245017162,4.92796013360698,0.0595,4.27073573065124,1.0882,0.546273265090599,0.383453210298675,0.617247197104707,0.412668760887061,0.162820054791923,0.204578436217646,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2302,36089,1080:1507,Pancreas,DAN-G,SIDM00950,1290797,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1507,Ruxolitinib,"JAK1, JAK2","Other, kinases",Targeted,Advanced clinical trials,10.0,0.539877323331756,0.0948916906085672,0.893065384365807,13.6248611173585,246.73,0.923842622775101,0.975621130196036,0.0696791443524095,0.482145749271658,0.469244775084011,0.0129009741876472,13.1262804582653,174.6362,0.498580659093243,72.0938,0.498761682363611,0.483739886112561,0.526715724356138,0.523561829655801,0.0150217962510498,0.0031538947003373,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2303,36089,1564:1507,Pancreas,DAN-G,SIDM00950,1290797,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1507,Ruxolitinib,"JAK1, JAK2","Other, kinases",Targeted,Advanced clinical trials,10.0,0.661948382463971,0.0948916906085672,0.893065384365807,13.6248611173585,246.73,0.923842622775101,0.975621130196036,0.0292148977931955,0.591163186615511,0.542182134104387,0.0489810525111237,12.2904632488474,97.8426,1.33439786851109,148.8874,0.611536129797251,0.638311504331205,0.645810829030937,0.63348346277553,-0.0267753745339541,0.0123273662554078,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2304,36089,1372:1507,Pancreas,DAN-G,SIDM00950,1290797,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1507,Ruxolitinib,"JAK1, JAK2","Other, kinases",Targeted,Advanced clinical trials,10.0,0.576174653134972,0.0948916906085672,0.893065384365807,13.6248611173585,246.73,0.923842622775101,0.975621130196036,0.0670631341467645,0.514561638063819,0.341253769295608,0.173307868768212,9.81360025972657,17.5759,3.81126085763196,229.1541,0.532294702728747,0.460491378134384,0.56212816628185,0.511288626549975,0.071803324594363,0.0508395397318754,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2305,36089,1085:1510,Pancreas,DAN-G,SIDM00950,1290797,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.565962505907355,0.101306983689671,0.699990634868449,10.8461886255465,35.9549,0.878941491005708,0.923223497148694,0.113663997347048,0.396168453821828,0.105962222525071,0.290206231296756,5.80087203389041,1.0888,5.04531659165607,34.8661,0.497447928795537,0.30639535759168,0.522509883958826,0.364661888813247,0.191052571203857,0.15784799514558,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2306,36089,1083:1510,Pancreas,DAN-G,SIDM00950,1290797,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.847814209082597,0.101306983689671,0.699990634868449,10.8461886255465,35.9549,0.878941491005708,0.923223497148694,0.0683859245526239,0.593462006466219,0.46969379928087,0.123768207185349,9.47256211248627,13.8757,1.3736265130602,22.0792,0.745179085026883,0.69228664843608,0.78272199904159,0.740214740535761,0.0528924365908024,0.0425072585058286,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2307,36089,1594:1510,Pancreas,DAN-G,SIDM00950,1290797,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.25465519620225,0.101306983689671,0.699990634868449,10.8461886255465,35.9549,0.878941491005708,0.923223497148694,0.0589847185704156,0.178256252462162,0.0671397250047041,0.111116527457458,6.76195197934971,2.1197,4.08423664619677,33.8352,0.223827017842357,0.12618300178718,0.235103660804928,0.182232256294368,0.0976440160551762,0.0528714045105604,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2308,36089,1053:1510,Pancreas,DAN-G,SIDM00950,1290797,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.717382362359614,0.101306983689671,0.699990634868449,10.8461886255465,35.9549,0.878941491005708,0.923223497148694,0.0793827795413347,0.502160935271534,0.353798463928815,0.148362471342719,8.94055036774405,9.5963,1.90563825780243,26.3586,0.630537123193556,0.561283669132819,0.662304253370434,0.60850672843014,0.0692534540607368,0.0537975249402945,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2309,36089,1561:1510,Pancreas,DAN-G,SIDM00950,1290797,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.518022972233955,0.101306983689671,0.699990634868449,10.8461886255465,35.9549,0.878941491005708,0.923223497148694,0.0989098818867475,0.362611229210487,0.18990890801868,0.172702321191807,7.80847090310708,4.3784,3.0377177224394,31.5765,0.455311883590521,0.32809691218099,0.478250980029193,0.406716506414844,0.127214971409531,0.071534473614349,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2310,36089,1558:1510,Pancreas,DAN-G,SIDM00950,1290797,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.226309218685499,0.101306983689671,0.699990634868449,10.8461886255465,35.9549,0.878941491005708,0.923223497148694,0.0428172610228205,0.158414333664245,0.0844727766651534,0.073941556999092,7.87072903512185,4.5715,2.97545959042463,31.3834,0.19891256209977,0.134781439869794,0.208933988311815,0.178546424888369,0.0641311222299751,0.0303875634234459,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2311,36089,1079:1510,Pancreas,DAN-G,SIDM00950,1290797,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.762899794200425,0.101306983689671,0.699990634868449,10.8461886255465,35.9549,0.878941491005708,0.923223497148694,0.0930963871292256,0.534022711283365,0.250934282083733,0.283088429199631,7.44620878893715,3.4061,3.39997983660932,32.5488,0.670544282602469,0.516773897863582,0.704327015975735,0.581464844349498,0.153770384738887,0.122862171626237,True,0.275056571421478,0.0408420227744738,1.24992265661787,39.5667159156265
2312,36968,1510:1558,Pancreas,DAN-G,SIDM00950,1290797,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.745216012149358,0.179971596340953,0.484350621429813,8.86355369436316,9.0976,0.877683433317757,0.844376707154096,0.080738949145972,0.360945838583988,0.199525972771901,0.161419865812087,6.80766527583966,2.188,2.05588841852351,6.9096,0.654063748106615,0.566374004534726,0.629243042457181,0.535687955246262,0.0876897435718892,0.0935550872109193,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2313,36968,1564:1561,Pancreas,DAN-G,SIDM00950,1290797,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.747456538510707,0.180335294828139,0.248822876775449,6.59239154539767,1.8847,0.670221233910147,0.703477888478109,0.0412072301600456,0.185984286176853,0.0435448300837958,0.142439456093058,2.93606576520812,0.1495,3.65632578018955,1.7352,0.500961243534853,0.293485323096782,0.525819147440669,0.309197474871249,0.207475920438071,0.21662167256942,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2314,36968,1011:1561,Pancreas,DAN-G,SIDM00950,1290797,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.849699903533252,0.180335294828139,0.248822876775449,6.59239154539767,1.8847,0.670221233910147,0.703477888478109,0.0734662357901196,0.211424774392965,0.0591841408207262,0.152240633572239,3.35188961710469,0.1994,3.24050192829298,1.6853,0.569486917799389,0.371913227040867,0.597745093977625,0.379975992847418,0.197573690758521,0.217769101130207,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2315,36968,1079:1561,Pancreas,DAN-G,SIDM00950,1290797,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.65264309821647,0.180335294828139,0.248822876775449,6.59239154539767,1.8847,0.670221233910147,0.703477888478109,0.0413069115329425,0.162392533205864,0.0289268977264494,0.133465635479415,2.30837139802623,0.0967,4.28402014737143,1.788,0.437415262589584,0.222292340491879,0.459119988663134,0.237644230335251,0.215122922097705,0.221475758327883,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2316,36968,1372:1561,Pancreas,DAN-G,SIDM00950,1290797,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.774442384878601,0.180335294828139,0.248822876775449,6.59239154539767,1.8847,0.670221233910147,0.703477888478109,0.0320230188463214,0.192698982102333,0.0443016002451554,0.148397381857178,2.89389150145244,0.1452,3.69850004394522,1.7395,0.519047730785653,0.310041153287115,0.544803093662349,0.317747645956787,0.209006577498538,0.227055447705563,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2317,36969,1011:1564,Pancreas,DAN-G,SIDM00950,1290797,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.641477113653981,0.0880113565705309,0.470462794558612,8.74225029390307,8.3639,0.804035474964126,0.838170894405702,0.0481702108055332,0.301791115535044,0.0227737482056871,0.279017367329357,1.80481134068797,0.0682,6.9374389532151,8.2957,0.515770355755395,0.204702118845288,0.537667446092145,0.208943191361567,0.311068236910107,0.328724254730578,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2318,36969,1561:1564,Pancreas,DAN-G,SIDM00950,1290797,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.631849830555052,0.0880113565705309,0.470462794558612,8.74225029390307,8.3639,0.804035474964126,0.838170894405702,0.0491933026918465,0.297261837024315,0.090729864705468,0.206531972318847,5.10879101410557,0.674,3.6334592797975,7.6899,0.508029678616333,0.374944269640789,0.529598137606419,0.37274227187475,0.133085408975544,0.156855865731669,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2319,36969,1053:1564,Pancreas,DAN-G,SIDM00950,1290797,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.850270171800407,0.0880113565705309,0.470462794558612,8.74225029390307,8.3639,0.804035474964126,0.838170894405702,0.0706621775091666,0.40002048115505,0.135717440454222,0.264303040700828,5.3804563563878,0.8136,3.36179393751527,7.5503,0.683647381431369,0.521213935912928,0.712671710384437,0.51994790192599,0.162433445518441,0.192723808458447,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2320,36969,1053:1594,Pancreas,DAN-G,SIDM00950,1290797,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.824441293119271,0.105981390274608,0.203698267356376,6.0292474834389,0.5102,0.661950035693464,0.661779413764115,0.109522019013023,0.167937262945445,0.0779316856839393,0.0900055772615062,4.07632081254617,0.1318,1.95292667089273,0.3784,0.545738943407467,0.41145558049143,0.5455982756434,0.417360306903925,0.134283362916037,0.128237968739475,True,0.308702688103801,0.048280611784538,1.13254613004352,43.5498506637625
2321,34831,1558:1011,Pancreas,Hs-766T,SIDM00664,1298141,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.474029583611523,0.120792633070361,0.527899098498177,9.32112195694981,12.493,0.867316621502426,0.824181586480037,0.0570367389195822,0.250239789849989,0.0939783853760098,0.156261404473979,4.98357292419863,0.6179,4.33754903275118,11.8751,0.411133736950148,0.235275188886679,0.390686454259416,0.26954720150388,0.175858548063468,0.121139252755536,True,0.506779323265705,0.0761582706803658,0.64125508989202,75.5116748244959
2322,35345,1085:1053,Pancreas,Hs-766T,SIDM00664,1298141,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,1.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.888187070759427,0.103606707881216,0.800272647985891,12.9898609129693,158.8795,0.900595315227417,0.938158723158831,0.0670984616836139,0.710791819023479,0.761424284628829,-0.0506324656053508,14.1536876753413,355.971,-1.16382676237197,-197.0915,0.799897114971502,0.836342432026587,0.833260448229847,0.850178657678676,-0.0364453170550852,-0.0169182094488296,True,0.446845140179036,0.0669855827485741,0.7640415898497,63.7539938041663
2323,35345,1372:1053,Pancreas,Hs-766T,SIDM00664,1298141,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.500354063922068,0.103606707881216,0.800272647985891,12.9898609129693,158.8795,0.900595315227417,0.938158723158831,0.0434014741979793,0.400419671665415,0.334219513346691,0.0662001583187238,11.0093041836151,40.2588,1.9805567293542,118.6207,0.450616525923214,0.411987541066079,0.469411529736459,0.444504989004672,0.0386289848571345,0.0249065407317874,True,0.446845140179036,0.0669855827485741,0.7640415898497,63.7539938041663
2324,35345,1011:1053,Pancreas,Hs-766T,SIDM00664,1298141,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.70227683301446,0.103606707881216,0.800272647985891,12.9898609129693,158.8795,0.900595315227417,0.938158723158831,0.114266222022351,0.562012940775627,0.332809120899445,0.229203819876182,8.69962702130918,8.1204,4.29023389166016,150.7591,0.632467225805569,0.466400801122028,0.658847136964873,0.558323588293896,0.166066424683541,0.100523548670978,True,0.446845140179036,0.0669855827485741,0.7640415898497,63.7539938041663
2325,35345,1558:1053,Pancreas,Hs-766T,SIDM00664,1298141,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.736750996638489,0.103606707881216,0.800272647985891,12.9898609129693,158.8795,0.900595315227417,0.938158723158831,0.0268658631991908,0.589601670986128,0.517630910470486,0.0719707605156413,11.4710777732805,55.4458,1.51878313968886,103.4337,0.663514496061753,0.664860813622886,0.691189374292361,0.664741825829871,-0.0013463175611323,0.0264475484624904,True,0.446845140179036,0.0669855827485741,0.7640415898497,63.7539938041663
2326,35345,1594:1053,Pancreas,Hs-766T,SIDM00664,1298141,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.347173205479034,0.103606707881216,0.800272647985891,12.9898609129693,158.8795,0.900595315227417,0.938158723158831,0.0720688075810607,0.277833220458457,0.241704655162402,0.0361285652960541,11.3838676426238,52.1934,1.60599327034553,106.6861,0.312662562426904,0.253969308108026,0.32570357116717,0.312370401938152,0.058693254318878,0.0133331692290178,True,0.446845140179036,0.0669855827485741,0.7640415898497,63.7539938041663
2327,35347,1372:1079,Pancreas,Hs-766T,SIDM00664,1298141,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.555385108213982,0.107799890912163,0.635893885246075,10.6028048595766,6.0747,0.81846886587949,0.874895136955148,0.0511661630648643,0.353165994270001,0.155076428841373,0.198089565428629,6.27402137602197,0.3023,4.32878348355467,5.7724,0.454565419646256,0.330516082111384,0.485903730313722,0.363945901738166,0.124049337534872,0.121957828575556,True,0.446845140179036,0.0669855827485741,0.7640415898497,63.7539938041663
2328,38369,1011:1083,Pancreas,Hs-766T,SIDM00664,1298141,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.805323212890258,0.0740212263856292,0.75032941684553,12.1630585915012,71.6581,0.914959431011178,0.920366011457894,0.0692465626803399,0.604257696700116,0.361793094097864,0.242464602602251,8.41447546109978,5.3313,3.74858313040147,66.3268,0.736838068646164,0.638199854354511,0.741192113382263,0.628680654196173,0.0986382142916535,0.11251145918609,True,0.412578623947329,0.074038859160901,0.819166773089714,58.9218745761449
2329,38369,1079:1083,Pancreas,Hs-766T,SIDM00664,1298141,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.767254050245365,0.0740212263856292,0.75032941684553,12.1630585915012,71.6581,0.914959431011178,0.920366011457894,0.0381967091167612,0.575693284092976,0.39352140591819,0.182171878174786,9.14831130751308,8.8662,3.01474728398816,62.7919,0.702006329253521,0.626715391481303,0.706154549999241,0.626364192622551,0.0752909377722185,0.0797903573766905,True,0.412578623947329,0.074038859160901,0.819166773089714,58.9218745761449
2330,38371,1053:1168,Pancreas,Hs-766T,SIDM00664,1298141,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.885788872018067,0.0868550432780332,0.748422600910605,12.1338738071251,87.7789,0.919075936384461,0.919664371336163,0.0878826188165374,0.662944411453433,0.43935950733022,0.223584904123213,8.95411315863012,9.6869,3.17976064849496,78.092,0.81410723698894,0.659814643608736,0.814628466121065,0.715114262753531,0.154292593380204,0.0995142033675342,True,0.412578623947329,0.074038859160901,0.819166773089714,58.9218745761449
2331,38373,1594:1510,Pancreas,Hs-766T,SIDM00664,1298141,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.392790981876081,0.0953227473630787,0.831869766440964,13.5962100934996,241.8784,0.919840083430419,0.948872023926205,0.0491223724940203,0.326750942353372,0.355896875344341,-0.0291459329909685,15.5154036621489,914.8122,-1.91919356864935,-672.9338,0.36130488953961,0.348145651059218,0.372708373952718,0.38201442878566,0.0131592384803924,-0.0093060548329418,True,0.412578623947329,0.074038859160901,0.819166773089714,58.9218745761449
2332,38086,1080:1011,Pancreas,KP-1N,SIDM00583,1298216,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.540461414159996,0.080000794768034,0.647013641751468,10.4276535655561,26.9009,0.900552069476767,0.899254876533613,0.0341396837211861,0.349685907801808,0.149003196873099,0.200682710928708,6.72421206426844,2.065,3.70344150128767,24.8359,0.486713644994125,0.369209958916032,0.486012562261629,0.381102616122203,0.117503686078093,0.104909946139426,True,0.26545189627022,0.0396774713456944,1.25397777780286,39.1824544315439
2333,38088,1558:1053,Pancreas,KP-1N,SIDM00583,1298216,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.952001175869087,0.0591504181232595,0.785513120215468,12.0584332108352,83.3067,0.92678370949784,0.944040480476596,0.0596015343948129,0.747809414105722,0.751044916347698,-0.0032355022419767,12.1062376372806,86.1134,-0.0478044264453903,-2.80669999999999,0.882299181218258,0.88929453643316,0.898727647481738,0.899678446633586,-0.0069953552149012,-0.0009507991518484,True,0.26545189627022,0.0396774713456944,1.25397777780286,39.1824544315439
2334,38088,1594:1053,Pancreas,KP-1N,SIDM00583,1298216,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.836384108250334,0.0591504181232595,0.785513120215468,12.0584332108352,83.3067,0.92678370949784,0.944040480476596,0.0457089224328338,0.656990690570352,0.400708774071838,0.256281916498513,8.80288257612989,8.7229,3.25555063470529,74.5838,0.775147166409287,0.687907257231691,0.789580455415634,0.694426226668394,0.0872399091775964,0.0951542287472406,True,0.26545189627022,0.0396774713456944,1.25397777780286,39.1824544315439
2335,38090,1510:1079,Pancreas,KP-1N,SIDM00583,1298216,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,2.5,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.908704358032345,0.0970409340440818,0.674925135452797,10.7212438182458,6.5944,0.850865376491199,0.908991283519674,0.11452163551461,0.613307411931527,0.376433832563183,0.236873579368345,8.18382260913777,1.1359,2.53742120910807,5.4585,0.773185075716385,0.634168985093862,0.826004340747742,0.72432209786686,0.139016090622523,0.101682242880882,True,0.26545189627022,0.0396774713456944,1.25397777780286,39.1824544315439
2336,38194,1594:1168,Pancreas,KP-1N,SIDM00583,1298216,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.84997707415274,0.057920711088845,0.87576768083518,13.6013496511795,242.7416,0.954810963771361,0.96922421138184,0.0746771721979308,0.744382450993817,0.470326127591545,0.274056323402272,9.50461663753193,14.1875,4.09673301364756,228.5541,0.811567429355339,0.685196855950555,0.823818359388333,0.733770258815212,0.126370573404783,0.0900481005731206,True,0.33080575099409,0.0537833085710134,1.03124901802824,47.2296886177584
2337,38195,1053:1372,Pancreas,KP-1N,SIDM00583,1298216,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.697382531672596,0.100332609065971,0.780030661901677,11.9824640734876,7.9033,0.879411830975907,0.942420404125375,0.046531155179253,0.543979757779242,0.118410056109277,0.425569701669965,5.26062248879302,0.0749,6.72184158469462,7.8284,0.613286449068811,0.385819047163074,0.657227527328865,0.41716938326371,0.227467401905737,0.240058144065155,True,0.33080575099409,0.0537833085710134,1.03124901802824,47.2296886177584
2338,38195,1561:1372,Pancreas,KP-1N,SIDM00583,1298216,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.890308887840402,0.100332609065971,0.780030661901677,11.9824640734876,7.9033,0.879411830975907,0.942420404125375,0.12568774915112,0.694468231079094,0.55232812571413,0.142140105364964,10.1572088733449,2.2303,1.82525520014275,5.673,0.782948169189851,0.692553991642397,0.839045261874965,0.791994448989935,0.0903941775474545,0.0470508128850295,True,0.33080575099409,0.0537833085710134,1.03124901802824,47.2296886177584
2339,38195,1079:1372,Pancreas,KP-1N,SIDM00583,1298216,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.943268673398973,0.100332609065971,0.780030661901677,11.9824640734876,7.9033,0.879411830975907,0.942420404125375,0.127461513377042,0.735778487662517,0.444343635833283,0.291434851829234,8.72702721446267,0.8276,3.25543685902497,7.0757,0.829521631176005,0.689572476724049,0.888955644383466,0.779525230666105,0.139949154451956,0.109430413717361,True,0.33080575099409,0.0537833085710134,1.03124901802824,47.2296886177584
2340,38587,1594:1510,Pancreas,KP-1N,SIDM00583,1298216,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.860005754563494,0.0439620332803062,0.814477013974044,12.4855451902037,112.0092,0.952022228143275,0.95241924082683,0.0796900697914649,0.70045491897737,0.363514609574169,0.336940309403201,8.26549326544355,6.0102,4.22005192476013,105.999,0.818744594675576,0.640976674388976,0.819086027868069,0.689452001168776,0.1777679202866,0.129634026699293,True,0.138002283349972,0.0257068406814575,1.82203715738827,27.0429835437031
2341,38587,1079:1510,Pancreas,KP-1N,SIDM00583,1298216,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.848632669265257,0.0439620332803062,0.814477013974044,12.4855451902037,112.0092,0.952022228143275,0.95241924082683,0.0505941432807649,0.69119180242399,0.522245217423401,0.168946585000589,10.1074920890445,21.5471,2.37805310115917,90.4621,0.807917164669085,0.718415236747037,0.808254082602463,0.753345351459491,0.089501927922048,0.0549087311429721,True,0.138002283349972,0.0257068406814575,1.82203715738827,27.0429835437031
2342,38589,1510:1564,Pancreas,KP-1N,SIDM00583,1298216,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.927246906093903,0.0686825117788234,0.759889691025287,11.7144094634993,65.6325,0.938020777108387,0.936371206744677,0.0226558931822967,0.704605364975849,0.627977543546135,0.076627821429714,10.7462517425622,33.5486,0.968157720937148,32.0839,0.869776863425551,0.847685061315467,0.868247304409416,0.843594630280262,0.0220918021100838,0.0246526741291548,True,0.138002283349972,0.0257068406814575,1.82203715738827,27.0429835437031
2343,38589,1053:1594,Pancreas,KP-1N,SIDM00583,1298216,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.874235082387403,0.0437145431734754,0.875190105511825,13.5888667558405,96.2601,0.977964581593238,0.969071315099278,0.0490870045902356,0.765121893996771,0.447123035368186,0.317998858628585,9.10787997514025,4.3106,4.48098678070029,91.9495,0.854970946561127,0.749601566970993,0.847196140995087,0.73892651746855,0.105369379590134,0.108269623526537,True,0.138002283349972,0.0257068406814575,1.82203715738827,27.0429835437031
2344,38589,1510:1594,Pancreas,KP-1N,SIDM00583,1298216,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.852900176917948,0.0437145431734754,0.875190105511825,13.5888667558405,96.2601,0.977964581593238,0.969071315099278,0.0498712865148178,0.746449795827873,0.427493734849635,0.318956060978238,9.01153216101651,4.0321,4.57733459482402,92.228,0.83410616466036,0.726052195978958,0.826521096094283,0.716950355038597,0.108053968681402,0.109570741055686,True,0.138002283349972,0.0257068406814575,1.82203715738827,27.0429835437031
2345,38653,1080:1011,Pancreas,KP-3,SIDM00571,1298219,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.922967293714595,0.163762691727457,0.503188227104427,9.03051977386817,10.2138,0.892482154513247,0.839234627055885,0.174306161040272,0.464426276199619,0.460199814854157,0.0042264613454612,8.98668475438188,9.9081,0.0438350194862842,0.305700000000002,0.823731838839663,0.840121512648591,0.774586112525348,0.772627663734351,-0.0163896738089282,0.0019584487909974,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2346,38655,1080:1053,Pancreas,KP-3,SIDM00571,1298219,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.664053377754501,0.0522850550333559,0.862140844831316,13.3870515769482,209.2349,0.953338587756455,0.965086638282502,0.0676192878728897,0.572507540110354,0.391442191489597,0.181065348620757,9.86581338111589,18.2237,3.52123819583227,191.0112,0.63306770934338,0.574019424466367,0.640869041977231,0.581748536401743,0.0590482848770126,0.0591205055754882,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2347,38655,1558:1053,Pancreas,KP-3,SIDM00571,1298219,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.930163025927891,0.0522850550333559,0.862140844831316,13.3870515769482,209.2349,0.953338587756455,0.965086638282502,0.0235068759614077,0.801931537004326,0.785077406680243,0.0168541303240828,13.0406991580699,164.578,0.346352418878242,44.6569,0.886760305521367,0.904125444845857,0.897687907747428,0.893044369757218,-0.0173651393244899,0.0046435379902098,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2348,38655,1594:1053,Pancreas,KP-3,SIDM00571,1298219,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.757880712680297,0.0522850550333559,0.862140844831316,13.3870515769482,209.2349,0.953338587756455,0.965086638282502,0.0715820468729251,0.653399917911551,0.520320335477531,0.13307958243402,10.8762681200461,36.7124,2.51078345690207,172.5225,0.72251692831449,0.640365592325173,0.731420549219774,0.690934744007157,0.0821513359893165,0.0404858052126167,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2349,38657,1564:1079,Pancreas,KP-3,SIDM00571,1298219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.837659754723115,0.137119160285933,0.697293145474078,10.9969254045374,7.983,0.816998062650931,0.915302139609334,0.145185858423175,0.584094405207926,0.399695384581426,0.184399020626499,8.78118459049838,1.7185,2.21574081403904,6.2645,0.684366396769439,0.585585301486461,0.766711765762697,0.692672545818856,0.0987810952829781,0.0740392199438414,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2350,38657,1372:1079,Pancreas,KP-3,SIDM00571,1298219,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.717678049201566,0.137119160285933,0.697293145474078,10.9969254045374,7.983,0.816998062650931,0.915302139609334,0.0592143608835921,0.50043198436546,0.274285038327755,0.226146946037705,7.85060702641508,0.9016,3.14631837812235,7.0814,0.586341575804779,0.510624859467358,0.656892253984846,0.556681598759525,0.0757167163374211,0.100210655225322,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2351,38657,1011:1080,Pancreas,KP-3,SIDM00571,1298219,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.8625633571621,0.0631300217591149,0.411415014816926,8.14297524056426,0.0552,0.788401958511631,0.792641820566212,0.110406004418461,0.354871516367383,0.170779729183755,0.184091787183628,5.65225452527819,0.0098,2.49072071528608,0.0454,0.680046640126968,0.557614436209145,0.683703789774671,0.540682841637785,0.122432203917823,0.143020948136886,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2352,38658,1057:1083,Pancreas,KP-3,SIDM00571,1298219,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.945502039470974,0.0475586394705695,0.784538090555337,12.0926674288702,68.2458,0.939134675174052,0.942933028138142,0.0255809939794557,0.741782364662734,0.700080384082479,0.0417019805802551,11.508519864644,45.5229,0.584147564226198,22.7229,0.887953750714977,0.860126423047798,0.891545101189154,0.878714838390272,0.027827327667179,0.0128302627988819,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2353,38658,1558:1083,Pancreas,KP-3,SIDM00571,1298219,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.922302999132876,0.0475586394705695,0.784538090555337,12.0926674288702,68.2458,0.939134675174052,0.942933028138142,0.0780957631359457,0.723581833853167,0.581331296208377,0.14225053764479,10.2767855638517,19.3839,1.81588186501846,48.8619,0.866166727502707,0.783856435261418,0.869669959833252,0.822403864027213,0.0823102922412891,0.0472660958060398,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2354,38658,1594:1083,Pancreas,KP-3,SIDM00571,1298219,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.770605419551359,0.0475586394705695,0.784538090555337,12.0926674288702,68.2458,0.939134675174052,0.942933028138142,0.025012989697824,0.604569304426418,0.464109156947255,0.140460147479163,9.99294341172599,15.9219,2.09972401714421,52.3239,0.72370227037773,0.662363806766223,0.726629301757226,0.67895248064201,0.0613384636115074,0.0476768211152168,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2355,38661,1079:1372,Pancreas,KP-3,SIDM00571,1298219,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.848955160995249,0.0803460180870064,0.797800147727956,12.2848131375346,9.746,0.931853905865344,0.946867263105091,0.0327507790080519,0.67729655285642,0.54664497479152,0.130651578064901,10.4175605253011,2.6713,1.8672526122335,7.0747,0.791102182677964,0.743492667737336,0.803847849790513,0.761234116539052,0.0476095149406284,0.0426137332514614,True,0.347072432253864,0.0355409668214554,0.996551159527555,49.0054395459439
2356,38410,1594:1561,Pancreas,KP-3,SIDM00571,1298219,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.724173520277815,0.0900730426809515,0.728620840941619,11.3635420389607,51.4632,0.866842609878725,0.925594694105228,0.0750782704435818,0.527647919332474,0.542682838510427,-0.015034919177953,11.6212442929336,61.5281,-0.257702253972859,-10.0649,0.627744464322685,0.637804837815255,0.67029116798065,0.675059881565772,-0.0100603734925704,-0.0047687135851215,True,0.634466269697662,0.0638489013406232,0.40856771207993,113.874985665625
2357,38410,1564:1561,Pancreas,KP-3,SIDM00571,1298219,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.89882037173454,0.0900730426809515,0.728620840941619,11.3635420389607,51.4632,0.866842609878725,0.925594694105228,0.162078788650026,0.65489925510868,0.446947028649691,0.207952226458989,8.97376689182395,9.8198,2.38977514713677,41.6434,0.779135796846535,0.623893863564493,0.831943367031179,0.751848689782773,0.155241933282042,0.0800946772484065,True,0.634466269697662,0.0638489013406232,0.40856771207993,113.874985665625
2358,35928,1080:1011,Pancreas,KP-4,SIDM00301,753572,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.269400912991236,0.118598323175334,0.510163773213546,9.0691406829246,10.4909,0.872072553997039,0.886012330542042,0.0710096591331542,0.137438586278783,0.0172860964240318,0.120152489854751,4.4428767729495,0.4248,4.6262639099751,10.0661,0.234937142241401,0.0952431221661377,0.238692530769518,0.145422346517351,0.139694020075263,0.093270184252167,True,0.254284907115451,0.0410854841185055,1.29522204292935,37.9637512506747
2359,38068,1372:1053,Pancreas,KP-4,SIDM00301,753572,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.757487934088403,0.0891367450932208,0.677732196906737,10.2640478659855,24.0169,0.870592299733819,0.934078367640932,0.0963731035727377,0.513373961700079,0.261902970828394,0.251470990871685,7.91552544703333,4.7156,2.34852241895217,19.3013,0.659463162558642,0.543876961465754,0.707553092980997,0.621370914662758,0.115586201092888,0.0861821783182389,True,0.409449867074642,0.0537613100257018,0.837855458363471,57.9784640117392
2360,38068,1558:1053,Pancreas,KP-4,SIDM00301,753572,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.983534869638782,0.0891367450932208,0.677732196906737,10.2640478659855,24.0169,0.870592299733819,0.934078367640932,0.0373472795622626,0.666573247934674,0.729417950550945,-0.0628447026162715,10.7930230176575,34.654,-0.528975151671961,-10.6371,0.856257884027229,0.91442959752343,0.91869864555013,0.933707437589622,-0.0581717134962008,-0.015008792039492,True,0.409449867074642,0.0537613100257018,0.837855458363471,57.9784640117392
2361,35932,1083:1079,Pancreas,KP-4,SIDM00301,753572,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.800986742096688,0.101658349840705,0.83677007783737,11.7791658134715,13.7291,0.908580026442986,0.969789917515025,0.192757189513026,0.670241738530947,0.12010925680143,0.550132481729517,6.04978614859006,0.2588,5.72937966488147,13.4703,0.72776055531469,0.455870331515852,0.776788866548575,0.544689956555108,0.271890223798838,0.232098909993467,True,0.254284907115451,0.0410854841185055,1.29522204292935,37.9637512506747
2362,35932,1561:1079,Pancreas,KP-4,SIDM00301,753572,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.83570192246425,0.101658349840705,0.83677007783737,11.7791658134715,13.7291,0.908580026442986,0.969789917515025,0.119659802389144,0.69929036270925,0.4749256598331,0.22436470287615,9.46744883142093,2.7653,2.3117169820506,10.9638,0.759302074811023,0.676549618146898,0.810455298453753,0.755697385515134,0.082752456664125,0.0547579129386182,True,0.254284907115451,0.0410854841185055,1.29522204292935,37.9637512506747
2363,35932,1564:1079,Pancreas,KP-4,SIDM00301,753572,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.719649710082925,0.101658349840705,0.83677007783737,11.7791658134715,13.7291,0.908580026442986,0.969789917515025,0.0822094537953479,0.60218134392173,0.394407115020687,0.207774228901043,9.32786393127062,2.5103,2.45130188220091,11.2188,0.653859352616831,0.596499802018952,0.697909032981031,0.646339327410611,0.0573595505978793,0.0515697055704206,True,0.254284907115451,0.0410854841185055,1.29522204292935,37.9637512506747
2364,35932,1372:1079,Pancreas,KP-4,SIDM00301,753572,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.773795706314458,0.101658349840705,0.83677007783737,11.7791658134715,13.7291,0.908580026442986,0.969789917515025,0.14038164149656,0.647489093402972,0.233549503073009,0.413939590329963,7.57396644958675,0.7443,4.20519936388478,12.9848,0.703055323304659,0.514474519611502,0.750419274200179,0.617023078972442,0.188580803693157,0.133396195227737,True,0.254284907115451,0.0410854841185055,1.29522204292935,37.9637512506747
2365,36564,1079:1083,Pancreas,KP-4,SIDM00301,753572,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.936748756324586,0.0674532554233376,0.333840342925898,7.82522954585476,3.5436,0.799927065858584,0.814391916373749,0.110985803734364,0.312724526046808,0.0886742904192582,0.22405023562755,5.16043063756386,0.5588,2.6647989082909,2.9848,0.749330684093404,0.561609058495487,0.762880614823905,0.565435082602854,0.187721625597917,0.197445532221051,True,0.257179332356438,0.039469590317983,1.30283383168008,37.8852395188822
2366,38201,1053:1372,Pancreas,KP-4,SIDM00301,753572,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.860055064342694,0.147406733780348,0.601842302499901,9.70252826356203,1.6274,0.801160459823331,0.913972809058226,0.153136309631341,0.517617520200708,0.281587963836702,0.236029556364006,7.77579753943149,0.428,1.92673072413055,1.1994,0.689042110822178,0.575605572291955,0.786066943102045,0.697599967865916,0.113436538530223,0.0884669752361293,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2367,38201,1561:1372,Pancreas,KP-4,SIDM00301,753572,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.772892808620316,0.147406733780348,0.601842302499901,9.70252826356203,1.6274,0.801160459823331,0.913972809058226,0.129884293294526,0.465159587525666,0.168479707940323,0.296679879585343,6.82779769376269,0.2219,2.87473056979934,1.4055,0.619211157948398,0.496490828908832,0.706403011395611,0.573999740310916,0.122720329039566,0.132403271084695,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2368,38201,1079:1372,Pancreas,KP-4,SIDM00301,753572,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.894266958454719,0.147406733780348,0.601842302499901,9.70252826356203,1.6274,0.801160459823331,0.913972809058226,0.119643039942961,0.538207685325972,0.280999117849031,0.257208567476941,7.67289862302278,0.3986,2.02962964053925,1.2288,0.716451327640395,0.624034488533209,0.817335684066815,0.719153681124185,0.0924168391071856,0.0981820029426305,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2369,38203,1053:1558,Pancreas,KP-4,SIDM00301,753572,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.860140764205788,0.0693916279916403,0.907370524309225,12.8802862263655,147.2592,0.956995443237525,0.983519534057975,0.028676797710259,0.780466376197143,0.746150601259298,0.0343157749378453,12.1947947912521,91.5649,0.68549143511334,55.6943,0.823150791887782,0.848317833109326,0.845965243635947,0.839409429893966,-0.0251670412215441,0.0065558137419805,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2370,38203,1372:1561,Pancreas,KP-4,SIDM00301,753572,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.677522748036021,0.10027185257796,0.610782756636784,9.76622024172302,17.0081,0.839227282302325,0.916468717132523,0.129901098416487,0.41381921172957,0.180627031055626,0.233192180673944,7.279256398051,3.0339,2.48696384367202,13.9742,0.568595574532273,0.434840328707403,0.620928403720674,0.526098320898404,0.13375524582487,0.0948300828222705,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2371,38203,1564:1561,Pancreas,KP-4,SIDM00301,753572,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.749551307296544,0.10027185257796,0.610782756636784,9.76622024172302,17.0081,0.839227282302325,0.916468717132523,0.169867514469038,0.457813013711289,0.167585923917267,0.290227089794021,6.88310899328176,2.3054,2.88311124844126,14.7027,0.629043906568634,0.44577479845034,0.68694032502307,0.559854942102642,0.183269108118294,0.127085382920428,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2372,38203,1079:1561,Pancreas,KP-4,SIDM00301,753572,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.924494608932983,0.10027185257796,0.610782756636784,9.76622024172302,17.0081,0.839227282302325,0.916468717132523,0.102871276655364,0.564665365739933,0.331137014400099,0.233528351339834,8.00819839938702,5.0285,1.758021842336,11.9796,0.775861098157979,0.679163394322951,0.847270388244745,0.763875651768917,0.0966977038350275,0.0833947364758276,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2373,38204,1053:1564,Pancreas,KP-4,SIDM00301,753572,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.897026134093022,0.105060962472058,0.560212138172193,9.41154337181219,13.3011,0.820789735295863,0.901842646048174,0.198953531781907,0.502524928576588,0.249530396705011,0.252994531871577,7.37858602982816,3.2502,2.03295734198403,10.0509,0.736269843155683,0.552169762795023,0.808976422344815,0.702960678110833,0.184100080360661,0.106015744233982,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2374,38204,1561:1564,Pancreas,KP-4,SIDM00301,753572,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.847203592695907,0.105060962472058,0.560212138172193,9.41154337181219,13.3011,0.820789735295863,0.901842646048174,0.163631289796446,0.474613736131337,0.219075869709685,0.255537866421653,7.2088933609007,2.8895,2.20265001091149,10.4116,0.695376012590578,0.543883316517301,0.764044329778396,0.65350646836337,0.151492696073277,0.110537861415026,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2375,38204,1079:1564,Pancreas,KP-4,SIDM00301,753572,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.891753813282687,0.105060962472058,0.560212138172193,9.41154337181219,13.3011,0.820789735295863,0.901842646048174,0.182048621662269,0.499571310462301,0.252780404127819,0.246790906334481,7.42311992257619,3.3521,1.988423449236,9.949,0.731942376353374,0.579107761093635,0.804221618594408,0.701656907471521,0.152834615259738,0.102564711122887,True,0.499388818305549,0.0778749642423169,0.641295764072827,74.6934036836966
2376,35935,1372:1011,Pancreas,BxPC-3,SIDM00132,906693,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.620533388318228,0.133094079333509,0.493324165394975,8.91262314493446,9.4123,0.78812212669517,0.784253307332126,0.0736500286262608,0.306124115891806,0.188081511825386,0.11804260406642,6.27579894310189,1.5133,2.63682420183258,7.899,0.489056093686722,0.399700581552839,0.486655362098581,0.399030810928822,0.0893555121338828,0.0876245511697596,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2377,35935,1564:1011,Pancreas,BxPC-3,SIDM00132,906693,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.698824074106012,0.133094079333509,0.493324165394975,8.91262314493446,9.4123,0.78812212669517,0.784253307332126,0.114312871410413,0.344746803116264,0.19256821696676,0.152178586149505,5.8373719921966,1.1167,3.07525115273787,8.2956,0.550758715470213,0.446006143335137,0.548055091360951,0.430776567399716,0.104752572135076,0.117278523961234,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2378,35935,1080:1011,Pancreas,BxPC-3,SIDM00132,906693,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.492169628125542,0.133094079333509,0.493324165394975,8.91262314493446,9.4123,0.78812212669517,0.784253307332126,0.0695422094459672,0.242799171027788,0.0413096374982949,0.201489533529493,1.1798689660806,0.0442,7.73275417885387,9.3681,0.387889774013073,0.103628612697929,0.385985658625879,0.159920938311779,0.284261161315144,0.2260647203141,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2379,35935,1558:1011,Pancreas,BxPC-3,SIDM00132,906693,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.611876910807545,0.133094079333509,0.493324165394975,8.91262314493446,9.4123,0.78812212669517,0.784253307332126,0.115071013849808,0.301853666348588,0.0983420314048595,0.203511634943728,3.59192381932478,0.2355,5.32069932560969,9.1768,0.482233732221313,0.261886229061837,0.479866490980982,0.28988369780648,0.220347503159476,0.189982793174502,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2380,35937,1168:1053,Pancreas,BxPC-3,SIDM00132,906693,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.683400396221406,0.0551626264398248,0.789806413412618,13.3312568711693,201.2974,0.92350522142811,0.926865487495955,0.0809855349714819,0.539754015864391,0.357697084778708,0.182056931085683,9.30657931962266,12.3677,4.02467755154663,188.9297,0.631123834236508,0.478784903393267,0.633420241398682,0.548022552732027,0.152338930843241,0.0853976886666551,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2381,35937,1372:1053,Pancreas,BxPC-3,SIDM00132,906693,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.664037671707401,0.0551626264398248,0.789806413412618,13.3312568711693,201.2974,0.92350522142811,0.926865487495955,0.0343673934190007,0.524461211862088,0.217311612901517,0.307149598960571,6.6421983077289,1.9509,6.6890585634404,199.3465,0.61324225704675,0.419454555647107,0.615473600302759,0.441410797194884,0.193787701399643,0.174062803107876,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2382,35937,1558:1053,Pancreas,BxPC-3,SIDM00132,906693,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.820548807898197,0.0551626264398248,0.789806413412618,13.3312568711693,201.2974,0.92350522142811,0.926865487495955,0.0546696287025921,0.648074710996074,0.515457845264197,0.132616865731877,10.7159532428605,32.8514,2.61530362830875,168.446,0.757781108530596,0.670095205255592,0.760538370846787,0.703104609440692,0.0876859032750038,0.057433761406095,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2383,35937,1054:1053,Pancreas,BxPC-3,SIDM00132,906693,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,2.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.903637727131858,0.0551626264398248,0.789806413412618,13.3312568711693,201.2974,0.92350522142811,0.926865487495955,0.0371358499902872,0.713698872290343,0.679701493066011,0.0339973792243323,12.6328076171669,124.0464,0.698449254002352,77.251,0.834514159285701,0.809279118201117,0.837550622477807,0.823989020557007,0.0252350410845844,0.0135616019207998,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2384,35937,1564:1053,Pancreas,BxPC-3,SIDM00132,906693,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.631777718310485,0.0551626264398248,0.789806413412618,13.3312568711693,201.2974,0.92350522142811,0.926865487495955,0.0572100527116452,0.498982093772812,0.291838171015262,0.20714392275755,8.50080581420763,7.075,4.83045105696166,194.2224,0.583450021641671,0.486668981660216,0.58557296287093,0.483156883856856,0.0967810399814542,0.102416079014074,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2385,35937,1079:1053,Pancreas,BxPC-3,SIDM00132,906693,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.586069083835838,0.0551626264398248,0.789806413412618,13.3312568711693,201.2974,0.92350522142811,0.926865487495955,0.102952608949868,0.462881121116402,0.277644192580747,0.185236928535655,8.65599520441633,7.8785,4.67526166675296,193.4189,0.541237859039985,0.418786060537469,0.543207207095812,0.452578809245641,0.122451798502516,0.0906283978501702,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2386,35939,1083:1079,Pancreas,BxPC-3,SIDM00132,906693,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.929843241456711,0.0818073720180705,0.437998176256584,8.18433748289052,1.1363,0.735103503885284,0.749072539002414,0.0669274594356238,0.40726964396255,0.323860034850086,0.083409609112464,6.9499973265397,0.483,1.23434015635082,0.6533,0.683531024858879,0.609240067889468,0.696520037752213,0.634637318139275,0.0742909569694108,0.0618827196129385,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2387,35939,1561:1079,Pancreas,BxPC-3,SIDM00132,906693,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.628846218064759,0.0818073720180705,0.437998176256584,8.18433748289052,1.1363,0.735103503885284,0.749072539002414,0.0474573090523678,0.275433496658215,0.106847302467126,0.168586194191089,3.80984030298608,0.0548,4.37449717990444,1.0815,0.462267058304414,0.285198196538409,0.471051433207835,0.306729687303839,0.177068861766005,0.164321745903996,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2388,35939,1372:1079,Pancreas,BxPC-3,SIDM00132,906693,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.602657400070063,0.0818073720180705,0.437998176256584,8.18433748289052,1.1363,0.735103503885284,0.749072539002414,0.0488042715194486,0.263962842138222,0.182100688703866,0.0818621534343563,6.26132402588439,0.2996,1.92301345700613,0.8367,0.443015566433899,0.392515271257582,0.451434108819076,0.387012751064007,0.0505002951763175,0.064421357755069,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2389,35939,1558:1079,Pancreas,BxPC-3,SIDM00132,906693,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.6050418862068,0.0818073720180705,0.437998176256584,8.18433748289052,1.1363,0.735103503885284,0.749072539002414,0.0860104047689083,0.265007242717422,0.0785094789528954,0.186497763764527,2.77319637388048,0.0267,5.41114110901005,1.1096,0.44476841054798,0.224361714190014,0.453220261903737,0.255084384592698,0.220406696357966,0.198135877311039,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2390,35939,1080:1079,Pancreas,BxPC-3,SIDM00132,906693,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.860046804472924,0.0818073720180705,0.437998176256584,8.18433748289052,1.1363,0.735103503885284,0.749072539002414,0.0307898488894451,0.376698931854444,0.406854118376759,-0.0301551865223151,8.64707995016694,1.566,-0.462742467276421,-0.4297,0.632223419473388,0.666260021435438,0.644237443487446,0.663786378456637,-0.0340366019620495,-0.0195489349691911,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2391,35939,1079:1080,Pancreas,BxPC-3,SIDM00132,906693,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.797782279081478,0.0787303942352291,0.424377622810249,8.00262117842604,0.0501,0.750174993013358,0.739798505597959,0.0792646720952219,0.33856094711674,0.181249217663451,0.157311729453289,4.99436621875477,0.0062,3.00825495967127,0.0439,0.598476315636129,0.457382751062344,0.590198137857012,0.449707417070329,0.141093564573785,0.140490720786683,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2392,35939,1011:1080,Pancreas,BxPC-3,SIDM00132,906693,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.845827701589552,0.0787303942352291,0.424377622810249,8.00262117842604,0.0501,0.750174993013358,0.739798505597959,0.159003733094539,0.35895034930763,0.154989255534145,0.203961093773486,4.10992467665083,0.0034,3.89269650177521,0.0467,0.634518790130446,0.438843877968085,0.625742069629307,0.428896332806605,0.195674912162361,0.196845736822702,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2393,35940,1168:1083,Pancreas,BxPC-3,SIDM00132,906693,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.734816114160753,0.0906237574490827,0.682833117882548,11.5089952560319,45.5379,0.889607107370287,0.88224927813679,0.0892910526650642,0.501756778302725,0.419299325111169,0.0824574531915557,9.93045126199011,15.247,1.57854399404175,30.2909,0.653697637767623,0.639064085688754,0.648290986281606,0.60829499274167,0.0146335520788684,0.039995993539936,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2394,35940,1558:1083,Pancreas,BxPC-3,SIDM00132,906693,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.68573593506884,0.0906237574490827,0.682833117882548,11.5089952560319,45.5379,0.889607107370287,0.88224927813679,0.0993085042534222,0.46824320658716,0.150926644808877,0.317316561778283,4.86061816211677,0.454,6.6483770939151,45.0839,0.61003556161645,0.374766987853674,0.604990033706941,0.380714830300162,0.235268573762777,0.224275203406779,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2395,35940,1011:1083,Pancreas,BxPC-3,SIDM00132,906693,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.671098571874989,0.0906237574490827,0.682833117882548,11.5089952560319,45.5379,0.889607107370287,0.88224927813679,0.111333001120001,0.458248330239923,0.255346444056816,0.202901886183108,7.40503498977089,2.6482,4.10396026626097,42.8897,0.597014059286039,0.504771113049545,0.592076230595339,0.475132156741717,0.0922429462364943,0.116944073853623,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2396,35940,1079:1083,Pancreas,BxPC-3,SIDM00132,906693,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.644317865457445,0.0906237574490827,0.682833117882548,11.5089952560319,45.5379,0.889607107370287,0.88224927813679,0.0963082739963509,0.439961576977735,0.229333557069009,0.210628019908726,7.05953414492066,2.0843,4.44946111111121,43.4536,0.573189752516595,0.461950990767759,0.568448971690468,0.44377043724491,0.111238761748836,0.124678534445558,True,0.314880243198491,0.0440165959695454,1.10619196739271,44.4799377208205
2397,36558,1080:1372,Pancreas,BxPC-3,SIDM00132,906693,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.416509815332707,0.0875846618866972,0.465438051434252,8.54693930104654,0.7305,0.722536672440609,0.766993765442657,0.0962698345389176,0.193859516851695,0.0882448416221597,0.105614675229535,4.70163603562773,0.0508,3.84530326541881,0.6797,0.300943616009346,0.175424677764191,0.319460431605858,0.227017412227049,0.125518938245155,0.0924430193788095,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2398,36558,1011:1372,Pancreas,BxPC-3,SIDM00132,906693,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.759620677942305,0.0875846618866972,0.465438051434252,8.54693930104654,0.7305,0.722536672440609,0.766993765442657,0.0616101164046613,0.353556368170632,0.152986776426123,0.200569591744509,4.49266356566115,0.044,4.0542757353854,0.6865,0.548853796957512,0.394871705438126,0.582624324083072,0.403864755135039,0.153982091519387,0.178759568948034,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2399,36558,1053:1372,Pancreas,BxPC-3,SIDM00132,906693,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.883626080489526,0.0875846618866972,0.465438051434252,8.54693930104654,0.7305,0.722536672440609,0.766993765442657,0.0382219394663816,0.411273201099531,0.161244878888829,0.250028322210701,4.09330788022897,0.0333,4.45363142081757,0.6972,0.63845224787864,0.432670697714523,0.677735694717998,0.44711819232747,0.205781550164117,0.230617502390528,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2400,36558,1561:1372,Pancreas,BxPC-3,SIDM00132,906693,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.612003980470165,0.0875846618866972,0.465438051434252,8.54693930104654,0.7305,0.722536672440609,0.766993765442657,0.0531464028055563,0.28484994014004,0.0810134354954855,0.203836504644554,2.84833416695057,0.0141,5.69860513409597,0.7164,0.442195319569321,0.229525839460567,0.469403237446707,0.260921759379431,0.212669480108754,0.208481478067276,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2401,36558,1558:1372,Pancreas,BxPC-3,SIDM00132,906693,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.515693316122754,0.0875846618866972,0.465438051434252,8.54693930104654,0.7305,0.722536672440609,0.766993765442657,0.108112479294044,0.240023292193843,0.0634864178936851,0.176536874300158,2.57615926606781,0.0116,5.97078003497873,0.7189,0.372607332631198,0.164207899804473,0.395533558346602,0.211032658730865,0.208399432826725,0.184500899615737,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2402,36558,1079:1372,Pancreas,BxPC-3,SIDM00132,906693,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.783036649733763,0.0875846618866972,0.465438051434252,8.54693930104654,0.7305,0.722536672440609,0.766993765442657,0.0901010818471455,0.364455052453688,0.165803338331124,0.198651714122564,4.6992186397584,0.0507,3.84772066128814,0.6798,0.565772695297676,0.387852094425421,0.600584228458902,0.426670764477873,0.177920600872255,0.173913463981029,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2403,36559,1594:1510,Pancreas,BxPC-3,SIDM00132,906693,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.563922354995975,0.0759451599005513,0.714080333551055,11.9947542362845,79.7096,0.894071446760154,0.895922449789482,0.0677854810519553,0.402685863352422,0.261872845404699,0.140813017947723,8.53299016515823,7.2346,3.46176407112622,72.475,0.504186875791645,0.386571115048162,0.505230697779048,0.432144433894705,0.117615760743483,0.0730862638843429,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2404,36559,1564:1510,Pancreas,BxPC-3,SIDM00132,906693,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.680718823131102,0.0759451599005513,0.714080333551055,11.9947542362845,79.7096,0.894071446760154,0.895922449789482,0.0735272971441656,0.486087924275939,0.315087980017696,0.170999944258242,8.51322629428131,7.1362,3.48152794200315,72.5734,0.608611263033694,0.462565080975225,0.60987127563743,0.520995640620388,0.146046182058469,0.0888756350170423,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2405,36559,1558:1510,Pancreas,BxPC-3,SIDM00132,906693,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.621840797293547,0.0759451599005513,0.714080333551055,11.9947542362845,79.7096,0.894071446760154,0.895922449789482,0.0737731604217786,0.444044283947029,0.134333625715922,0.309710658231108,4.78254233885847,0.5375,7.21221189742598,79.1721,0.555970101290729,0.301991401658082,0.557121130490279,0.342145453793545,0.253978699632647,0.214975676696734,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2406,36559,1079:1510,Pancreas,BxPC-3,SIDM00132,906693,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.769515653657428,0.0759451599005513,0.714080333551055,11.9947542362845,79.7096,0.894071446760154,0.895922449789482,0.0960957739974371,0.549495994636454,0.321922371641453,0.227573622995001,7.92165262428879,4.7357,4.07310161199566,74.9739,0.688001973770082,0.495377787603,0.689426349576118,0.566059460865596,0.192624186167083,0.123366888710522,True,0.340433650194604,0.0547006637101056,1.03635336927785,47.5045657541501
2407,36083,1053:1564,Pancreas,BxPC-3,SIDM00132,906693,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.814017436873731,0.138530074793341,0.514849942522932,9.19440952902308,11.4426,0.731609486257334,0.796980192357129,0.0858712574895824,0.419096830587105,0.211971702247767,0.207125128339338,5.58448750293755,0.9372,3.60992202608553,10.5054,0.595542878795702,0.446818836017566,0.648755773421683,0.489061567605348,0.148724042778136,0.159694205816336,True,0.558778680575379,0.0760685721714648,0.551920810350209,87.7338503990836
2408,36083,1561:1564,Pancreas,BxPC-3,SIDM00132,906693,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.636339528288927,0.138530074793341,0.514849942522932,9.19440952902308,11.4426,0.731609486257334,0.796980192357129,0.0742940465859337,0.327619369564624,0.0756657597635447,0.251953609801079,2.44691885984336,0.1065,6.74749066917972,11.3361,0.465552035376696,0.213599149951192,0.507149999660154,0.255270127640791,0.251952885425504,0.251879872019363,True,0.558778680575379,0.0760685721714648,0.551920810350209,87.7338503990836
2409,36083,1011:1564,Pancreas,BxPC-3,SIDM00132,906693,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.707416889429096,0.138530074793341,0.514849942522932,9.19440952902308,11.4426,0.731609486257334,0.796980192357129,0.0406992292867637,0.364213544862321,0.127653946463042,0.23655959839928,4.04858880693563,0.3232,5.14582072208745,11.1194,0.517552907044982,0.333315593240578,0.563797248613883,0.355920190550682,0.184237313804404,0.2078770580632,True,0.558778680575379,0.0760685721714648,0.551920810350209,87.7338503990836
2410,36083,1558:1564,Pancreas,BxPC-3,SIDM00132,906693,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.798967340204464,0.138530074793341,0.514849942522932,9.19440952902308,11.4426,0.731609486257334,0.796980192357129,0.130635404609457,0.411348289181969,0.223931210545067,0.187417078636901,5.91425519869988,1.1779,3.2801543303232,10.2647,0.584532085303377,0.434526718628117,0.636761144483218,0.496274218151575,0.15000536667526,0.140486926331642,True,0.558778680575379,0.0760685721714648,0.551920810350209,87.7338503990836
2411,34789,1080:1011,Pancreas,PANC-02-03,SIDM01139,1298475,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.687225785730422,0.0711595339841642,0.688838191974551,10.9839174919348,39.5566,0.909599572805439,0.908990214331678,0.0952693730361851,0.473387367720835,0.142493794813774,0.33089357290706,5.65226292892497,0.9823,5.33165456300985,38.5743,0.625100281121275,0.404939125795801,0.624681514265353,0.428841773556762,0.220161155325473,0.195839740708591,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2412,34789,1085:1011,Pancreas,PANC-02-03,SIDM01139,1298475,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.858210469873189,0.0711595339841642,0.688838191974551,10.9839174919348,39.5566,0.909599572805439,0.908990214331678,0.157043841178984,0.591168148401078,0.318557498895266,0.272610649505811,7.68405952389948,4.0166,3.29985796803535,35.54,0.780627876773808,0.601491128125706,0.78010491895172,0.65239032051783,0.179136748648102,0.127714598433891,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2413,34789,1372:1011,Pancreas,PANC-02-03,SIDM01139,1298475,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.3567894021998,0.0711595339841642,0.688838191974551,10.9839174919348,39.5566,0.909599572805439,0.908990214331678,0.0570876908117564,0.245770166726991,0.0855159492541804,0.160254217472811,6.11802933834321,1.3566,4.86588815359162,38.2,0.324535487822446,0.21363389684728,0.324318075176868,0.234559318486216,0.110901590975167,0.0897587566906518,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2414,34789,1083:1011,Pancreas,PANC-02-03,SIDM01139,1298475,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.86324769118964,0.0711595339841642,0.688838191974551,10.9839174919348,39.5566,0.909599572805439,0.908990214331678,0.108577819977871,0.594637978825277,0.438823934569699,0.155814044255578,9.08329649961763,10.5944,1.9006209923172,28.9622,0.785209731131378,0.647342836223486,0.784683703835797,0.721198517208174,0.137866894907892,0.0634851866276229,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2415,34789,1564:1011,Pancreas,PANC-02-03,SIDM01139,1298475,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.429830673630977,0.0711595339841642,0.688838191974551,10.9839174919348,39.5566,0.909599572805439,0.908990214331678,0.0616160947977834,0.296083784079165,0.0739353467962018,0.222148437282964,5.07695403286887,0.6592,5.90696345906596,38.8974,0.390973797113411,0.222926741372412,0.390711876150151,0.249968953899189,0.168047055740999,0.140742922250963,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2416,34789,1558:1011,Pancreas,PANC-02-03,SIDM01139,1298475,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.603376456530674,0.0711595339841642,0.688838191974551,10.9839174919348,39.5566,0.909599572805439,0.908990214331678,0.0830892232912066,0.415628747396601,0.0827351292691486,0.332893618127452,4.40797494361735,0.4146,6.57594254831748,39.142,0.548830967101161,0.300650925293347,0.548463294544506,0.320432983450658,0.248180041807813,0.228030311093848,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2417,34791,1168:1053,Pancreas,PANC-02-03,SIDM01139,1298475,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.848071778697765,0.0684974864688076,0.676684821780889,10.8438279343466,35.8961,0.892569073104958,0.90466387277439,0.098458518108724,0.573877300425498,0.418543699279261,0.155333601146237,8.93532726022024,9.5616,1.90850067412633,26.3345,0.756962641438737,0.643161566052099,0.767219899707385,0.702480768055525,0.113801075386638,0.0647391316518598,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2418,34791,1564:1053,Pancreas,PANC-02-03,SIDM01139,1298475,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.411298301789482,0.0684974864688076,0.676684821780889,10.8438279343466,35.8961,0.892569073104958,0.90466387277439,0.0537699075229087,0.278319318045198,0.0996059499608946,0.178713368084303,6.15205533365801,1.3889,4.69177260068856,34.5072,0.367112143997881,0.249143454087801,0.372086714562403,0.271380746391285,0.11796868991008,0.100705968171117,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2419,34791,1558:1053,Pancreas,PANC-02-03,SIDM01139,1298475,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.692276619452207,0.0684974864688076,0.676684821780889,10.8438279343466,35.8961,0.892569073104958,0.90466387277439,0.105648497976512,0.468453080857093,0.208824034876041,0.259629045981052,6.9043212720817,2.3396,3.93950666226486,33.5565,0.61790470055669,0.456761198581884,0.626277647584796,0.492285636096965,0.161143501974806,0.13399201148783,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2420,34791,1372:1053,Pancreas,PANC-02-03,SIDM01139,1298475,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.371194769343294,0.0684974864688076,0.676684821780889,10.8438279343466,35.8961,0.892569073104958,0.90466387277439,0.0415932994586397,0.251181866339065,0.0925811269683234,0.158600739370742,6.24955202470206,1.486,4.5942759096445,34.4101,0.331316971214153,0.234588715646598,0.335806497587701,0.247457808142651,0.0967282555675544,0.0883486894450498,True,0.421021199615924,0.0580147568595395,0.820347834806952,59.4535220477674
2421,38665,1510:1079,Pancreas,PANC-02-03,SIDM01139,1298475,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.837268446711131,0.0886141314275738,0.516192005730378,9.16174712182169,2.2373,0.811000563788787,0.839140532793532,0.123543490752549,0.432191278842577,0.148025011263373,0.284166267579204,5.15991720822525,0.1397,4.00182991359644,2.0976,0.679025182325289,0.44395129081462,0.702585890464391,0.492098739945924,0.235073891510669,0.210487150518467,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2422,38665,1083:1079,Pancreas,PANC-02-03,SIDM01139,1298475,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.956176650210231,0.0886141314275738,0.516192005730378,9.16174712182169,2.2373,0.811000563788787,0.839140532793532,0.180046163349611,0.493570742904573,0.304681017011428,0.188889725893145,7.10267966814759,0.5369,2.05906745367411,1.7004,0.775459802402171,0.598221906273893,0.802366583702147,0.692294074448878,0.177237896128278,0.11007250925327,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2423,38665,1561:1079,Pancreas,PANC-02-03,SIDM01139,1298475,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.563358439494002,0.0886141314275738,0.516192005730378,9.16174712182169,2.2373,0.811000563788787,0.839140532793532,0.0951188424738094,0.290801122827545,0.165843719955594,0.124957402871951,6.81763236132169,0.4406,2.34411476050001,1.7967,0.456884012044807,0.333635828540527,0.47273690107073,0.397383070098768,0.12324818350428,0.0753538309719622,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2424,38665,1564:1079,Pancreas,PANC-02-03,SIDM01139,1298475,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.489141473083767,0.0886141314275738,0.516192005730378,9.16174712182169,2.2373,0.811000563788787,0.839140532793532,0.0297980950438993,0.252490918077021,0.128413073721636,0.124077844355385,6.42147702157131,0.3348,2.74027010025038,1.9025,0.396694010443413,0.315992915979227,0.410458436334925,0.331921528469655,0.0807010944641855,0.0785369078652698,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2425,38665,1011:1080,Pancreas,PANC-02-03,SIDM01139,1298475,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.798345226892838,0.0683844407203839,0.559013053160871,9.59205354374038,0.1507,0.855532660832652,0.85837155044413,0.0649828553574654,0.446285402761773,0.179060484874279,0.267224917887494,5.90229290928408,0.0117,3.6897606344563,0.139,0.683010416226677,0.522912137161081,0.685276830197676,0.512596902735952,0.160098279065596,0.172679927461724,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2426,38666,1011:1083,Pancreas,PANC-02-03,SIDM01139,1298475,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.848485384620754,0.100900779152605,0.521967844090486,9.2195083993269,9.3147,0.878494802076377,0.841822540295354,0.13371708646365,0.442882086952782,0.237672278447125,0.205209808505657,6.64359881865055,1.5622,2.57590958067634,7.7525,0.745390000027108,0.643604106220058,0.714274121884924,0.588619922526712,0.10178589380705,0.125654199358212,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2427,38666,1011:1085,Pancreas,PANC-02-03,SIDM01139,1298475,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.848485384620754,0.112298603330665,0.646309374910155,10.5050031553239,28.3825,0.940020665469174,0.893511171194921,0.11893365294667,0.548384058554642,0.330720711816084,0.217663346738558,7.88097180441396,4.604,2.62403135090991,23.7785,0.797593795892069,0.687289707692415,0.758131169754263,0.654867384084904,0.110304088199654,0.103263785669359,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2428,38668,1510:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.855584867469442,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.0460070367208478,0.640533556583189,0.420216487689479,0.22031706889371,8.91156926978583,9.4055,2.81312560030935,56.6965,0.79468046824278,0.736907761304925,0.795055167723024,0.707709600783976,0.0577727069378544,0.0873455669390482,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2429,38668,1053:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.880273877517091,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.0407748287463588,0.659016982384199,0.434659224424914,0.224357757959285,8.93785760103751,9.5784,2.78683726905766,56.5236,0.817612002928691,0.739507960494501,0.817997514847986,0.729263335908924,0.0781040424341897,0.0887341789390624,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2430,38668,1083:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.939635898397392,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.0759329893936661,0.703458355538549,0.47233605882187,0.231122296716679,9.02676105410832,10.1872,2.69793381598685,55.9148,0.872748366768927,0.742345497184116,0.873159876013813,0.782483007741328,0.130402869584811,0.0906768682724847,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2431,38668,1561:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.523243843742716,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.052588284556912,0.391726470319732,0.28440309093585,0.107323379383882,9.43587020797887,13.5273,2.28882466211631,52.5747,0.485996981200073,0.434258977101149,0.486226133448723,0.44559002191255,0.051738004098924,0.040636111536173,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2432,38668,1564:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.509289836851019,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.035377165070657,0.38127980394827,0.133801563171693,0.247478240776576,6.42398271727522,1.677,5.30071215281995,64.425,0.473036283609249,0.33619034392924,0.47325932476439,0.345681691787907,0.136845939680009,0.127577632976483,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2433,38668,1057:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.983586528473118,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.0636171055099737,0.736361991947807,0.626601011926024,0.109760980021783,10.4045434302397,26.4734,1.32015143985547,39.6286,0.913570392281657,0.906635085144907,0.914001149504005,0.875404556933679,0.00693530713675,0.0385965925703261,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2434,38668,1372:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.360474545541981,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.0499831686377265,0.269869245580083,0.134870122045789,0.134999123534295,7.71564575963833,4.1055,4.00904911045685,61.9965,0.334814337574917,0.238318968311836,0.33497220575374,0.274704227607026,0.0964953692630817,0.0602679781467141,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2435,38668,1594:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.713936127837244,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.0480793701929926,0.534488236671803,0.295152337268017,0.239335899403786,8.1265817950543,5.4585,3.59811307504087,60.6435,0.663114926334765,0.533976039627968,0.663427591397226,0.561051367439742,0.129138886706797,0.102376223957483,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2436,38668,1079:1168,Pancreas,PANC-02-03,SIDM01139,1298475,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.61124990866696,0.0743016400428064,0.748649936361884,11.7246948700952,66.102,0.928815478694944,0.92925342412209,0.0392842197448436,0.457612205224728,0.377544569170753,0.080067636053975,10.1973693668602,22.9321,1.52732550323498,43.1699,0.567738376520744,0.523744847986937,0.568006070623088,0.53943723105526,0.043993528533807,0.0285688395678275,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2437,38669,1011:1372,Pancreas,PANC-02-03,SIDM01139,1298475,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.791088183803997,0.0805289354549323,0.231667656284567,6.00695178005728,0.1256,0.633076983422072,0.649546204452517,0.02847337005647,0.183269545456286,0.0593670609225547,0.123902484533732,2.72974982412382,0.013,3.27720195593347,0.1126,0.50081972102348,0.302012126554841,0.513848327177121,0.319643296986486,0.198807594468639,0.194205030190635,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2438,38669,1053:1372,Pancreas,PANC-02-03,SIDM01139,1298475,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.930038602075469,0.0805289354549323,0.231667656284567,6.00695178005728,0.1256,0.633076983422072,0.649546204452517,0.0381574434805986,0.215459863196999,0.0658218306190292,0.149638032577969,2.57194341637096,0.0116,3.43500836368633,0.114,0.588786032668019,0.349816579942064,0.604103043972445,0.364940990598601,0.238969452725955,0.239162053373844,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2439,38670,1372:1510,Pancreas,PANC-02-03,SIDM01139,1298475,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.320608135807377,0.0542107424888774,0.787421532209589,12.2689915462399,96.3972,0.940424669860801,0.941561204046405,0.0678201808649123,0.252453749536305,0.11025089066741,0.142202858868895,7.38716750944143,3.2696,4.88182403679844,93.1276,0.30150780027134,0.192397679383209,0.301872182377868,0.237904187615086,0.109110120888131,0.0639679947627817,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2440,38670,1168:1510,Pancreas,PANC-02-03,SIDM01139,1298475,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.84878751268265,0.0542107424888774,0.787421532209589,12.2689915462399,96.3972,0.940424669860801,0.941561204046405,0.0800554747193486,0.668353563756938,0.409738535806608,0.25861502795033,8.82751548239734,8.8731,3.44147606384254,87.5241,0.798220716396551,0.630084994985855,0.799185392421029,0.698561026246141,0.168135721410696,0.100624366174888,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2441,38670,1594:1510,Pancreas,PANC-02-03,SIDM01139,1298475,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.681766172053563,0.0542107424888774,0.787421532209589,12.2689915462399,96.3972,0.940424669860801,0.941561204046405,0.0627285780330087,0.536837363807082,0.438455777186212,0.0983815866208703,10.4702157207746,27.7063,1.79877582546529,68.6909,0.641149727275734,0.565544886784799,0.641924577836861,0.608346630216093,0.0756048404909342,0.0335779476207674,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2442,38670,1564:1510,Pancreas,PANC-02-03,SIDM01139,1298475,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.443980846192073,0.0542107424888774,0.787421532209589,12.2689915462399,96.3972,0.940424669860801,0.941561204046405,0.101686914787513,0.349600078180272,0.125040646937111,0.22455943124316,6.66240593728338,1.9784,5.60658560895649,94.4188,0.417530540704699,0.255787706316134,0.41803514011415,0.308566184456927,0.161742834388565,0.109468955657223,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2443,38670,1558:1510,Pancreas,PANC-02-03,SIDM01139,1298475,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.619597922819382,0.0542107424888774,0.787421532209589,12.2689915462399,96.3972,0.940424669860801,0.941561204046405,0.02563946256079,0.487884745740316,0.278537259030773,0.209347486709543,8.49444623795903,7.0439,3.77454530828084,89.3533,0.582685172013855,0.48667450348771,0.583389366234469,0.499339850150187,0.0960106685261452,0.0840495160842815,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2444,38670,1079:1510,Pancreas,PANC-02-03,SIDM01139,1298475,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.815082354618517,0.0542107424888774,0.787421532209589,12.2689915462399,96.3972,0.940424669860801,0.941561204046405,0.0433371198837486,0.641813396550712,0.364368973375548,0.277444423175164,8.4690920347755,6.9212,3.79989951146437,89.476,0.766523554251483,0.621528437365017,0.76744992321159,0.655787761371093,0.144995116886466,0.111662161840497,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2445,38671,1372:1558,Pancreas,PANC-02-03,SIDM01139,1298475,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.435451064320879,0.0724281151943905,0.694583048354299,11.0511732798498,41.4443,0.918606379555629,0.911009454503977,0.0866018801791805,0.30245692766512,0.169126585412527,0.133330342252593,7.86643903370195,4.5579,3.18473424614786,36.8864,0.400008125669448,0.276992583781296,0.39670003657014,0.335715384928641,0.123015541888153,0.0609846516414993,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2446,38671,1011:1558,Pancreas,PANC-02-03,SIDM01139,1298475,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.7938115099598,0.0724281151943905,0.694583048354299,11.0511732798498,41.4443,0.918606379555629,0.911009454503977,0.122102679974017,0.551368018406607,0.326446935225013,0.224921083181594,8.10416594966489,5.3744,2.94700733018492,36.0699,0.729200317213759,0.648415124283066,0.723169790667456,0.622821274917866,0.0807851929306931,0.10034851574959,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2447,38671,1510:1558,Pancreas,PANC-02-03,SIDM01139,1298475,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,2.5,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.825781220082704,0.0724281151943905,0.694583048354299,11.0511732798498,41.4443,0.918606379555629,0.911009454503977,0.0877824580205483,0.573573637118777,0.423939930706791,0.149633706411986,9.13364672030354,10.9706,1.91752655954626,30.4737,0.758567896885203,0.728018789720786,0.752294498847173,0.691859725793121,0.0305491071644176,0.0604347730540515,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2448,38671,1053:1558,Pancreas,PANC-02-03,SIDM01139,1298475,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.853407674321674,0.0724281151943905,0.694583048354299,11.0511732798498,41.4443,0.918606379555629,0.911009454503977,0.103981752503284,0.592762503919301,0.303031562745859,0.289730941173442,7.51020224026248,3.5606,3.54097103958733,37.8837,0.783945733993622,0.65772650202443,0.777462459853295,0.63974913945545,0.126219231969192,0.137713320397845,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2449,38671,1564:1558,Pancreas,PANC-02-03,SIDM01139,1298475,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.405641572536044,0.0724281151943905,0.694583048354299,11.0511732798498,41.4443,0.918606379555629,0.911009454503977,0.0595790142389358,0.281751759991317,0.115323387039153,0.166428372952164,6.69517815326831,2.0239,4.3559951265815,39.4204,0.372624936344588,0.264770235765358,0.369543307720197,0.282814998187417,0.10785470057923,0.0867283095327806,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2450,38671,1372:1561,Pancreas,PANC-02-03,SIDM01139,1298475,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.435451064320879,0.0921085012269138,0.436928927828706,8.36681042886553,6.4475,0.755232311378671,0.799088625844353,0.11566751534827,0.19026116665559,0.0379321210244314,0.152329045631159,3.13471405086188,0.1715,5.23209637800364,6.276,0.32886671379936,0.154706350800473,0.347963992610632,0.18912731090634,0.174160362998887,0.158836681704292,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2451,38671,1564:1561,Pancreas,PANC-02-03,SIDM01139,1298475,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.405641572536044,0.0921085012269138,0.436928927828706,8.36681042886553,6.4475,0.755232311378671,0.799088625844353,0.0916968737687506,0.177236537370924,0.0476356304643106,0.129600906906613,3.96472536103672,0.305,4.40208506782881,6.1425,0.306353622417676,0.163969047565204,0.32414356678317,0.201730187444589,0.142384574852471,0.122413379338581,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2452,38672,1510:1564,Pancreas,PANC-02-03,SIDM01139,1298475,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.861134760706972,0.0871916505797526,0.247320898277914,6.22156279796485,1.4575,0.636111176327165,0.66469463728703,0.0457515269790702,0.212976622556385,0.0735218135247141,0.139454809031671,3.0798411214964,0.1651,3.14172167646844,1.2924,0.547777445609524,0.353009286206666,0.572391657423375,0.37045896576343,0.194768159402858,0.201932691659945,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2453,38672,1053:1564,Pancreas,PANC-02-03,SIDM01139,1298475,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.859568705486618,0.0871916505797526,0.247320898277914,6.22156279796485,1.4575,0.636111176327165,0.66469463728703,0.0468343970919444,0.212589304372534,0.058792211660378,0.153797092712156,2.48032243716879,0.109,3.74124036079605,1.3485,0.546781260381111,0.314618385392526,0.57135070891671,0.331504010380626,0.232162874988585,0.239846698536084,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2454,38672,1083:1564,Pancreas,PANC-02-03,SIDM01139,1298475,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.910437378186543,0.0871916505797526,0.247320898277914,6.22156279796485,1.4575,0.636111176327165,0.66469463728703,0.0540306747049187,0.225170190198885,0.115913625825435,0.10925656437345,4.19457660160222,0.3576,2.02698619636263,1.0999,0.579139391610462,0.457797648667002,0.605162842866259,0.468717999216887,0.121341742943461,0.136444843649373,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2455,38672,1561:1564,Pancreas,PANC-02-03,SIDM01139,1298475,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.626849620045277,0.0871916505797526,0.247320898277914,6.22156279796485,1.4575,0.636111176327165,0.66469463728703,0.0594535478542793,0.155033011114767,0.0411254217973862,0.113907589317381,2.36885544931727,0.1009,3.85270734864758,1.3566,0.398746049187237,0.212191404625708,0.416663580829508,0.236647435248269,0.186554644561529,0.180016145581239,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2456,38672,1011:1564,Pancreas,PANC-02-03,SIDM01139,1298475,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.861012347462504,0.0871916505797526,0.247320898277914,6.22156279796485,1.4575,0.636111176327165,0.66469463728703,0.0784139953196996,0.212946347202802,0.0369210174453566,0.176025329757445,1.24725280574861,0.0464,4.97430999221623,1.4111,0.547699577176587,0.218806435932325,0.572310289996244,0.257389960552655,0.328893141244262,0.314920329443588,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2457,38672,1372:1594,Pancreas,PANC-02-03,SIDM01139,1298475,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.354183827621931,0.052391917127259,0.706834656873299,11.1970316929983,18.3414,0.929205721807117,0.915261937297933,0.0452835306624566,0.250349404267219,0.148634964739028,0.101714439528191,8.19067275538581,2.2826,3.00635893761246,16.0588,0.329109639197844,0.248052839285507,0.324170976228846,0.279605671961874,0.0810567999123371,0.0445653042669721,True,0.198516970435106,0.0316313780823744,1.50188535768895,32.7086878167275
2458,34803,1080:1011,Pancreas,PANC-04-03,SIDM01137,1298476,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.662101983686631,0.100200581896185,0.687745159462619,11.9397640037563,76.7286,0.900002112486069,0.871976914240318,0.091916777655307,0.455357434351078,0.305378967537119,0.14997846681396,8.42140579252903,6.6962,3.51835821122731,70.0324,0.595893183999185,0.483330429228498,0.577337644647462,0.490222068737049,0.112562754770687,0.0871155759104124,True,0.637311945120776,0.0818472420360246,0.429995454776877,112.628212479526
2459,34803,1564:1011,Pancreas,PANC-04-03,SIDM01137,1298476,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.437673064947884,0.100200581896185,0.687745159462619,11.9397640037563,76.7286,0.900002112486069,0.871976914240318,0.0727533439526358,0.301007531845076,0.186148353594037,0.114859178251039,7.87935356107407,4.5989,4.06041044268227,72.1297,0.393906683031348,0.310530925362486,0.381640808619358,0.312717713236007,0.083375757668862,0.068923095383351,True,0.637311945120776,0.0818472420360246,0.429995454776877,112.628212479526
2460,34803,1558:1011,Pancreas,PANC-04-03,SIDM01137,1298476,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.652196052339669,0.100200581896185,0.687745159462619,11.9397640037563,76.7286,0.900002112486069,0.871976914240318,0.0935458771496507,0.448544678017237,0.220819311606613,0.227725366410623,6.50686665049863,1.7762,5.4328973532577,74.9524,0.586977824860777,0.408243066704412,0.568699901198862,0.419574581488313,0.178734758156365,0.149125319710549,True,0.637311945120776,0.0818472420360246,0.429995454776877,112.628212479526
2461,34805,1564:1053,Pancreas,PANC-04-03,SIDM01137,1298476,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.557580208544892,0.0685298307569971,0.720239863730981,12.5207667535592,114.7774,0.858654744907229,0.887546782439281,0.0583916022398709,0.401591493421465,0.316350873596711,0.0852406198247542,10.0093499564339,20.13,2.51141679712533,94.6474,0.478768891733434,0.414773208257703,0.494878520045842,0.450444015979475,0.0639956834757312,0.0444345040663675,True,0.637311945120776,0.0818472420360246,0.429995454776877,112.628212479526
2462,34805,1372:1053,Pancreas,PANC-04-03,SIDM01137,1298476,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.453959047856158,0.0685298307569971,0.720239863730981,12.5207667535592,114.7774,0.858654744907229,0.887546782439281,0.0719452574852346,0.326959402767365,0.281806950225036,0.0451524525423288,10.8349127255663,35.675,1.68585402799288,79.1024,0.389794090435258,0.318913297584576,0.402909892283932,0.380270400760737,0.0708807928506814,0.0226394915231952,True,0.637311945120776,0.0818472420360246,0.429995454776877,112.628212479526
2463,34805,1558:1053,Pancreas,PANC-04-03,SIDM01137,1298476,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.835507521330887,0.0685298307569971,0.720239863730981,12.5207667535592,114.7774,0.858654744907229,0.887546782439281,0.0585233164412143,0.601765823309568,0.566757470623939,0.035008352685629,11.7779985049284,68.59,0.742768248630826,46.1874,0.717412497596444,0.679236955241513,0.741552012261048,0.724673915531255,0.0381755423549313,0.0168780967297928,True,0.637311945120776,0.0818472420360246,0.429995454776877,112.628212479526
2464,34806,1564:1057,Pancreas,PANC-04-03,SIDM01137,1298476,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.499979002590757,0.0734492872214773,0.581132971884712,10.2190438028058,0.2328,0.827989102344603,0.815773918791995,0.0595563109846436,0.290554283655521,0.325720757616599,-0.0351664739610781,11.3288139481951,0.5024,-1.10977014538923,-0.2696,0.413977165546271,0.429093606450404,0.407869830257175,0.426876794479812,-0.0151164409041331,-0.0190069642226364,True,0.637311945120776,0.0818472420360246,0.429995454776877,112.628212479526
2465,37949,1564:1168,Pancreas,PANC-04-03,SIDM01137,1298476,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.480845657836477,0.0628523989520838,0.671246454991283,11.6576611954694,63.1009,0.838273638038805,0.863815105084976,0.0645655761562968,0.322765943220687,0.172892865166339,0.149873078054348,6.85074316386395,2.2543,4.80691803160549,60.8466,0.403080238929746,0.274275067704458,0.415361742453671,0.318238896946916,0.128805171225289,0.0971228455067556,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2466,37949,1372:1168,Pancreas,PANC-04-03,SIDM01137,1298476,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.427193003465834,0.0628523989520838,0.671246454991283,11.6576611954694,63.1009,0.838273638038805,0.863815105084976,0.0579539931423068,0.28675178917352,0.180095351503664,0.106656437669856,7.82239038570352,4.4208,3.83527080976592,58.6801,0.358104633160028,0.259500254839505,0.369015769180406,0.304033350846247,0.098604378320523,0.0649824183341592,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2467,37950,1011:1372,Pancreas,PANC-04-03,SIDM01137,1298476,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.903611098391413,0.0588795756761858,0.411527438936295,7.66841205367572,0.3973,0.697376374049639,0.704058284086518,0.138491900657144,0.37186076111543,0.207376882264843,0.164483878850587,4.49075990578759,0.0439,3.17765214788813,0.3534,0.630157031347215,0.489420120085134,0.636194879414992,0.477765328827063,0.140736911262081,0.15842955058793,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2468,37950,1561:1372,Pancreas,PANC-04-03,SIDM01137,1298476,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.748169167591181,0.0588795756761858,0.411527438936295,7.66841205367572,0.3973,0.697376374049639,0.704058284086518,0.0539334445474466,0.307892141429898,0.207719731094524,0.100172410335374,5.43991853711725,0.0848,2.22849351655847,0.3125,0.521755501270474,0.433230756982715,0.526754700340685,0.436696562883259,0.088524744287759,0.0900581374574261,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2469,37950,1558:1372,Pancreas,PANC-04-03,SIDM01137,1298476,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.68590226696937,0.0588795756761858,0.411527438936295,7.66841205367572,0.3973,0.697376374049639,0.704058284086518,0.0475298681470555,0.282267603286503,0.135472955561156,0.146794647725347,3.78047135404808,0.0268,3.88794069962764,0.3705,0.478332035891526,0.299122048250855,0.482915173133507,0.334129805713554,0.179209987640672,0.148785367419953,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2470,37951,1594:1510,Pancreas,PANC-04-03,SIDM01137,1298476,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.514427308753141,0.189221530950709,0.749179914538076,13.073989652135,168.4198,0.820415528966849,0.900885659849128,0.0741426443716151,0.385398607207731,0.272689339229686,0.112709267978044,9.44855609977058,13.6467,3.62543355236439,154.7731,0.4220441526257,0.346021599301361,0.463440185490484,0.404097353638453,0.0760225533243398,0.059342831852031,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2471,37951,1564:1510,Pancreas,PANC-04-03,SIDM01137,1298476,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.467231342255677,0.189221530950709,0.749179914538076,13.073989652135,168.4198,0.820415528966849,0.900885659849128,0.0752430478333837,0.350040337060619,0.199747518365631,0.150292818694988,7.91283309213568,4.7068,5.16115655999929,163.713,0.383323848806582,0.269457304208924,0.420922016070199,0.334602995249146,0.113866544597658,0.0863190208210524,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2472,37859,1372:1558,Pancreas,PANC-04-03,SIDM01137,1298476,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.563091859717724,0.08234955630482,0.789534950080426,13.9224168540736,303.246,0.937059808680168,0.918722441208541,0.0391868381357363,0.444580703352927,0.298657942627383,0.145922760725544,9.45313071659454,13.6901,4.4692861374791,289.5559,0.52765075033645,0.428764205912186,0.517325127984525,0.442431088174847,0.0988865444242635,0.0748940398096772,True,0.443763398937816,0.0512387775856909,0.783515460877759,62.6601112551757
2473,37859,1372:1561,Pancreas,PANC-04-03,SIDM01137,1298476,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.504898876052651,0.0954531995704151,0.588541253562842,10.3326440370798,25.1864,0.803839049712807,0.819965859022967,0.0667973245026587,0.297153817434497,0.202424184707192,0.0947296327273051,7.50467859638356,3.547,2.82796544069628,21.6394,0.405857432727227,0.321009120312369,0.413999840622242,0.35131855533775,0.0848483124148586,0.062681285284492,True,0.443763398937816,0.0512387775856909,0.783515460877759,62.6601112551757
2474,37859,1564:1561,Pancreas,PANC-04-03,SIDM01137,1298476,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.541575492520627,0.0954531995704151,0.588541253562842,10.3326440370798,25.1864,0.803839049712807,0.819965859022967,0.0630385558539406,0.318739519267003,0.134592118400273,0.18414740086673,4.88028977547633,0.5752,5.4523542616035,24.6112,0.435339529255526,0.261828214318192,0.444073413950462,0.298637464962675,0.173511314937334,0.145435948987786,True,0.443763398937816,0.0512387775856909,0.783515460877759,62.6601112551757
2475,37953,1011:1564,Pancreas,PANC-04-03,SIDM01137,1298476,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.887603345345935,0.074343044849634,0.414434986516591,7.71306519240408,4.0982,0.703149968370556,0.706285111473152,0.122953206469851,0.367853880460524,0.147442159929789,0.220411720530735,2.99301277336217,0.1555,4.7200524190419,3.9427,0.624118264205594,0.36438576399509,0.626901027711597,0.391637753577504,0.259732500210505,0.235263274134093,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2476,37953,1561:1564,Pancreas,PANC-04-03,SIDM01137,1298476,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.745742799326834,0.074343044849634,0.414434986516591,7.71306519240408,4.0982,0.703149968370556,0.706285111473152,0.128613676495811,0.309061906983861,0.212651815865371,0.0964100911184904,5.57832672966745,0.9332,2.13473846273662,3.165,0.524369025759234,0.457597002758844,0.526707036152854,0.441167276105421,0.0667720230003892,0.0855397600474331,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2477,37953,1053:1564,Pancreas,PANC-04-03,SIDM01137,1298476,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.826601851122588,0.074343044849634,0.414434986516591,7.71306519240408,4.0982,0.703149968370556,0.706285111473152,0.033943798146685,0.342572727024579,0.13486040740172,0.207712319622859,2.91281692460523,0.1471,4.80024826779884,3.9511,0.581225065471891,0.338141602500966,0.583816580564031,0.360887878343174,0.243083462970925,0.222928702220857,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2478,37953,1564:1594,Pancreas,PANC-04-03,SIDM01137,1298476,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.49974548942981,0.0842040224389601,0.538265499361362,9.57098337107721,5.9421,0.823341005757867,0.79054466941096,0.056027200590011,0.268995755421525,0.112993143352175,0.156002612069351,4.41886989642967,0.1671,5.15211347464754,5.775,0.411460953890097,0.241580932274028,0.395071132730908,0.262129921410982,0.16988002161607,0.132941211319926,True,0.348765568471667,0.0482780117240611,0.97132243443711,49.87153460355
2479,34796,1080:1011,Pancreas,PANC-10-05,SIDM01135,925348,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.696887463866123,0.111142113753159,0.530693373797153,9.41506065590052,13.3335,0.836729524969163,0.80118139606239,0.0952988569668886,0.369833559356055,0.120632199025515,0.249201360330539,3.71988976498578,0.2574,5.69517089091474,13.0761,0.583106316597666,0.320511531237979,0.558333271198639,0.336161759195718,0.262594785359687,0.222171512002921,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2480,34796,1085:1011,Pancreas,PANC-10-05,SIDM01135,925348,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.752628886814874,0.111142113753159,0.530693373797153,9.41506065590052,13.3335,0.836729524969163,0.80118139606239,0.0960305214869402,0.399415163160981,0.212260088172625,0.187155074988356,5.84491017672891,1.1226,3.57015047917162,12.2109,0.629746810942679,0.457854514896529,0.602992262255223,0.46241160566014,0.17189229604615,0.140580656595083,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2481,34796,1083:1011,Pancreas,PANC-10-05,SIDM01135,925348,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.958276642414878,0.111142113753159,0.530693373797153,9.41506065590052,13.3335,0.836729524969163,0.80118139606239,0.120192327056882,0.50855106439416,0.383945018612742,0.124606045781418,7.64027723237964,3.8966,1.77478342352089,9.4369,0.801818359796845,0.705936505157732,0.767753418183932,0.686455454236102,0.0958818546391138,0.0812979639478294,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2482,34796,1564:1011,Pancreas,PANC-10-05,SIDM01135,925348,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.659368309572054,0.111142113753159,0.530693373797153,9.41506065590052,13.3335,0.836729524969163,0.80118139606239,0.068774424962472,0.349922392781719,0.217778409609245,0.132143983172473,6.61317436170233,1.912,2.8018862941982,11.4215,0.551712932447945,0.445718853733195,0.528273622782236,0.434942940642588,0.10599407871475,0.0933306821396482,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2483,34796,1558:1011,Pancreas,PANC-10-05,SIDM01135,925348,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.345788140421311,0.111142113753159,0.530693373797153,9.41506065590052,13.3335,0.836729524969163,0.80118139606239,0.0617239039433837,0.183507474859229,0.0782780159566752,0.105229458902554,4.85071026418261,0.5636,4.56435039171791,12.7699,0.289331146474694,0.158651681049265,0.277039025084564,0.191349862630277,0.130679465425428,0.0856891624542862,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2484,34796,1079:1011,Pancreas,PANC-10-05,SIDM01135,925348,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.736648292300338,0.111142113753159,0.530693373797153,9.41506065590052,13.3335,0.836729524969163,0.80118139606239,0.103998774339021,0.390934367542778,0.235020631215982,0.155913736326796,6.44002558739835,1.6958,2.97503506850217,11.6377,0.616375375685807,0.484361733852672,0.59018890723216,0.478544867223287,0.132013641833134,0.111644040008873,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2485,34800,1011:1079,Pancreas,PANC-10-05,SIDM01135,925348,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.628270021799055,0.122275266806657,0.514303657298939,9.19323515304042,2.2866,0.748065400141437,0.791590788198649,0.0503465121019133,0.323121569982538,0.185263564490105,0.137858005492433,6.05639304665626,0.26,3.13684210638416,2.0266,0.469987065253979,0.379306607805797,0.497332761757496,0.393956610034535,0.0906804574481822,0.103376151722961,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2486,34800,1011:1080,Pancreas,PANC-10-05,SIDM01135,925348,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.628270021799055,0.109490447429348,0.542921181419339,9.58111538461926,0.1496,0.780117042840325,0.808163270182193,0.107288202191893,0.341101102485497,0.137281522963742,0.203819579521755,4.69709401621295,0.0051,4.8840213684063,0.1445,0.490124151511106,0.328578193696117,0.507744755374562,0.341641405331259,0.161545957814988,0.166103350043303,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2487,34801,1011:1083,Pancreas,PANC-10-05,SIDM01135,925348,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.660185252581162,0.134049679330471,0.623591959271885,10.7045086663017,26.0734,0.883852078458873,0.850925988863807,0.142206687816889,0.411686215139491,0.237049045020752,0.174637170118739,7.04359252081863,2.0614,3.66091614548308,24.012,0.583506107661755,0.481772936994541,0.561768788885927,0.451558656180062,0.101733170667214,0.110210132705866,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2488,34801,1558:1085,Pancreas,PANC-10-05,SIDM01135,925348,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.299930958902025,0.139499302771171,0.630770418064376,10.808168638215,35.0197,0.897924374442036,0.85448132199843,0.0586776943312342,0.18918757633708,0.103749682065631,0.0854378942714491,6.84900440954341,2.2516,3.95916422867162,32.7681,0.269315318647901,0.177403639908031,0.256285402270859,0.201876531894565,0.09191167873987,0.0544088703762944,True,0.503706153735019,0.072365194714124,0.655614271389737,74.3860304729108
2489,38820,1080:1011,Pancreas,PANC-03-27,SIDM01138,925346,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.536665399757355,0.0791809609038411,0.825476489277227,12.5837720981384,119.901,0.933920523417384,0.956403688750453,0.0521355920794937,0.443004670108261,0.115490897556676,0.327513772551584,6.01597310300489,1.2639,6.56779899513353,118.6371,0.501202831041388,0.323528942315602,0.513268767952671,0.352301356712943,0.177673888725786,0.160967411239727,True,0.506212168950367,0.0457146802459805,0.638007704311463,75.6277239581174
2490,38820,1372:1011,Pancreas,PANC-03-27,SIDM01138,925346,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.512724044263898,0.0791809609038411,0.825476489277227,12.5837720981384,119.901,0.933920523417384,0.956403688750453,0.150068696277383,0.423241644026983,0.112107644169758,0.311133999857226,6.06281575219349,1.3056,6.52095634594493,118.5954,0.478843507787617,0.295077016867412,0.490371167245042,0.338357099954041,0.183766490920206,0.152014067291002,True,0.506212168950367,0.0457146802459805,0.638007704311463,75.6277239581174
2491,38820,1564:1011,Pancreas,PANC-03-27,SIDM01138,925346,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.513195174042178,0.0791809609038411,0.825476489277227,12.5837720981384,119.901,0.933920523417384,0.956403688750453,0.0595686380317261,0.423630550582352,0.04813133876565,0.375499211816702,3.76874152088977,0.2662,8.81503057724865,119.6348,0.479283505556746,0.21686793325861,0.49082175750287,0.24716927287774,0.262415572298136,0.24365248462513,True,0.506212168950367,0.0457146802459805,0.638007704311463,75.6277239581174
2492,38677,1372:1053,Pancreas,PANC-03-27,SIDM01138,925346,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.516728078175221,0.0394529570143333,0.606715029775383,9.99984076311586,19.9978,0.879732389175414,0.886703421129744,0.0538257937129571,0.313506691335855,0.0853934680247006,0.228113223311155,5.26467310673434,0.7509,4.73516765638151,19.2469,0.454582426767107,0.298997467742844,0.458184554711766,0.309816547473727,0.155584959024263,0.148368007238039,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2493,38677,1564:1053,Pancreas,PANC-03-27,SIDM01138,925346,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.552684516924224,0.0394529570143333,0.606715029775383,9.99984076311586,19.9978,0.879732389175414,0.886703421129744,0.0555354716585855,0.335322003142073,0.0809460516016901,0.254375951540383,4.93480838417901,0.5974,5.06503237893684,19.4004,0.486214470534007,0.305705557574253,0.490067251962149,0.317192370916404,0.180508912959754,0.172874881045745,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2494,38679,1083:1079,Pancreas,PANC-03-27,SIDM01138,925346,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.736808957447505,0.115729110719491,0.325634674830994,7.32101868903357,0.6246,0.686084050403249,0.747405864007129,0.0477705965143127,0.239930545270982,0.0532705777093866,0.186659967561596,3.11454058235846,0.0338,4.2064781066751,0.5908,0.505512873898979,0.308953880884626,0.550695335449244,0.316793413399705,0.196558993014353,0.233901922049539,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2495,38679,1561:1079,Pancreas,PANC-03-27,SIDM01138,925346,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.757530227671515,0.115729110719491,0.325634674830994,7.32101868903357,0.6246,0.686084050403249,0.747405864007129,0.0711812232712628,0.246678109362463,0.0929340214355552,0.153744087926908,4.46282739870395,0.0861,2.85819129032962,0.5385,0.519729406903768,0.396019357575858,0.566182534324345,0.406592322766056,0.12371004932791,0.159590211558289,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2496,38679,1011:1080,Pancreas,PANC-03-27,SIDM01138,925346,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.743718055397196,0.0683633798362898,0.361522257760017,7.68825794688467,0.0403,0.768169633773786,0.770619974581729,0.0866688843034788,0.268870630524084,0.0807335553653945,0.188137075158689,4.14384804617139,0.0035,3.54440990071328,0.0368,0.571301626245417,0.381260271441303,0.57312398894616,0.380359603193495,0.190041354804114,0.192764385752665,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2497,38680,1011:1083,Pancreas,PANC-03-27,SIDM01138,925346,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.644493075887244,0.0903479031192118,0.598395844976971,9.9197215919708,15.134,0.924967747197989,0.88358775082042,0.0963195630373791,0.385661978727355,0.165212540096252,0.220449438631103,6.54366100390767,1.4577,3.37606058806313,13.6763,0.596135308488126,0.473627508633572,0.569466187342544,0.447699630300187,0.122507799854554,0.121766557042357,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2498,38680,1079:1083,Pancreas,PANC-03-27,SIDM01138,925346,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.591880764502083,0.0903479031192118,0.598395844976971,9.9197215919708,15.134,0.924967747197989,0.88358775082042,0.0663096252834417,0.35417899019984,0.160434115572042,0.193744874627798,6.71846247145907,1.6454,3.20125912051173,13.4886,0.547470617351315,0.403841822010546,0.522978593460266,0.418405601126855,0.143628795340769,0.104572992333412,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2499,38682,1083:1168,Pancreas,PANC-03-27,SIDM01138,925346,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.954334753004223,0.0544490838816602,0.589313617896805,9.83287318193954,17.8123,0.865160748700882,0.880137550246204,0.0945323241324613,0.562402465977573,0.395509327180011,0.166893138797562,8.20279587297114,5.7546,1.6300773089684,12.0577,0.825652969420405,0.715521882645056,0.839945851623953,0.764496350720359,0.110131086775349,0.0754495009035938,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2500,38683,1011:1372,Pancreas,PANC-03-27,SIDM01138,925346,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.6384205887794,0.128709020963077,0.376782335089557,7.83940177684449,0.4473,0.709666131456768,0.779824382092013,0.0416930986962657,0.240545600209552,0.0285371826339481,0.212008417575604,1.93795252989524,0.0075,5.90144924694925,0.4398,0.453065469481429,0.191657946299705,0.497855941159715,0.217149897650533,0.261407523181724,0.280706043509182,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2501,38683,1053:1372,Pancreas,PANC-03-27,SIDM01138,925346,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.783139180974925,0.128709020963077,0.376782335089557,7.83940177684449,0.4473,0.709666131456768,0.779824382092013,0.0448220802547376,0.295073009307855,0.140840701958164,0.154232307349692,5.50035659796807,0.0884,2.33904517887641,0.3589,0.555767352954697,0.471403889055102,0.610711027895817,0.483732215589648,0.0843634638995951,0.126978812306169,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2502,38683,1561:1372,Pancreas,PANC-03-27,SIDM01138,925346,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.748524077308677,0.128709020963077,0.376782335089557,7.83940177684449,0.4473,0.709666131456768,0.779824382092013,0.0581955211314736,0.282030649719119,0.112327572481918,0.169703077237201,5.00066195986817,0.0625,2.83873981697632,0.3848,0.531202186245896,0.429529346472051,0.583717326068233,0.433440799141184,0.101672839773845,0.150276526927049,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2503,38683,1558:1372,Pancreas,PANC-03-27,SIDM01138,925346,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.526981771611,0.128709020963077,0.376782335089557,7.83940177684449,0.4473,0.709666131456768,0.779824382092013,0.0807292524982036,0.198557422457224,0.0346090144186236,0.163948408038601,2.87647618168598,0.0143,4.9629255951585,0.433,0.373981115207413,0.199336556160796,0.410953234420303,0.216782639807763,0.174644559046617,0.19417059461254,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2504,38684,1011:1510,Pancreas,PANC-03-27,SIDM01138,925346,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.668167757404731,0.0730266220859258,0.835046890852019,12.7404286682537,133.6538,0.942127877190787,0.959020388338345,0.0759919017413162,0.557951408388387,0.337620773563561,0.220330634824826,9.04883484365324,10.3443,3.69159382460046,123.3095,0.629499470891048,0.494645232766867,0.640786502181447,0.564938973068098,0.134854238124181,0.0758475291133487,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2505,38685,1011:1558,Pancreas,PANC-03-27,SIDM01138,925346,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.641781476319212,0.0633041708824835,0.573893135887679,9.68670964291366,16.0961,0.878358390324694,0.874158672823563,0.0681122084308541,0.368313983999456,0.142396023734935,0.225917960264521,6.10612511482335,1.3454,3.58058452809031,14.7507,0.563714144479949,0.430076545010756,0.56101884358195,0.425568943617457,0.133637599469193,0.135449899964492,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2506,38685,1079:1561,Pancreas,PANC-03-27,SIDM01138,925346,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.744368063342112,0.0803198095726011,0.436976166172611,8.4154821536591,6.6687,0.775063759066195,0.812923536349956,0.0598247377502005,0.325271102540567,0.102907708638646,0.222363393901922,4.7796562596124,0.5365,3.6358258940467,6.1322,0.576932709302761,0.394260960759571,0.605114318398038,0.418141173805744,0.18267174854319,0.186973144592294,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2507,38685,1564:1561,Pancreas,PANC-03-27,SIDM01138,925346,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.610640740782197,0.0803198095726011,0.436976166172611,8.4154821536591,6.6687,0.775063759066195,0.812923536349956,0.0372351178669829,0.266835449815807,0.0426725299334971,0.22416291988231,3.03010343243101,0.1595,5.38537872122808,6.5092,0.473285507989615,0.235915848021053,0.49640423043602,0.258510607958068,0.237369659968562,0.237893622477953,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2508,38685,1011:1561,Pancreas,PANC-03-27,SIDM01138,925346,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.801031277893258,0.0803198095726011,0.436976166172611,8.4154821536591,6.6687,0.775063759066195,0.812923536349956,0.0436437753783361,0.350031576798143,0.174523712872537,0.175507863925606,6.05230964298937,1.2962,2.36317251066973,5.3725,0.620850313373547,0.521583631099838,0.651177179151912,0.527996748586767,0.0992666822737086,0.123180430565145,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2509,38685,1372:1561,Pancreas,PANC-03-27,SIDM01138,925346,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.569304899064395,0.0803198095726011,0.436976166172611,8.4154821536591,6.6687,0.775063759066195,0.812923536349956,0.0516807581429501,0.248772672176445,0.0432669630503089,0.205505709126136,3.23888432530334,0.1844,5.17659782835576,6.4843,0.441247595123651,0.231579323024302,0.462801351808783,0.250333855982577,0.209668272099349,0.212467495826206,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2510,38686,1057:1564,Pancreas,PANC-03-27,SIDM01138,925346,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.940289398408084,0.12326670565707,0.356075127865413,7.63365127413892,3.8787,0.710491001301292,0.7672433930183,0.116402956460672,0.33481366776865,0.364899836301936,-0.0300861685332854,7.94965188864865,4.8285,-0.316000614509734,-0.9498,0.668067156187949,0.683738958934439,0.721430828453755,0.739448273163902,-0.0156718027464905,-0.0180174447101467,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2511,38686,1011:1564,Pancreas,PANC-03-27,SIDM01138,925346,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.609335344830934,0.12326670565707,0.356075127865413,7.63365127413892,3.8787,0.710491001301292,0.7672433930183,0.0680061647230234,0.21696916082359,0.0260021690738299,0.19096699174976,1.82605370109709,0.0693,5.80759757304183,3.8094,0.432927279277198,0.164650172840975,0.467508517454062,0.202255355197565,0.268277106436223,0.265253162256497,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2512,38686,1558:1564,Pancreas,PANC-03-27,SIDM01138,925346,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.814806926444484,0.12326670565707,0.356075127865413,7.63365127413892,3.8787,0.710491001301292,0.7672433930183,0.128564847510759,0.290132480519343,0.220367402537124,0.06976507798222,6.71139982068154,2.0467,0.922251453457376,1.832,0.57891298903677,0.504789348256403,0.625155230900079,0.575593960994589,0.0741236407803668,0.0495612699054897,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2513,38686,1561:1564,Pancreas,PANC-03-27,SIDM01138,925346,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.769532886574513,0.12326670565707,0.356075127865413,7.63365127413892,3.8787,0.710491001301292,0.7672433930183,0.0623954205913664,0.27401152098366,0.0929894063246499,0.18102211465901,4.42310983562136,0.419,3.21054143851756,3.4597,0.546746191116599,0.393146513662521,0.590419022934596,0.410613983278609,0.153599677454078,0.179805039655987,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2514,38686,1053:1564,Pancreas,PANC-03-27,SIDM01138,925346,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.791361171573591,0.12326670565707,0.356075127865413,7.63365127413892,3.8787,0.710491001301292,0.7672433930183,0.0779649672802658,0.281784030355789,0.0471719611925613,0.234612069163228,2.6380646518119,0.1216,4.99558662232702,3.7571,0.562254991182284,0.289917167796729,0.60716663038106,0.310947498026491,0.272337823385555,0.296219132354568,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2515,38686,1079:1594,Pancreas,PANC-03-27,SIDM01138,925346,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.745127231359131,0.061615745252942,0.626794624052528,10.1957967909247,9.1629,0.895891239424696,0.894054577677405,0.0695084973580246,0.467041742851047,0.235737393505724,0.231304349345324,7.22300229137382,1.1672,2.97279449955084,7.9957,0.667552958831425,0.503638601583581,0.666184412148722,0.552150141624481,0.163914357247844,0.114034270524241,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2516,38686,1510:1594,Pancreas,PANC-03-27,SIDM01138,925346,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.835418329904486,0.061615745252942,0.626794624052528,10.1957967909247,9.1629,0.895891239424696,0.894054577677405,0.0316157415264183,0.523635718019073,0.461809900055328,0.0618258179637448,9.48881019699891,5.6131,0.70698659392575,3.5498,0.74844396301624,0.717669924458023,0.746909582126719,0.723235351198681,0.0307740385582168,0.023674230928038,True,0.372937468483931,0.0447603246852157,0.929766719435217,52.4646283034947
2517,38632,1564:1011,Pancreas,CAPAN-1,SIDM00934,753624,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.642536695727056,0.187607027658433,0.502515008213282,9.03014572819548,10.2112,0.876587814503564,0.804159170897592,0.119709365857044,0.322884332930617,0.159721110213565,0.163163222717052,5.68519072535269,1.0049,3.34495500284279,9.2063,0.563239837845722,0.424694018824831,0.516701776507148,0.394168628171041,0.138545819020891,0.122533148336107,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2518,38632,1080:1011,Pancreas,CAPAN-1,SIDM00934,753624,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.480567102635513,0.187607027658433,0.502515008213282,9.03014572819548,10.2112,0.876587814503564,0.804159170897592,0.0550469731290655,0.241492181527918,0.104193856427498,0.13729832510042,5.15143592180607,0.6942,3.87870980638941,9.517,0.421259266221575,0.27123651402966,0.386452442816032,0.277817221507022,0.150022752191914,0.10863522130901,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2519,38632,1372:1011,Pancreas,CAPAN-1,SIDM00934,753624,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.554584529726895,0.187607027658433,0.502515008213282,9.03014572819548,10.2112,0.876587814503564,0.804159170897592,0.0836434218159645,0.27868704951067,0.120273888063778,0.158413161446892,5.15245373059442,0.6947,3.87769199760106,9.5165,0.486142040870786,0.327311631912318,0.445974235617811,0.320644694022472,0.158830408958468,0.125329541595339,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2520,38634,1564:1053,Pancreas,CAPAN-1,SIDM00934,753624,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.610794417816825,0.0634680081116009,0.893430933788154,15.3715090348196,827.9714,0.960210821644233,0.967500454495859,0.0384447993114913,0.545702627062678,0.306887383099486,0.238815243963192,9.02924341810179,10.2048,6.34226561671782,817.7666,0.586491409787605,0.464945238581073,0.590943876841312,0.491150386199207,0.121546171206532,0.0997934906421049,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2521,38634,1372:1053,Pancreas,CAPAN-1,SIDM00934,753624,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.527476267689419,0.0634680081116009,0.893430933788154,15.3715090348196,827.9714,0.960210821644233,0.967500454495859,0.0644340261649837,0.471263614392848,0.265724317572992,0.205539296819856,9.04513437305225,10.3178,6.32637466176735,817.6536,0.506488420395891,0.369223624851871,0.510333528725293,0.424540897863962,0.137264795544019,0.0857926308613302,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2522,38634,1558:1053,Pancreas,CAPAN-1,SIDM00934,753624,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.85915993216429,0.0634680081116009,0.893430933788154,15.3715090348196,827.9714,0.960210821644233,0.967500454495859,0.0816622559472973,0.767600060466909,0.741232823495622,0.026367236971287,14.5084173224173,455.1964,0.863091712402253,372.775,0.824974664387277,0.758291108271663,0.831237624853583,0.822601107801469,0.0666835561156142,0.0086365170521135,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2523,38636,1564:1079,Pancreas,CAPAN-1,SIDM00934,753624,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.637164141615962,0.0832549852832895,0.870741889767799,14.7160376571995,105.1305,0.940140207148595,0.96010138896238,0.0663370806639555,0.55480550876296,0.320449010964728,0.234356497798232,9.03512099011393,2.0493,5.68091666708554,103.0812,0.599023628086487,0.48040689940008,0.611742177362508,0.512528262505835,0.118616728686407,0.0992139148566732,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2524,38636,1372:1079,Pancreas,CAPAN-1,SIDM00934,753624,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.607672250492992,0.0832549852832895,0.870741889767799,14.7160376571995,105.1305,0.940140207148595,0.96010138896238,0.0514964357934813,0.529125683753719,0.342567194152874,0.186558489600845,9.76814264171785,3.4062,4.94789501548162,101.7243,0.571297115456935,0.474579342183329,0.583426971732217,0.508242916402376,0.096717773273606,0.0751840553298408,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2525,38636,1011:1080,Pancreas,CAPAN-1,SIDM00934,753624,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.740142945662325,0.0960691540645348,0.39814380222622,7.7618062978485,0.0424,0.769989341191093,0.739714582314223,0.15748679700451,0.294683326576913,0.124050664108415,0.170632662468498,4.19739610433541,0.0036,3.56441019351309,0.0388,0.569902179117768,0.37392700824459,0.547494529903425,0.380044953117433,0.195975170873178,0.167449576785992,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2526,38637,1168:1083,Pancreas,CAPAN-1,SIDM00934,753624,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.740975612366829,0.0831189292901549,0.726009303451525,11.9200521086484,60.5499,0.918812896016056,0.908044640220795,0.0870022114502321,0.537955188209009,0.355121533577176,0.182833654631832,8.75128811213666,6.7332,3.16876399651172,53.8167,0.680817948276037,0.612985831482831,0.672838933344021,0.586077407337506,0.0678321167932062,0.0867615260065148,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2527,38637,1011:1083,Pancreas,CAPAN-1,SIDM00934,753624,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.704055483265676,0.0831189292901549,0.726009303451525,11.9200521086484,60.5499,0.918812896016056,0.908044640220795,0.136057093905004,0.51115083099694,0.299645586045012,0.211505244951928,8.1015462567045,4.2917,3.81850585194388,56.2582,0.64689525753532,0.581612698789735,0.639313807997459,0.533712946787017,0.0652825587455843,0.105600861210442,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2528,38637,1558:1083,Pancreas,CAPAN-1,SIDM00934,753624,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.852267272617629,0.0831189292901549,0.726009303451525,11.9200521086484,60.5499,0.918812896016056,0.908044640220795,0.058696465965685,0.618753968947656,0.50758238192617,0.111171587021486,10.159753088238,17.8735,1.76029902041039,42.6764,0.78307416093351,0.749045835518307,0.773896728936034,0.726005263613633,0.0340283254152027,0.047891465322401,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2529,38637,1011:1085,Pancreas,CAPAN-1,SIDM00934,753624,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.704055483265676,0.101174391241438,0.632192414018002,10.623037394786,30.8023,0.915378425446314,0.868721800386077,0.127502588624361,0.445098535568339,0.271155710271314,0.173942825297025,7.59817112541065,3.7845,3.02486626937534,27.0178,0.644477199698578,0.562583816158179,0.611628346994247,0.514393963484227,0.0818933835403984,0.0972343835100205,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2530,38639,1083:1168,Pancreas,CAPAN-1,SIDM00934,753624,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.935835812385847,0.0703024360615016,0.732626385577255,12.0204973478673,81.1447,0.887925581463808,0.910632672240781,0.0778704755329602,0.685618008721997,0.497751369281453,0.187866639440544,9.38262754900448,13.0371,2.63786979886282,68.1076,0.830952557867358,0.719588133584266,0.852202666611546,0.767426949233721,0.111364424283092,0.084775717377825,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2531,38639,1372:1168,Pancreas,CAPAN-1,SIDM00934,753624,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.566151355363584,0.0703024360615016,0.732626385577255,12.0204973478673,81.1447,0.887925581463808,0.910632672240781,0.0260094704459461,0.414777421169686,0.26367892485658,0.151098496313106,8.58869851852893,7.5194,3.43179882933837,73.6253,0.502700271407733,0.440835103935548,0.51555592162748,0.443295145702729,0.0618651674721843,0.0722607759247513,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2532,38639,1011:1168,Pancreas,CAPAN-1,SIDM00934,753624,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.752998447736595,0.0703024360615016,0.732626385577255,12.0204973478673,81.1447,0.887925581463808,0.910632672240781,0.0380570707215884,0.551666531110545,0.370986520499242,0.180680010611303,8.9122424902836,9.4098,3.10825485758369,71.7349,0.668606584547861,0.598046567273913,0.685704988655536,0.601377762394011,0.0705600172739478,0.0843272262615242,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2533,38640,1011:1372,Pancreas,CAPAN-1,SIDM00934,753624,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.774593416601452,0.0887657411132094,0.486890431405612,8.84282963700319,0.8968,0.754967384008596,0.795350340448877,0.0810212215931758,0.377142122773028,0.107450955730918,0.269691167042111,3.52837734779943,0.0225,5.31445228920376,0.8743,0.584792765401879,0.348777717103034,0.616073137603424,0.362381394049238,0.236015048298845,0.253691743554186,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2534,38640,1168:1372,Pancreas,CAPAN-1,SIDM00934,753624,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.801799637242862,0.0887657411132094,0.486890431405612,8.84282963700319,0.8968,0.754967384008596,0.795350340448877,0.0642843460413231,0.39038857127804,0.281748693890969,0.108639877387071,7.16337574434274,0.28,1.67945389266045,0.6168,0.605332574628284,0.528845974456401,0.637711614452896,0.565786077457352,0.0764866001718835,0.0719255369955437,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2535,38640,1561:1372,Pancreas,CAPAN-1,SIDM00934,753624,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.866819532014261,0.0887657411132094,0.486890431405612,8.84282963700319,0.8968,0.754967384008596,0.795350340448877,0.0398798091331745,0.422046135893235,0.208929717837138,0.213116418056097,5.56282924532842,0.0923,3.28000039167477,0.8045,0.654420474492362,0.50353138075148,0.689425209895279,0.524794422069782,0.150889093740882,0.164630787825496,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2536,38640,1558:1372,Pancreas,CAPAN-1,SIDM00934,753624,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.779123833465017,0.0887657411132094,0.486890431405612,8.84282963700319,0.8968,0.754967384008596,0.795350340448877,0.0627761595972461,0.379347939394177,0.200175805088989,0.179172134305188,5.81760512745795,0.1102,3.02522450954524,0.7866,0.588213082369833,0.464846522758371,0.619676406198235,0.484687232376788,0.123366559611462,0.134989173821448,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2537,38642,1564:1558,Pancreas,CAPAN-1,SIDM00934,753624,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.687885186919842,0.0776742113585329,0.80830878797796,13.3122220778564,198.659,0.936373764816791,0.938744761112035,0.051323481548974,0.55602364170717,0.388675392289542,0.167348249417629,9.7838982666108,17.2178,3.52832381124564,181.4412,0.644117642237835,0.53657567165294,0.645748615467575,0.575774337534949,0.107541970584894,0.0699742779326261,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2538,38642,1011:1558,Pancreas,CAPAN-1,SIDM00934,753624,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.752370744714066,0.0776742113585329,0.80830878797796,13.3122220778564,198.659,0.936373764816791,0.938744761112035,0.0903232200166627,0.608147884769902,0.348898235249963,0.259249649519939,8.5645159947616,7.3945,4.74770608309484,191.2645,0.704500226765922,0.628759162859028,0.70628409501429,0.588202148659244,0.0757410639068939,0.118081946355046,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2539,38642,1372:1561,Pancreas,CAPAN-1,SIDM00934,753624,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.553182891098224,0.0974237916749433,0.716294973591467,11.7752833465505,68.461,0.881721512172544,0.90420427330972,0.0751105932277593,0.396242124370454,0.160785693466906,0.235456430903549,6.3264641674168,1.5674,5.44881917913372,66.8936,0.487753255247106,0.313389234323523,0.50019033405284,0.362148710539592,0.174364020923584,0.138041623513248,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2540,38642,1011:1561,Pancreas,CAPAN-1,SIDM00934,753624,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.752370744714066,0.0974237916749433,0.716294973591467,11.7752833465505,68.461,0.881721512172544,0.90420427330972,0.0470552956434552,0.538919382715954,0.234866769986201,0.304052612729753,6.63272265079951,1.9381,5.142560695751,66.5229,0.663381470743669,0.478156753958778,0.680296842483675,0.506893387080482,0.185224716784891,0.173403455403193,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2541,38642,1564:1561,Pancreas,CAPAN-1,SIDM00934,753624,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.639747185029622,0.0974237916749433,0.716294973591467,11.7752833465505,68.461,0.881721512172544,0.90420427330972,0.0742563889665499,0.458247693006009,0.159560872992353,0.298686820013656,5.69854595568535,1.0143,6.07673739086517,67.4467,0.564078855392447,0.345673334443305,0.578462138541649,0.393016325309315,0.218405520949142,0.185445813232334,True,0.305274045335564,0.0389814915922333,1.13207434836762,43.4340624718065
2542,39368,1011:1564,Pancreas,CAPAN-1,SIDM00934,753624,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.767198858251203,0.107415676210893,0.352237943741631,7.17444727636459,2.8213,0.656908291322689,0.706294817894837,0.065930335046026,0.270236548271331,0.0813832470116052,0.188853301259726,2.61301789818355,0.1195,4.56142937818104,2.7018,0.503979291078515,0.287480998106878,0.54186857787766,0.311634086534667,0.216498292971637,0.230234491342993,True,0.612725676459437,0.0659993247272664,0.448566718225788,105.275715718148
2543,38056,1080:1011,Pancreas,CFPAC-1,SIDM00130,906821,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.742141851980848,0.164998039717901,0.451976678191296,8.56512082755844,7.3976,0.855480416740917,0.824007094930823,0.120225171721395,0.33543080900504,0.0778245333531663,0.257606275651874,4.16048548851266,0.3493,4.40463533904578,7.0483,0.634887820813452,0.373963034277929,0.61153015147732,0.380636443021556,0.260924786535523,0.230893708455764,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2544,38056,1564:1011,Pancreas,CFPAC-1,SIDM00130,906821,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.696664952194706,0.164998039717901,0.451976678191296,8.56512082755844,7.3976,0.855480416740917,0.824007094930823,0.102450605351371,0.314876310905261,0.139467143727432,0.175409167177829,5.87396387885189,1.1454,2.69115694870654,6.2522,0.595983223632318,0.469818463668623,0.57405686339808,0.451067699165539,0.126164759963695,0.122989164232542,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2545,38056,1558:1011,Pancreas,CFPAC-1,SIDM00130,906821,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.575123759059799,0.164998039717901,0.451976678191296,8.56512082755844,7.3976,0.855480416740917,0.824007094930823,0.0662465072019786,0.259942526168739,0.0413590182130068,0.218583507955733,3.2275628964333,0.1829,5.33755793112514,7.2147,0.492007113078079,0.233265939720973,0.47390605792856,0.25200128248603,0.258741173357107,0.221904775442529,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2546,38058,1054:1053,Pancreas,CFPAC-1,SIDM00130,906821,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.78551034007676,0.0923685560321681,0.667015187286268,10.5679162514855,29.6476,0.864313459755695,0.909945163006783,0.064597198075743,0.5239473266016,0.304687218487403,0.219260108114197,7.97036343350386,4.8983,2.59755281798161,24.7493,0.678927159705617,0.594543674595423,0.714771334444661,0.620914346036158,0.0843834851101936,0.0938569884085033,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2547,38058,1564:1053,Pancreas,CFPAC-1,SIDM00130,906821,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.768341712515516,0.0923685560321681,0.667015187286268,10.5679162514855,29.6476,0.864313459755695,0.909945163006783,0.0509415828182755,0.512495591273389,0.298915181702971,0.213580409570419,7.98133609496811,4.9357,2.58658015651736,24.7119,0.664088083818902,0.58386396466503,0.699148824839843,0.607843299472138,0.0802241191538717,0.0913055253677044,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2548,38058,1168:1053,Pancreas,CFPAC-1,SIDM00130,906821,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.704777667055069,0.0923685560321681,0.667015187286268,10.5679162514855,29.6476,0.864313459755695,0.909945163006783,0.114678330009353,0.470097407585916,0.223216605051787,0.246880802534129,7.26467809250505,3.0034,3.30323815898042,26.6442,0.609148823770914,0.456811897187211,0.641309029131965,0.525930811211994,0.152336926583703,0.115378217919971,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2549,38058,1372:1053,Pancreas,CFPAC-1,SIDM00130,906821,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.700828671539752,0.0923685560321681,0.667015187286268,10.5679162514855,29.6476,0.864313459755695,0.909945163006783,0.0920586023131914,0.467463367602674,0.215421396336845,0.25204197126583,7.1664982002766,2.8058,3.40141805120887,26.8418,0.605735653794511,0.452147542190176,0.637715659764067,0.51842623868498,0.153588111604335,0.119289421079087,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2550,38058,1558:1053,Pancreas,CFPAC-1,SIDM00130,906821,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.867547674671505,0.0923685560321681,0.667015187286268,10.5679162514855,29.6476,0.864313459755695,0.909945163006783,0.0576329125134334,0.578667474700781,0.418530827835577,0.160136646865204,8.84131648127202,8.9584,1.72659977021346,20.6892,0.749833132198337,0.703262477599326,0.789420810245119,0.727311251303921,0.046570654599011,0.062109558941198,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2551,38058,1594:1053,Pancreas,CFPAC-1,SIDM00130,906821,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.493897083012536,0.0923685560321681,0.667015187286268,10.5679162514855,29.6476,0.864313459755695,0.909945163006783,0.0931442429121092,0.329436855325748,0.176587441127858,0.152849414197891,7.67730685938677,3.9979,2.8906093920987,25.6497,0.426881896581811,0.326837678616174,0.449419261710417,0.381609863907537,0.100044217965637,0.0678093978028799,True,0.314267536765588,0.0658033702660865,1.08440509005812,45.043648930332
2552,36150,1510:1079,Pancreas,CFPAC-1,SIDM00130,906821,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.813813879121223,0.119816714247916,0.759812940362298,11.5991881092327,12.1189,0.851740570830004,0.938854059236039,0.124431874014752,0.618346316402744,0.407585894595589,0.210760421807155,9.00753168099696,2.0105,2.59165642823575,10.1084,0.69315829795209,0.609319855397243,0.764052463875588,0.688975461358686,0.0838384425548477,0.0750770025169013,True,0.153819654442303,0.0254477514493984,1.81327092325405,27.3831716055986
2553,36150,1053:1079,Pancreas,CFPAC-1,SIDM00130,906821,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.819183990365352,0.119816714247916,0.759812940362298,11.5991881092327,12.1189,0.851740570830004,0.938854059236039,0.123737431791652,0.622426596417218,0.566403069414522,0.0560235270026962,10.8208418143813,7.0657,0.778346294851382,5.0532,0.697732239568586,0.671762246123871,0.769094214615687,0.751941319093019,0.025969993444715,0.0171528955226683,True,0.153819654442303,0.0254477514493984,1.81327092325405,27.3831716055986
2554,36150,1564:1079,Pancreas,CFPAC-1,SIDM00130,906821,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.707461920465663,0.119816714247916,0.759812940362298,11.5991881092327,12.1189,0.851740570830004,0.938854059236039,0.0811878194586778,0.537538721983373,0.148241810188219,0.389296911795154,6.00349490450882,0.2506,5.59569320472389,11.8683,0.602574019977915,0.441309767313746,0.664203495784112,0.464940234159508,0.161264252664169,0.199263261624604,True,0.153819654442303,0.0254477514493984,1.81327092325405,27.3831716055986
2555,36150,1057:1079,Pancreas,CFPAC-1,SIDM00130,906821,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.820378043040124,0.119816714247916,0.759812940362298,11.5991881092327,12.1189,0.851740570830004,0.938854059236039,0.0922865398976645,0.623333853090984,0.331309081312219,0.292024771778764,8.12103961635576,1.0875,3.47814849287695,11.0314,0.698749262675396,0.593895633083997,0.770215255816338,0.655723237535776,0.104853629591399,0.114492018280562,True,0.153819654442303,0.0254477514493984,1.81327092325405,27.3831716055986
2556,36150,1168:1079,Pancreas,CFPAC-1,SIDM00130,906821,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.589757084022748,0.119816714247916,0.759812940362298,11.5991881092327,12.1189,0.851740570830004,0.938854059236039,0.0739475542436045,0.448105064110818,0.24133591238272,0.206769151728099,8.1712098999598,1.126,3.42797820927291,10.9929,0.502320035396574,0.415314427877963,0.553695832297966,0.473094725795591,0.0870056075186109,0.0806011065023749,True,0.153819654442303,0.0254477514493984,1.81327092325405,27.3831716055986
2557,36150,1372:1079,Pancreas,CFPAC-1,SIDM00130,906821,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.671021433338738,0.119816714247916,0.759812940362298,11.5991881092327,12.1189,0.851740570830004,0.938854059236039,0.138274238297581,0.50985076831123,0.162345640043531,0.347505128267698,6.42241287700774,0.335,5.17677523222497,11.7839,0.571536178671104,0.385899159040432,0.629991196524459,0.461657492811726,0.185637019630672,0.168333703712733,True,0.153819654442303,0.0254477514493984,1.81327092325405,27.3831716055986
2558,36150,1594:1079,Pancreas,CFPAC-1,SIDM00130,906821,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.513881600704941,0.119816714247916,0.759812940362298,11.5991881092327,12.1189,0.851740570830004,0.938854059236039,0.0858608820730289,0.390453890029705,0.214983835054685,0.17547005497502,8.25625835883631,1.1944,3.3429297503964,10.9245,0.437693807923462,0.345120072142347,0.482459826788547,0.414718074883601,0.0925737357811151,0.0677417519049457,True,0.153819654442303,0.0254477514493984,1.81327092325405,27.3831716055986
2559,36150,1011:1080,Pancreas,CFPAC-1,SIDM00130,906821,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.792183396112274,0.106093801363313,0.415657102058706,8.23123239043745,0.0587,0.757549987118837,0.805612369742608,0.0601400175904609,0.329276654727052,0.0759960582853372,0.253280596441715,3.93714752264563,0.003,4.29408486779182,0.0557,0.60011852152061,0.377684576764779,0.638192743012756,0.392092353113915,0.222433944755831,0.246100389898841,True,0.153819654442303,0.0254477514493984,1.81327092325405,27.3831716055986
2560,38551,1011:1083,Pancreas,CFPAC-1,SIDM00130,906821,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.89269739485386,0.0711175105959627,0.518341438192515,9.1656547501804,8.9734,0.856965359914849,0.854176153476385,0.129167494591272,0.462722051519261,0.230250084602791,0.232471966916471,6.61494650470204,1.5315,2.55070824547836,7.4419,0.765010744275986,0.641597715871486,0.762520826954659,0.626468236456645,0.123413028404499,0.136052590498015,True,0.464883638664183,0.0609165069772765,0.711457111782502,67.7003996980466
2561,38551,1558:1083,Pancreas,CFPAC-1,SIDM00130,906821,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.91846309177642,0.0711175105959627,0.518341438192515,9.1656547501804,8.9734,0.856965359914849,0.854176153476385,0.0849060021140632,0.476077479918134,0.362736770952864,0.11334070896527,8.03720251251121,4.1045,1.12845223766919,4.8689,0.787091054012684,0.744300946735933,0.78452927084361,0.729632678412225,0.0427901072767514,0.0548965924313848,True,0.464883638664183,0.0609165069772765,0.711457111782502,67.7003996980466
2562,38366,1011:1372,Pancreas,CFPAC-1,SIDM00130,906821,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.763453324425032,0.100262215186652,0.642696830038171,10.3250100207411,2.5053,0.839766440020478,0.901714504925522,0.0466431459055036,0.490669031490072,0.148808743949839,0.341860287540233,5.79882877371014,0.1087,4.52618124703101,2.3966,0.641122480374208,0.492350914511164,0.688416936467662,0.489972541816089,0.148771565863044,0.198444394651573,True,0.293157774847416,0.0425166141701456,1.14100021198174,42.7648364334743
2563,38366,1053:1372,Pancreas,CFPAC-1,SIDM00130,906821,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.81225558766942,0.100262215186652,0.642696830038171,10.3250100207411,2.5053,0.839766440020478,0.901714504925522,0.0804211204910965,0.522034091375928,0.439409915789477,0.0826241755864506,9.37073957110323,1.293,0.954270449637917,1.2123,0.68210498324389,0.679021614577899,0.73242264510832,0.701469892290275,0.0030833686659903,0.0309527528180449,True,0.293157774847416,0.0425166141701456,1.14100021198174,42.7648364334743
2564,38366,1561:1372,Pancreas,CFPAC-1,SIDM00130,906821,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.797737498113344,0.100262215186652,0.642696830038171,10.3250100207411,2.5053,0.839766440020478,0.901714504925522,0.0785347407709177,0.512703361240028,0.368590773515067,0.144112587724961,8.65669614153716,0.7882,1.66831387920399,1.7171,0.669913178861486,0.608361074480368,0.719331473171799,0.661206185063467,0.0615521043811176,0.0581252881083321,True,0.293157774847416,0.0425166141701456,1.14100021198174,42.7648364334743
2565,38366,1558:1372,Pancreas,CFPAC-1,SIDM00130,906821,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.602464231631526,0.100262215186652,0.642696830038171,10.3250100207411,2.5053,0.839766440020478,0.901714504925522,0.0826361485650109,0.387201851880964,0.18639724690422,0.200804604976744,7.18777201896859,0.2848,3.13723800177256,2.2205,0.505929243036879,0.399850485973075,0.543250736360956,0.446515889751429,0.106078757063804,0.0967348466095274,True,0.293157774847416,0.0425166141701456,1.14100021198174,42.7648364334743
2566,38366,1079:1372,Pancreas,CFPAC-1,SIDM00130,906821,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.706244929712712,0.100262215186652,0.642696830038171,10.3250100207411,2.5053,0.839766440020478,0.901714504925522,0.074004233478398,0.453901377556891,0.243071134579511,0.210830242977381,7.54485674437884,0.3647,2.78015327636231,2.1406,0.593080790407357,0.492708758857681,0.636831297152058,0.539809779242662,0.100372031549676,0.0970215179093965,True,0.293157774847416,0.0425166141701456,1.14100021198174,42.7648364334743
2567,38180,1594:1510,Pancreas,CFPAC-1,SIDM00130,906821,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.626469493861923,0.0724203922948254,0.823871261308052,12.4819695922504,111.7319,0.936225719010704,0.956847920698464,0.107701933328355,0.516130212079039,0.290477260693604,0.225652951385436,8.67147695038483,7.9635,3.81049264186553,103.7684,0.586516852329151,0.433135528537168,0.5994360325828,0.519735145757205,0.153381323791983,0.0797008868255951,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2568,38180,1564:1510,Pancreas,CFPAC-1,SIDM00130,906821,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.81968572349747,0.0724203922948254,0.823871261308052,12.4819695922504,111.7319,0.936225719010704,0.956847920698464,0.140069058999498,0.675315510894064,0.454716170325146,0.220599340568918,9.49620463360369,14.105,2.98576495864666,97.6269,0.767410855844228,0.58747214638902,0.78431458015477,0.71243638120516,0.179938709455209,0.0718781989496101,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2569,38180,1558:1510,Pancreas,CFPAC-1,SIDM00130,906821,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.641025784371502,0.0724203922948254,0.823871261308052,12.4819695922504,111.7319,0.936225719010704,0.956847920698464,0.0744464865479156,0.528122721501132,0.323353790435056,0.204768931066076,9.04000987063191,10.2812,3.44195972161845,101.4507,0.60014482587761,0.478197997055729,0.613364188889973,0.543704172498552,0.12194682882188,0.0696600163914215,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2570,38181,1510:1558,Pancreas,CFPAC-1,SIDM00130,906821,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.915861995591324,0.0677505012343901,0.724068764287469,11.1773261641742,45.2314,0.934857294997776,0.928152741576078,0.110071659792818,0.663147063405665,0.343302307705425,0.319844755700241,7.84557435590553,4.4925,3.33175180826865,40.7389,0.85620026778977,0.687750741770653,0.850059822113426,0.717098119533509,0.168449526019117,0.132961702579917,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2571,38181,1053:1558,Pancreas,CFPAC-1,SIDM00130,906821,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.888162110532362,0.0677505012343901,0.724068764287469,11.1773261641742,45.2314,0.934857294997776,0.928152741576078,0.0527540295150511,0.643090441860118,0.503755817746441,0.139334624113677,9.61025145151821,15.2653,1.56707471265597,29.9661,0.8303048281718,0.789834180548208,0.824350097854608,0.776306662962668,0.0404706476235922,0.0480434348919399,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2572,38181,1080:1558,Pancreas,CFPAC-1,SIDM00130,906821,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.940334787277035,0.0677505012343901,0.724068764287469,11.1773261641742,45.2314,0.934857294997776,0.928152741576078,0.096895299177562,0.680867047440203,0.440315426819485,0.240551620620718,8.71302065028335,8.1962,2.46430551389083,37.0352,0.879078835626118,0.725088296578049,0.872774310810539,0.782159467134378,0.153990539048069,0.0906148436761607,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2573,38181,1054:1558,Pancreas,CFPAC-1,SIDM00130,906821,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.843760009040723,0.0677505012343901,0.724068764287469,11.1773261641742,45.2314,0.934857294997776,0.928152741576078,0.0940910264170396,0.610940267101299,0.399348403256115,0.211591863845185,8.75869731909496,8.4598,2.41862884507922,36.7716,0.788795199679109,0.727717701846176,0.783138165623403,0.703818442766767,0.0610774978329328,0.0793197228566369,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2574,38181,1564:1558,Pancreas,CFPAC-1,SIDM00130,906821,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.910218806132341,0.0677505012343901,0.724068764287469,11.1773261641742,45.2314,0.934857294997776,0.928152741576078,0.0986172951142823,0.659061006187459,0.387156237584983,0.271904768602476,8.32095512088512,6.2458,2.85637104328906,38.9856,0.850924690956985,0.684951882235589,0.844822080345838,0.737884353397668,0.165972808721397,0.10693772694817,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2575,38181,1011:1558,Pancreas,CFPAC-1,SIDM00130,906821,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.833267731633452,0.0677505012343901,0.724068764287469,11.1773261641742,45.2314,0.934857294997776,0.928152741576078,0.0943970207748677,0.603343136764455,0.282862116222149,0.320481020542306,7.49757948607847,3.5296,3.67974667809571,41.7018,0.778986417603781,0.658078800907989,0.773399729582468,0.63439351221566,0.120907616695792,0.139006217366808,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2576,38181,1594:1561,Pancreas,CFPAC-1,SIDM00130,906821,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.615295314836022,0.085362928898266,0.520950268403357,9.18924287404209,11.4017,0.833821448108872,0.855283543361914,0.128448524726532,0.320538259411153,0.256559789137374,0.0639784702737792,8.24342793928198,5.919,0.945814934760104,5.4827,0.513046430431176,0.396121185912034,0.526251957086937,0.496115188113288,0.116925244519141,0.0301367689736492,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2577,38181,1564:1561,Pancreas,CFPAC-1,SIDM00130,906821,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.795328264776725,0.085362928898266,0.520950268403357,9.18924287404209,11.4017,0.833821448108872,0.855283543361914,0.0679632955305216,0.414326473004211,0.197392116735717,0.216934356268493,6.49867735642607,1.7661,2.69056551761601,9.6356,0.663161765458045,0.510345085125973,0.68023117643412,0.551544164383839,0.152816680332072,0.12868701205028,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2578,38182,1510:1564,Pancreas,CFPAC-1,SIDM00130,906821,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.863189256612742,0.0842208394157446,0.679040830605797,10.6912599485398,32.2939,0.909678429264676,0.913906996680102,0.124262264642555,0.586140749780317,0.358359765600669,0.227780984179648,8.22659217120476,5.8503,2.46466777733503,26.4436,0.785224647113622,0.62758115231594,0.788874701077481,0.69516839032016,0.157643494797683,0.0937063107573215,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2579,38182,1053:1564,Pancreas,CFPAC-1,SIDM00130,906821,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.902409984293571,0.0842208394157446,0.679040830605797,10.6912599485398,32.2939,0.909678429264676,0.913906996680102,0.0816999183357577,0.612773225281671,0.364972660634922,0.247800564646749,8.12659634442809,5.4586,2.56466360411169,26.8353,0.820902897064937,0.658573471853726,0.824718798519876,0.72158101354334,0.162329425211211,0.103137784976535,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2580,38182,1561:1564,Pancreas,CFPAC-1,SIDM00130,906821,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.782331973047511,0.0842208394157446,0.679040830605797,10.6912599485398,32.2939,0.909678429264676,0.913906996680102,0.0800559680718425,0.531235352787654,0.304596230563512,0.226639122224142,7.98422781130699,4.9456,2.70703213723279,27.3483,0.711670520405395,0.575712996512981,0.71497866389467,0.61904517620911,0.135957523892413,0.0959334876855595,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2581,38182,1011:1564,Pancreas,CFPAC-1,SIDM00130,906821,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.844931164911712,0.0842208394157446,0.679040830605797,10.6912599485398,32.2939,0.909678429264676,0.913906996680102,0.104009438312331,0.573742760026372,0.160570777109828,0.413171982916544,5.72803484092511,1.0352,4.96322510761468,31.2587,0.768615654933659,0.526094074049222,0.772188503325883,0.537718008310165,0.242521580884436,0.234470495015717,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2582,38182,1558:1564,Pancreas,CFPAC-1,SIDM00130,906821,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.939276609276558,0.0842208394157446,0.679040830605797,10.6912599485398,32.2939,0.909678429264676,0.913906996680102,0.0848377435603626,0.637807168931751,0.441395680555133,0.196411488376617,8.72822375799897,8.283,1.96303619054081,24.0109,0.85443967057175,0.721705223985692,0.858411465035809,0.782018434490018,0.132734446586058,0.0763930305457907,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2583,38182,1079:1564,Pancreas,CFPAC-1,SIDM00130,906821,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.857318364559563,0.0842208394157446,0.679040830605797,10.6912599485398,32.2939,0.909678429264676,0.913906996680102,0.0803412193241763,0.582154174364129,0.205199247876406,0.376954926487723,6.39044913280251,1.6385,4.30081081573728,30.6554,0.779884023252304,0.577776989333886,0.783509251753328,0.587846663592294,0.202107033918418,0.195662588161034,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2584,38182,1053:1594,Pancreas,CFPAC-1,SIDM00130,906821,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.902409984293571,0.0739844054211781,0.612752186888605,10.0356896737891,8.2004,0.887812462197763,0.891149045331972,0.0416033314601219,0.552953691345998,0.417262528301105,0.135691163044893,8.65979843733047,3.1597,1.37589123645861,5.0407,0.80117083006752,0.718028787440993,0.804181796001256,0.748110897020696,0.0831420426265269,0.0560708989805603,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2585,38182,1079:1594,Pancreas,CFPAC-1,SIDM00130,906821,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.841989958786085,0.0739844054211781,0.612752186888605,10.0356896737891,8.2004,0.887812462197763,0.891149045331972,0.0602208683101254,0.51593118858442,0.300537011175883,0.215394177408537,7.6713861901638,1.5926,2.36430348362528,6.6078,0.747529178455667,0.617441969986379,0.750338547951326,0.65025405143128,0.130087208469288,0.100084496520047,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2586,38182,1510:1594,Pancreas,CFPAC-1,SIDM00130,906821,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.863189256612742,0.0739844054211781,0.612752186888605,10.0356896737891,8.2004,0.887812462197763,0.891149045331972,0.0352948161690477,0.528921104688207,0.35883230517788,0.170088799510327,8.23167977134903,2.3484,1.80400990244005,5.852,0.766350179256015,0.685282155073498,0.76923028197126,0.695417871853573,0.0810680241825172,0.0738124101176868,True,0.502183676309534,0.0724094325979286,0.632473164787291,75.4844644810485
2587,38114,1085:1011,Pancreas,SW1990,SIDM01165,910907,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,1.25,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.931912989259712,0.10213474263219,0.44929647439282,8.38063864106002,6.5096,0.808042546587079,0.770154417224811,0.0979910028028227,0.418705220515263,0.344915705362805,0.073789515152458,7.38179433713474,3.2574,0.998844303925285,3.2522,0.753025345038994,0.691947904627211,0.717716905147545,0.667523311933661,0.0610774404117838,0.0501935932138836,True,0.339336687452299,0.042342449682687,1.01630724604075,48.0495712811403
2588,38114,1080:1011,Pancreas,SW1990,SIDM01165,910907,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.7439937592398,0.10213474263219,0.44929647439282,8.38063864106002,6.5096,0.808042546587079,0.770154417224811,0.0726950674216288,0.334273772996703,0.0827219216630389,0.251551851333664,2.67386694605415,0.1246,5.70677169500588,6.385,0.601178611861022,0.277129796937005,0.572990080066224,0.305883231753161,0.324048814924017,0.267106848313063,True,0.339336687452299,0.042342449682687,1.01630724604075,48.0495712811403
2589,38116,1372:1053,Pancreas,SW1990,SIDM01165,910907,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.682423325241859,0.0725968120181995,0.862464864376704,14.5873152619997,480.7834,0.922705907917115,0.956780547329429,0.065530573965543,0.588566140652219,0.403185675549333,0.185380465102885,10.1179225359492,21.7034,4.46939272605043,459.08,0.629676033901106,0.527265453153114,0.652929362635274,0.578440850395506,0.102410580747992,0.0744885122397686,True,0.339336687452299,0.042342449682687,1.01630724604075,48.0495712811403
2590,38116,1558:1053,Pancreas,SW1990,SIDM01165,910907,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.910485630744046,0.0725968120181995,0.862464864376704,14.5873152619997,480.7834,0.922705907917115,0.956780547329429,0.0649372970857,0.785261866036601,0.708347303198491,0.0769145628381095,12.8162955524744,140.8703,1.77101970952526,339.9131,0.840110470561172,0.797867216565856,0.871134940118868,0.843865798008895,0.042243253995316,0.0272691421099728,True,0.339336687452299,0.042342449682687,1.01630724604075,48.0495712811403
2591,38118,1561:1079,Pancreas,SW1990,SIDM01165,910907,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.78394194057345,0.0698095756915817,0.722207121391699,11.9077180230924,15.0086,0.875868220631945,0.905304330196566,0.0418980811908085,0.566168452239773,0.317276596764319,0.248891855475454,7.82576203818236,0.8862,4.08195598491,14.1224,0.686629832568821,0.562714686475171,0.709706033423843,0.580910257599446,0.12391514609365,0.128795775824397,True,0.339336687452299,0.042342449682687,1.01630724604075,48.0495712811403
2592,38118,1558:1079,Pancreas,SW1990,SIDM01165,910907,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.864707203034584,0.0698095756915817,0.722207121391699,11.9077180230924,15.0086,0.875868220631945,0.905304330196566,0.0650265516542521,0.624497699950275,0.479894937365285,0.144602762584989,9.672004999246,3.1866,2.23571302384636,11.822,0.757369559289527,0.722452196851333,0.782823175259371,0.717530212061638,0.0349173624381941,0.0652929631977325,True,0.339336687452299,0.042342449682687,1.01630724604075,48.0495712811403
2593,38118,1011:1080,Pancreas,SW1990,SIDM01165,910907,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.693219568645198,0.0728957647479088,0.647468286482341,10.8501359078328,0.3605,0.85681139797077,0.873846777392592,0.0962362410200788,0.448837686266733,0.138575134536672,0.310262551730062,4.77914607241192,0.0054,6.07098983542091,0.3551,0.593958427711586,0.372594213936295,0.605767686086088,0.383006568695682,0.221364213775291,0.222761117390407,True,0.339336687452299,0.042342449682687,1.01630724604075,48.0495712811403
2594,38119,1558:1083,Pancreas,SW1990,SIDM01165,910907,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.89100473803467,0.0836074451523236,0.849643898394391,14.2704907872521,308.7918,0.926687299013817,0.952420448907777,0.0697191932413824,0.75703673911165,0.592039617989268,0.164997121122382,11.0793524813439,33.8094,3.19113830590824,274.9824,0.825682774097862,0.794682019817778,0.848611132577937,0.785234270769906,0.0310007542800843,0.0633768618080311,True,0.339336687452299,0.042342449682687,1.01630724604075,48.0495712811403
2595,38261,1053:1168,Pancreas,SW1990,SIDM01165,910907,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.959281237266738,0.0663455669024085,0.793659568433047,13.0997674442681,171.4561,0.929591440408889,0.932613731338692,0.0622782431900661,0.761342732775038,0.526044184374839,0.235298548400199,9.59071297956786,15.0599,3.5090544647002,156.3962,0.891739627108008,0.752772711686658,0.894638854090529,0.792741302570138,0.138966915421351,0.101897551520391,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2596,38261,1561:1168,Pancreas,SW1990,SIDM01165,910907,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.875246916741443,0.0663455669024085,0.793659568433047,13.0997674442681,171.4561,0.929591440408889,0.932613731338692,0.0511714001487715,0.694648090213368,0.444211026629984,0.250437063583384,9.09163005436126,10.6557,4.00813738990679,160.8004,0.813622042047117,0.673822294313979,0.816267292864922,0.704092282602523,0.139799747733138,0.112175010262399,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2597,38261,1057:1168,Pancreas,SW1990,SIDM01165,910907,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.970307913938177,0.0663455669024085,0.793659568433047,13.0997674442681,171.4561,0.929591440408889,0.932613731338692,0.0473412097401443,0.770094160223343,0.623351798060824,0.146742362162519,10.7831322231964,34.4173,2.31663522107166,137.0388,0.901989931357934,0.824342696479107,0.904922484165345,0.845723303182522,0.0776472348788274,0.059199180982823,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2598,38262,1053:1372,Pancreas,SW1990,SIDM01165,910907,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.947486709667279,0.105680161055176,0.642597309034154,10.785391564536,3.4471,0.80964313983058,0.871679177010687,0.121315254373535,0.608852409977818,0.5017052093568,0.107147200621017,9.35967357385619,1.2831,1.42571799067985,2.164,0.76712611456276,0.692179502293179,0.825904435311337,0.773580692109232,0.0749466122695814,0.0523237432021049,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2599,38262,1561:1372,Pancreas,SW1990,SIDM01165,910907,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.875653008639418,0.105680161055176,0.642597309034154,10.785391564536,3.4471,0.80964313983058,0.871679177010687,0.09555880321572,0.562692266999351,0.306058727824601,0.25663353917475,7.10963694848674,0.2697,3.67575461604929,3.1774,0.708966451316912,0.56134458310177,0.76328849391774,0.613455055127292,0.147621868215142,0.149833438790448,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2600,38263,1085:1510,Pancreas,SW1990,SIDM01165,910907,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.647743005621465,0.0726105154605954,0.861478214772111,14.5620773405558,472.4459,0.931863324729541,0.956447221462737,0.122525473236041,0.558016488113901,0.336282469613433,0.221734018500469,9.23335988369246,11.7557,5.32871745686333,460.6902,0.603607950788724,0.4370925384933,0.619531997948572,0.525230058206734,0.166515412295424,0.094301939741838,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2601,38264,1372:1558,Pancreas,SW1990,SIDM01165,910907,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.719244027748948,0.0657286666990924,0.740951504297676,12.1983075253136,91.7881,0.886987464825164,0.912708963867118,0.0452295762820625,0.532924944317702,0.421024136351552,0.11190080796615,10.0495236890971,20.6985,2.14878383621647,71.0896,0.637960436763679,0.582360809013158,0.656460471334355,0.607750313472139,0.0555996277505209,0.0487101578622156,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2602,38264,1079:1561,Pancreas,SW1990,SIDM01165,910907,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.803170601590662,0.0731897417110747,0.620373908126953,10.4946929993421,28.1804,0.840473612663668,0.861588953166078,0.0470441713526855,0.498266085001475,0.273089611862975,0.2251764731385,6.98156555054292,2.4683,3.51312744879919,25.7121,0.675043697104155,0.565079201939099,0.692002917838267,0.556618962350517,0.109964495165056,0.13538395548775,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2603,38264,1372:1561,Pancreas,SW1990,SIDM01165,910907,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.784696603911959,0.0731897417110747,0.620373908126953,10.4946929993421,28.1804,0.840473612663668,0.861588953166078,0.0445816651695212,0.48680529886281,0.185126409885717,0.301678888977092,5.4235443491904,0.8383,5.07114865015171,27.3421,0.659516789534795,0.461323091775227,0.676085925517481,0.467103452222986,0.198193697759569,0.208982473294495,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2604,38264,1564:1561,Pancreas,SW1990,SIDM01165,910907,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.750020596057995,0.0731897417110747,0.620373908126953,10.4946929993421,28.1804,0.840473612663668,0.861588953166078,0.0336677547879831,0.465293208352206,0.172498944444774,0.292794263907432,5.32256432004739,0.7816,5.17212867929472,27.3988,0.630372519941021,0.424953164160275,0.646209460210606,0.441483211349275,0.205419355780746,0.20472624886133,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2605,38265,1053:1564,Pancreas,SW1990,SIDM01165,910907,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.968174730624721,0.078421332209166,0.62337178390968,10.5334925338095,28.9486,0.840094234253322,0.862969775268986,0.0753034830467795,0.603532808965806,0.461011836098666,0.142520972867139,8.70963932864447,8.177,1.82385320516502,20.7716,0.813358008947591,0.725296340481264,0.835505529708326,0.761431628448861,0.088061668466327,0.0740739012594652,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2606,38265,1561:1564,Pancreas,SW1990,SIDM01165,910907,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.801222299493769,0.078421332209166,0.62337178390968,10.5334925338095,28.9486,0.840094234253322,0.862969775268986,0.0696640716625092,0.499459374143646,0.180233674669081,0.319225699474565,5.23520903384172,0.7357,5.29828349996777,28.2129,0.673102234159904,0.432609265387109,0.691430627734638,0.467003940730471,0.240492968772794,0.224426687004166,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2607,38265,1168:1594,Pancreas,SW1990,SIDM01165,910907,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.754164244783054,0.079759874497961,0.644630455446111,10.8123673418331,14.0487,0.854637416349127,0.872585811489659,0.0442765470861387,0.486157240595672,0.529531710593135,-0.043374469997463,11.6097475274295,24.4159,-0.797380185596364,-10.3672,0.64453698166428,0.657555755434454,0.658073019530507,0.676616403173102,-0.0130187737701742,-0.018543383642595,True,0.520907623391559,0.0668857988212235,0.603420252656573,79.3279578831798
2608,35315,1080:1011,Pancreas,MIA-PaCa-2,SIDM00505,724870,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.435482097201787,0.177399487690534,0.608818806579207,10.1762094837259,22.5982,0.908747288973969,0.8719964223564,0.0605126789070356,0.265129690705002,0.0918829394861173,0.173246751218885,5.49288058030576,0.8795,4.68332890342016,21.7187,0.395743175228823,0.220677177053178,0.379738830760221,0.26497229042251,0.175065998175644,0.114766540337711,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2609,35315,1558:1011,Pancreas,MIA-PaCa-2,SIDM00505,724870,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.646846585618333,0.177399487690534,0.608818806579207,10.1762094837259,22.5982,0.908747288973969,0.8719964223564,0.153470506738784,0.393812366295989,0.0535811134662715,0.340231252829717,2.6065729417624,0.119,7.56963654196352,22.4792,0.587820081062729,0.220791239550732,0.56404790847264,0.257839846613649,0.367028841511997,0.30620806185899,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2610,35317,1372:1053,Pancreas,MIA-PaCa-2,SIDM00505,724870,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.526412467797044,0.0883527413162036,0.787647592613781,12.4854304915266,112.0003,0.911218402572153,0.938191001119234,0.0656843029062069,0.414627512982221,0.258518149755208,0.156109363227013,8.90526859841043,9.3645,3.58016189311614,102.6358,0.479676728000088,0.370722158448751,0.493875440164156,0.430209363574818,0.108954569551337,0.0636660765893377,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2611,35317,1558:1053,Pancreas,MIA-PaCa-2,SIDM00505,724870,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.934310880858949,0.0883527413162036,0.787647592613781,12.4854304915266,112.0003,0.911218402572153,0.938191001119234,0.0511957554729039,0.735907716061412,0.678309805367231,0.0575979106941811,11.5909921757996,60.2513,0.894438315726923,51.749,0.851361268362073,0.885699053691403,0.876562060669651,0.856933025285481,-0.0343377853293293,0.0196290353841703,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2612,35317,1564:1053,Pancreas,MIA-PaCa-2,SIDM00505,724870,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.528652466225116,0.0883527413162036,0.787647592613781,12.4854304915266,112.0003,0.911218402572153,0.938191001119234,0.084081825447127,0.41639184235155,0.319219627351416,0.097172215000134,10.1207065443714,21.7453,2.36472394715516,90.255,0.481717855789479,0.393615723778439,0.495976986531893,0.45987162271365,0.0881021320110396,0.0361053638182437,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2613,35319,1510:1079,Pancreas,MIA-PaCa-2,SIDM00505,724870,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.662320652126592,0.106670889592723,0.901634936117265,14.8910847289833,118.6925,0.899288661983785,0.973141235027578,0.111946037965148,0.597171438869305,0.366960348472761,0.230211090396544,9.57715736995724,2.9838,5.31392735902603,115.7087,0.595617453055151,0.476912272758405,0.644531537394742,0.561594945596465,0.118705180296746,0.0829365917982776,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2614,35319,1564:1079,Pancreas,MIA-PaCa-2,SIDM00505,724870,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.602531908726621,0.106670889592723,0.901634936117265,14.8910847289833,118.6925,0.899288661983785,0.973141235027578,0.102548281416226,0.543263819033341,0.313217694250168,0.230046124783173,9.21108524349334,2.3151,5.67999948548992,116.3774,0.541850114001299,0.418035641977395,0.586348645801748,0.50111996734069,0.123814472023904,0.0852286784610576,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2615,35319,1372:1079,Pancreas,MIA-PaCa-2,SIDM00505,724870,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.557341742688768,0.106670889592723,0.901634936117265,14.8910847289833,118.6925,0.899288661983785,0.973141235027578,0.152151894382166,0.502518786564673,0.172231452154223,0.330287334410449,6.86032554193755,0.4539,8.03075918704572,118.2386,0.501211110050293,0.294136365019549,0.54237223181257,0.390823253484872,0.207074745030744,0.151548978327698,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2616,35320,1558:1083,Pancreas,MIA-PaCa-2,SIDM00505,724870,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.920440606478824,0.0648591228398288,0.568108316794854,9.72893180554371,13.2593,0.847228151864774,0.8543102740228,0.0590958225624739,0.522909963656319,0.48491795562562,0.0379920080306988,9.28566440885516,9.7518,0.443267396688546,3.5075,0.779823193928346,0.80226288058094,0.786341866742636,0.768651212965671,-0.0224396866525942,0.0176906537769653,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2617,35320,1558:1085,Pancreas,MIA-PaCa-2,SIDM00505,724870,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.681202638995479,0.108404740332611,0.553477135896428,9.57096725419366,14.8552,0.886343746573885,0.847655194062956,0.125115360763313,0.377030085596306,0.194400172021926,0.18262991357438,6.55919582152152,1.8418,3.01177143267214,13.0134,0.603779699223271,0.469090604221619,0.57742495515391,0.464330315583388,0.134689095001652,0.113094639570523,True,0.313590183088734,0.0437245510185746,1.11922508169183,44.0838055198425
2618,35523,1561:1372,Pancreas,MIA-PaCa-2,SIDM00505,724870,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.857145571063925,0.106551018877023,0.42232088904872,8.1670590583442,0.5614,0.714357213812277,0.779126634324169,0.121279793843466,0.361990479615889,0.215700008301362,0.146290471314527,6.10212365670562,0.1342,2.06493540163858,0.4272,0.612308121976758,0.504769150875825,0.667824943908903,0.557933278171515,0.107538971100933,0.109891665737389,True,,,,
2619,35523,1079:1372,Pancreas,MIA-PaCa-2,SIDM00505,724870,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.930784731832801,0.106551018877023,0.42232088904872,8.1670590583442,0.5614,0.714357213812277,0.779126634324169,0.0847556601830042,0.393089835460603,0.169811033859766,0.223278801600836,5.01172823173194,0.063,3.15533082661226,0.4984,0.664912787691087,0.496737152086549,0.725199175393215,0.534254424971301,0.168175635604538,0.190944750421913,True,,,,
2620,37945,1594:1510,Pancreas,MIA-PaCa-2,SIDM00505,724870,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.526555401016262,0.0491665921183561,0.918777604364415,15.4503503222644,874.4781,0.978231214265539,0.978021582649092,0.0643218995848179,0.483787309910865,0.333975453849032,0.149811856061833,10.4639303124425,27.5859,4.98642000982184,846.8922,0.515092929314216,0.418608121671502,0.514982546654352,0.464675615662628,0.0964848076427144,0.0503069309917232,True,0.448307625429596,0.0590480514235753,0.738409164172256,65.0209490418883
2621,37945,1564:1510,Pancreas,MIA-PaCa-2,SIDM00505,724870,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.421153599073134,0.0491665921183561,0.918777604364415,15.4503503222644,874.4781,0.978231214265539,0.978021582649092,0.0463251766411356,0.386946494825865,0.292375586558613,0.0945709082672521,11.1802471310912,45.3231,4.27010319117318,829.155,0.411985596613614,0.349329127364454,0.411897309503868,0.381425468975578,0.0626564692491595,0.0304718405282899,True,0.448307625429596,0.0590480514235753,0.738409164172256,65.0209490418883
2622,35525,1510:1558,Pancreas,MIA-PaCa-2,SIDM00505,724870,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.801835268125514,0.0737112372703379,0.809011937153825,12.8385438557144,143.0595,0.936101460718708,0.9451010699257,0.0964098390346579,0.648694303544479,0.4292598151201,0.219434488424379,9.37657540533475,12.9826,3.46196845037964,130.0769,0.750599165748071,0.69106658857004,0.757815369809584,0.672876435499669,0.0595325771780311,0.0849389343099155,True,,,,
2623,35525,1053:1558,Pancreas,MIA-PaCa-2,SIDM00505,724870,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.954571383574694,0.0737112372703379,0.809011937153825,12.8385438557144,143.0595,0.936101460718708,0.9451010699257,0.0671820838786959,0.77225964417737,0.673585742115975,0.0986739020613947,11.3247973977702,50.0995,1.51374645794423,92.96,0.893575666524549,0.85627092252275,0.902166435936899,0.868528927833293,0.037304744001799,0.0336375081036067,True,,,,
2624,35525,1085:1558,Pancreas,MIA-PaCa-2,SIDM00505,724870,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.983767456651344,0.0737112372703379,0.809011937153825,12.8385438557144,143.0595,0.936101460718708,0.9451010699257,0.0572484493822938,0.795879615814395,0.82684688893882,-0.0309672731244243,13.4189431706867,213.9117,-0.580399314972297,-70.8522,0.920906153178852,0.967083955859068,0.92975967583927,0.93946441434322,-0.0461778026802164,-0.0097047385039493,True,,,,
2625,35525,1054:1558,Pancreas,MIA-PaCa-2,SIDM00505,724870,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.927539197616719,0.0737112372703379,0.809011937153825,12.8385438557144,143.0595,0.936101460718708,0.9451010699257,0.103752548681601,0.750390283050006,0.421218138176845,0.329172144873161,8.51068994304395,7.1237,4.32785391267045,135.9358,0.868270797762869,0.748989066895346,0.876618288065586,0.73965355127603,0.119281730867523,0.136964736789557,True,,,,
2626,35525,1011:1558,Pancreas,MIA-PaCa-2,SIDM00505,724870,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.831702115589972,0.0737112372703379,0.809011937153825,12.8385438557144,143.0595,0.936101460718708,0.9451010699257,0.166326700670811,0.672856939668378,0.408813503879001,0.264043435789377,8.90999343383006,9.3952,3.92855042188433,133.6643,0.778557565286613,0.701171459165303,0.786042559303551,0.679897269694743,0.0773861061213105,0.106145289608809,True,,,,
2627,35525,1372:1561,Pancreas,MIA-PaCa-2,SIDM00505,724870,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.611805233990623,0.0856609098308386,0.762469746102119,12.1011095199444,85.8078,0.890593487823146,0.929810055595266,0.0937055792434083,0.466482981424778,0.247928982347922,0.218553999076855,7.97981638126111,4.9305,4.1212931386833,80.8773,0.544869757208165,0.397813414218474,0.568862658630296,0.470323702710427,0.14705634298969,0.0985389559198692,True,,,,
2628,35525,1564:1561,Pancreas,MIA-PaCa-2,SIDM00505,724870,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.65707660007852,0.0856609098308386,0.762469746102119,12.1011095199444,85.8078,0.890593487823146,0.929810055595266,0.076753718550881,0.501001028431513,0.230240665424801,0.270760363006712,7.35866511872374,3.2056,4.74244440122067,82.6022,0.585188141030903,0.422836393587862,0.610956430049357,0.481232898579611,0.162351747443041,0.129723531469746,True,,,,
2629,37946,1079:1564,Pancreas,MIA-PaCa-2,SIDM00505,724870,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,1.0,0.0822234456620379,0.219526394594799,5.62724510367054,0.9654,0.604243613558714,0.617951015436434,0.0818768275891645,0.219526394594799,0.100588399940782,0.118937994654016,3.17491220722484,0.1764,2.4523328964457,0.789,0.604243613558714,0.424202616939783,0.617951015436434,0.439553236213094,0.18004099661893,0.17839777922334,True,0.448307625429596,0.0590480514235753,0.738409164172256,65.0209490418883
2630,38571,1080:1011,Pancreas,PSN1,SIDM00469,910546,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.423881948576822,0.0734372326632305,0.736131648778382,11.0236114112882,40.66,0.937321730560874,0.940019644480766,0.0417064369120784,0.31203291769325,0.0164320374881758,0.295600880205074,2.66721177140301,0.1241,8.35639963988523,40.5359,0.397313761593543,0.14051606301532,0.398457358602999,0.164245785825278,0.256797698578223,0.234211572777721,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2631,38571,1085:1011,Pancreas,PSN1,SIDM00469,910546,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.586416044059238,0.0734372326632305,0.736131648778382,11.0236114112882,40.66,0.937321730560874,0.940019644480766,0.133792850058142,0.431679409383423,0.107990597412651,0.323688811970772,6.06415363757417,1.3068,4.95945777371406,39.3532,0.549660501246267,0.328763996823834,0.551242601254382,0.393887527801921,0.220896504422433,0.157355073452461,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2632,38571,1372:1011,Pancreas,PSN1,SIDM00469,910546,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.173062533365968,0.0734372326632305,0.736131648778382,11.0236114112882,40.66,0.937321730560874,0.940019644480766,0.0370000232337455,0.127396808028454,0.0274974394063359,0.0998993686221179,5.71291815738814,1.0244,5.3106932539001,39.6356,0.162215273269838,0.0811040656380484,0.162682181087618,0.111385939832391,0.0811112076317898,0.0512962412552268,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2633,38571,1083:1011,Pancreas,PSN1,SIDM00469,910546,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.93895452272626,0.0734372326632305,0.736131648778382,11.0236114112882,40.66,0.937321730560874,0.940019644480766,0.0813076753312309,0.691194140942401,0.564500324445842,0.126693816496559,9.80961813300362,17.5275,1.21399327828462,23.1325,0.880102478159738,0.790522677204077,0.882635696636746,0.84548999109865,0.0895798009556609,0.0371457055380964,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2634,38571,1564:1011,Pancreas,PSN1,SIDM00469,910546,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.176537425094623,0.0734372326632305,0.736131648778382,11.0236114112882,40.66,0.937321730560874,0.940019644480766,0.0444160461629958,0.129954785805995,0.035632385035182,0.0943224007708129,6.28826867154119,1.5265,4.73534273974704,39.1335,0.165472364798453,0.0924695569455679,0.165948647574997,0.121669602418129,0.0730028078528848,0.0442790451568686,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2635,38573,1054:1053,Pancreas,PSN1,SIDM00469,910546,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.733802374421509,0.0614480839510606,0.879573819563909,12.9219416554765,151.5731,0.941488455253216,0.97486006309675,0.0864481405342845,0.645433357274992,0.416544489053204,0.228888868221788,9.53704453775016,14.51,3.3848971177263,137.0631,0.690866463955248,0.574381820565824,0.715354629029097,0.652537107234494,0.116484643389425,0.0628175217946029,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2636,38573,1564:1053,Pancreas,PSN1,SIDM00469,910546,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.264076292656999,0.0614480839510606,0.879573819563909,12.9219416554765,151.5731,0.941488455253216,0.97486006309675,0.0556167730372905,0.232274593388593,0.0930645133746898,0.139210080013903,7.79990769022287,4.3525,5.12203396525359,147.2206,0.248624780842634,0.15944730591775,0.257437431321958,0.210350643368175,0.0891774749248844,0.0470867879537828,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2637,38573,1372:1053,Pancreas,PSN1,SIDM00469,910546,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.259615386307696,0.0614480839510606,0.879573819563909,12.9219416554765,151.5731,0.941488455253216,0.97486006309675,0.0610129256387888,0.22835089695222,0.128514463511469,0.0998364334407514,8.96069780195399,9.7313,3.96124385352247,141.8418,0.2444248890148,0.16470408611348,0.253088671876808,0.223935969166829,0.0797208029013201,0.0291527027099793,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2638,38573,1558:1053,Pancreas,PSN1,SIDM00469,910546,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.958738464273237,0.0614480839510606,0.879573819563909,12.9219416554765,151.5731,0.941488455253216,0.97486006309675,0.0396246988582314,0.843281252983647,0.792622812401581,0.0506584405820668,12.0822129885391,84.6913,0.839728666937395,66.8818,0.902641195720451,0.921415333683574,0.934635839774689,0.923006591487645,-0.0187741379631235,0.0116292482870441,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2639,38573,1079:1053,Pancreas,PSN1,SIDM00469,910546,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.529958349503371,0.0614480839510606,0.879573819563909,12.9219416554765,151.5731,0.941488455253216,0.97486006309675,0.108719241983999,0.466137489682465,0.270866803513603,0.195270686168862,9.0876652371025,10.6265,3.83427641837396,140.9466,0.498949667822473,0.363473579258704,0.516635230035505,0.460427446258701,0.135476088563769,0.0562077837768041,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2640,38573,1561:1054,Pancreas,PSN1,SIDM00469,910546,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,0.879763209050645,0.0791983900621373,0.660720541988264,10.3146249439098,19.899,0.900779142807611,0.918893840911051,0.111608801415131,0.581277624305276,0.358686583716039,0.222591040589238,8.26340708451623,4.8012,2.05121785939355,15.0978,0.792472349322313,0.646313099446391,0.808408994256779,0.725652184980471,0.146159249875923,0.0827568092763082,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2641,38574,1372:1057,Pancreas,PSN1,SIDM00469,910546,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.168467294422745,0.057921405359166,0.718819985017678,10.8513355882979,0.3608,0.918100582963586,0.935366147007606,0.0302905577902452,0.121097658052926,0.057762701295521,0.0633349567574052,7.71690358592747,0.0411,3.13443200237047,0.3197,0.15466992121982,0.111796802294127,0.157578604080999,0.133297113302504,0.0428731189256933,0.0242814907784945,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2642,38576,1372:1083,Pancreas,PSN1,SIDM00469,910546,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.249051630802676,0.0859938704440824,0.542122780157151,9.33312320813602,10.0779,0.859410640706061,0.880280545997675,0.0273483985244011,0.135016562493419,0.0657176410094429,0.0692989214839764,6.97642111755094,1.9676,2.35670209058508,8.1103,0.214037621597018,0.170512987780636,0.219235305544591,0.184458681732535,0.0435246338163816,0.034776623812056,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2643,38576,1011:1083,Pancreas,PSN1,SIDM00469,910546,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.940551605637474,0.0859938704440824,0.542122780157151,9.33312320813602,10.0779,0.859410640706061,0.880280545997675,0.0640775718883243,0.509894451329459,0.250779788923935,0.259114662405524,7.00434364002392,2.006,2.3287795681121,8.0719,0.808320058018016,0.719082626529274,0.827949280949545,0.69849894586859,0.0892374314887423,0.129450335080955,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2644,38576,1558:1083,Pancreas,PSN1,SIDM00469,910546,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.956889799431383,0.0859938704440824,0.542122780157151,9.33312320813602,10.0779,0.859410640706061,0.880280545997675,0.0566930089305997,0.51875175837176,0.54587233842542,-0.0271205800536601,9.55967030752272,11.7915,-0.226547099386694,-1.7136,0.82236127561442,0.882417403707985,0.842331475103064,0.85184136786801,-0.0600561280935653,-0.0095098927649461,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2645,38576,1079:1083,Pancreas,PSN1,SIDM00469,910546,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.544793186901766,0.0859938704440824,0.542122780157151,9.33312320813602,10.0779,0.859410640706061,0.880280545997675,0.047686780019343,0.29534479709386,0.266096743002048,0.0292480540918116,8.90874991666287,7.5097,0.424373291473156,2.5682,0.468201061807543,0.448783661579914,0.4795708440217,0.468501069024253,0.0194174002276292,0.0110697749974463,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2646,38576,1011:1085,Pancreas,PSN1,SIDM00469,910546,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.940551605637474,0.0856193182281902,0.497921797088109,8.98360363046978,9.887,0.886241284353916,0.863707045021904,0.104947295961,0.468321145733118,0.251539773450089,0.216781372283029,7.01248634434884,2.5217,1.97111728612094,7.3653,0.833555662981292,0.74113341185917,0.812361047995749,0.699047313726909,0.092422251122122,0.11331373426884,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2647,38578,1564:1168,Pancreas,PSN1,SIDM00469,910546,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.228223795657369,0.0494604013981097,0.912487887006129,13.6241139015002,246.6022,0.976279232582858,0.982055386535217,0.0133381227873734,0.208251449063911,0.114574179002185,0.093677270061726,9.01598103514453,10.1114,4.60813286635572,236.4908,0.222810152081523,0.201003512602253,0.224128407860832,0.197483370214746,0.0218066394792699,0.0266450376460859,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2648,38578,1372:1168,Pancreas,PSN1,SIDM00469,910546,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.247047865304854,0.0494604013981097,0.912487887006129,13.6241139015002,246.6022,0.976279232582858,0.982055386535217,0.0489185233591753,0.225428184601401,0.16977323496895,0.0556549496324509,10.5524800455582,29.3321,3.0716338559421,217.2701,0.241187700351056,0.202440246999132,0.242614686854659,0.228908250690671,0.0387474533519246,0.0137064361639876,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2649,38579,1079:1507,Pancreas,PSN1,SIDM00469,910546,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1507,Ruxolitinib,"JAK1, JAK2","Other, kinases",Targeted,Advanced clinical trials,10.0,0.514879584400941,0.0553363455686282,0.878227052790495,12.8969835661328,148.9735,0.957117599329416,0.97455998308882,0.0599443461895293,0.452181179950433,0.390286008532908,0.0618951714175253,11.252142981024,47.639,1.64484058510879,101.3345,0.492800311765556,0.434092985569548,0.50178103906656,0.486946824394227,0.0587073261960084,0.0148342146723325,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2650,38579,1085:1510,Pancreas,PSN1,SIDM00469,910546,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.593479409589112,0.056398290659004,0.829413269732577,12.1193169435888,86.8976,0.93640796825534,0.963363391895197,0.0869884385065047,0.492239697626265,0.299025332897916,0.193214364728349,9.03038545527267,10.2128,3.08893148831611,76.6848,0.55573884813472,0.443194206918988,0.571736337041726,0.513960814131789,0.112544641215732,0.0577755229099373,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2651,38579,1372:1510,Pancreas,PSN1,SIDM00469,910546,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.194259402209477,0.056398290659004,0.829413269732577,12.1193169435888,86.8976,0.93640796825534,0.963363391895197,0.056774310713269,0.161121325962858,0.0786516048901353,0.082469721072723,8.24027614231177,5.9061,3.87904080127701,80.9915,0.181906052137474,0.109991590291725,0.187142396620055,0.159967653218481,0.071914461845749,0.0271747434015745,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2652,38579,1594:1510,Pancreas,PSN1,SIDM00469,910546,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.675205994702966,0.056398290659004,0.829413269732577,12.1193169435888,86.8976,0.93640796825534,0.963363391895197,0.0663740354316932,0.560024811809624,0.431585078675861,0.128439733133762,10.1279253136687,21.8544,1.9913916299201,65.0432,0.63226827365363,0.565722071605855,0.650468737285019,0.616073097844879,0.0665462020477747,0.0343956394401407,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2653,38579,1564:1510,Pancreas,PSN1,SIDM00469,910546,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.212184418401382,0.056398290659004,0.829413269732577,12.1193169435888,86.8976,0.93640796825534,0.963363391895197,0.0762010787068893,0.175988572252595,0.0820511319980923,0.0939374402545027,8.09029165607613,5.3229,4.02902528751265,81.5747,0.198691180130679,0.10279188285951,0.204410701018465,0.172835749145337,0.0958992972711685,0.0315749518731271,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2654,38579,1079:1510,Pancreas,PSN1,SIDM00469,910546,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.7450783083658,0.056398290659004,0.829413269732577,12.1193169435888,86.8976,0.93640796825534,0.963363391895197,0.147566115440047,0.617977835948495,0.210635195370703,0.407342640577792,7.16349354771669,2.8,4.95582339587209,84.0976,0.697697264927944,0.456521449929986,0.717781166374812,0.561738928545812,0.241175814997958,0.156042237829,True,0.285165227878671,0.0370029438850035,1.16344452835307,41.9269351804705
2655,38426,1372:1561,Pancreas,PSN1,SIDM00469,910546,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.244505319897397,0.0623172577739819,0.777586849154978,11.4687843800064,55.3577,0.927916334755173,0.950736197137508,0.0645738217459427,0.190124121300647,0.0877863628906765,0.10233775840997,7.85689366830208,4.5278,3.61189071170428,50.8299,0.226880480267334,0.131609739900444,0.232460058019141,0.195643355234703,0.0952707403668897,0.0368167027844384,True,0.649825479625236,0.0614096177339222,0.397017214516151,119.033578749027
2656,38426,1564:1561,Pancreas,PSN1,SIDM00469,910546,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.29965194112627,0.0623172577739819,0.777586849154978,11.4687843800064,55.3577,0.927916334755173,0.950736197137508,0.0832156779043202,0.233005408743549,0.0356477781261519,0.197357630617397,5.0506861968604,0.6473,6.41809818314596,54.7104,0.278051930912161,0.111312616833445,0.284889946971262,0.176512132468505,0.166739314078716,0.108377814502756,True,0.649825479625236,0.0614096177339222,0.397017214516151,119.033578749027
2657,38426,1079:1561,Pancreas,PSN1,SIDM00469,910546,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.81434140883105,0.0623172577739819,0.777586849154978,11.4687843800064,55.3577,0.927916334755173,0.950736197137508,0.168325014973061,0.633221170229362,0.25929899691225,0.373922173317112,7.49887210129976,3.5328,3.9699122787066,51.8249,0.755640695321872,0.501383963444258,0.774223854203633,0.632672210615512,0.254256731877614,0.141551643588122,True,0.649825479625236,0.0614096177339222,0.397017214516151,119.033578749027
2658,38426,1054:1561,Pancreas,PSN1,SIDM00469,910546,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,2.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.911206811534247,0.0623172577739819,0.777586849154978,11.4687843800064,55.3577,0.927916334755173,0.950736197137508,0.10158418705313,0.708542433509469,0.493987881370909,0.21455455213856,9.33313987624039,12.5975,2.13564450376596,42.7602,0.845523684762806,0.71677317154015,0.866317298803864,0.802118316983705,0.128750513222656,0.0641989818201585,True,0.649825479625236,0.0614096177339222,0.397017214516151,119.033578749027
2659,38427,1564:1594,Pancreas,PSN1,SIDM00469,910546,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.323083489654325,0.0636788636634315,0.67749671697104,10.464103166516,11.0357,0.901819827168196,0.923793111683952,0.0546548203399537,0.218888003548353,0.0855602764409255,0.133327727107427,6.98608184284707,0.9904,3.47802132366894,10.0453,0.291363096800961,0.21604946907889,0.298462302241479,0.239514209129583,0.0753136277220716,0.0589480931118961,True,0.649825479625236,0.0614096177339222,0.397017214516151,119.033578749027
2660,35907,1080:1011,Pancreas,HuP-T3,SIDM00533,907285,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.474135434617761,0.171288037998888,0.556962625154128,9.73579876097284,16.6532,0.878178902331681,0.823031028735949,0.0686922752173043,0.264075716343301,0.147892571589158,0.116183144754143,6.456207932176,1.7149,3.27959082879683,14.9383,0.41637573552918,0.292472326923529,0.390228174513622,0.310836601216489,0.123903408605651,0.0793915732971324,True,0.489442115244753,0.0646968318356043,0.677336585695036,71.7365152885609
2661,35907,1079:1011,Pancreas,HuP-T3,SIDM00533,907285,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.629917359256571,0.171288037998888,0.556962625154128,9.73579876097284,16.6532,0.878178902331681,0.823031028735949,0.0751971791351865,0.350840426041696,0.198044265025331,0.152796161016364,6.49323105754344,1.7595,3.24256770342939,14.8937,0.553180135111607,0.416470497567682,0.518441532207568,0.414359103182961,0.136709637543925,0.104082429024607,True,0.489442115244753,0.0646968318356043,0.677336585695036,71.7365152885609
2662,38065,1564:1053,Pancreas,HuP-T3,SIDM00533,907285,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.565085151881154,0.069805830485734,0.80598743188782,13.5790331594958,239.0156,0.910970710226345,0.934083500158676,0.0523187221231702,0.45545153036263,0.328272601292912,0.127178929069718,10.0500332848476,20.7058,3.5289998746482,218.3098,0.514776022147537,0.492951627666334,0.527836716556845,0.47215590484232,0.021824394481203,0.055680811714525,True,0.369808795563852,0.0642067048978295,0.926557537378413,52.4048352055779
2663,38065,1372:1053,Pancreas,HuP-T3,SIDM00533,907285,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.552552550715366,0.069805830485734,0.80598743188782,13.5790331594958,239.0156,0.910970710226345,0.934083500158676,0.0658592991685012,0.445350411334142,0.316988201202062,0.12836221013208,9.95455528553126,19.3798,3.62447787396456,219.6358,0.503359189562556,0.409533200597054,0.516130220593813,0.459621135455197,0.0938259889655019,0.0565090851386166,True,0.369808795563852,0.0642067048978295,0.926557537378413,52.4048352055779
2664,38065,1558:1053,Pancreas,HuP-T3,SIDM00533,907285,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.993661927193398,0.069805830485734,0.80598743188782,13.5790331594958,239.0156,0.910970710226345,0.934083500158676,0.0378847914399074,0.800879024863309,0.616292645847911,0.184586379015398,10.5770900178864,29.8367,3.00194314160944,209.1789,0.905196911540249,0.823006714861493,0.928163210927225,0.849656280490611,0.0821901966787563,0.0785069304366138,True,0.369808795563852,0.0642067048978295,0.926557537378413,52.4048352055779
2665,38066,1011:1080,Pancreas,HuP-T3,SIDM00533,907285,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.840974638053407,0.0792380278968204,0.571599194664197,9.92722017794727,0.1902,0.823121183504274,0.830734189874524,0.133973574137779,0.480700425844342,0.261947733578838,0.218752692265504,6.44962299616374,0.0171,3.47759718178353,0.1731,0.692224039371599,0.569541176764937,0.698626384648318,0.550999764540755,0.122682862606662,0.147626620107564,True,0.369808795563852,0.0642067048978295,0.926557537378413,52.4048352055779
2666,37973,1011:1083,Pancreas,HuP-T3,SIDM00533,907285,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.858342518881404,0.111697283673475,0.695463224574581,11.6551384931925,50.3925,0.888416879397566,0.889446326359252,0.18397735454514,0.596945655970729,0.417146571686102,0.179799084284628,8.81977859465821,7.0605,2.83535989853432,43.332,0.762565982078863,0.713515475250666,0.763449600177012,0.671922853931006,0.0490505068281976,0.0915267462460062,True,0.604942543826536,0.0765820801337218,0.468033224658346,102.037628948287
2667,37973,1558:1083,Pancreas,HuP-T3,SIDM00533,907285,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.948370530499217,0.111697283673475,0.695463224574581,11.6551384931925,50.3925,0.888416879397566,0.889446326359252,0.0647853560711351,0.659556827232491,0.625666048588306,0.0338907786441849,11.1287753624087,34.9877,0.52636313078388,15.4048,0.842548387218728,0.861139647383164,0.843524684379903,0.828476369127167,-0.0185912601644359,0.015048315252736,True,0.604942543826536,0.0765820801337218,0.468033224658346,102.037628948287
2668,37973,1079:1083,Pancreas,HuP-T3,SIDM00533,907285,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.497191361895838,0.111697283673475,0.695463224574581,11.6551384931925,50.3925,0.888416879397566,0.889446326359252,0.0561495639851485,0.345778307774707,0.335353445598797,0.0104248621759103,11.3426238180362,40.5779,0.312514675156358,9.8146,0.441713198198926,0.44906085087441,0.442225030335807,0.437643475198139,-0.0073476526754838,0.0045815551376672,True,0.604942543826536,0.0765820801337218,0.468033224658346,102.037628948287
2669,37973,1558:1085,Pancreas,HuP-T3,SIDM00533,907285,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.884765811562232,0.149315262781665,0.641389854013426,10.8693720673426,36.5374,0.905538445883965,0.865121951964616,0.171849483879107,0.567479814713971,0.322303275540374,0.245176539173597,7.20962761185014,2.891,3.65974445549248,33.6464,0.801189457973328,0.640662466153653,0.765430325930275,0.618811727221946,0.160526991819675,0.146618598708329,True,0.604942543826536,0.0765820801337218,0.468033224658346,102.037628948287
2670,36976,1558:1372,Pancreas,HuP-T3,SIDM00533,907285,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.72625051279128,0.120843627471871,0.465420569224278,8.55455797408896,0.7344,0.714723109055412,0.770151646907656,0.0420356488363872,0.338011927062741,0.163086936375578,0.174924990687163,5.01533962225983,0.0632,3.53921835182913,0.6712,0.519068024455271,0.393157765736142,0.559323028493734,0.410921827931501,0.125910258719129,0.148401200562233,True,0.313981693349164,0.0499614999477045,1.10163855141757,44.5667541160392
2671,38188,1057:1510,Pancreas,HuP-T3,SIDM00533,907285,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.990881470891128,0.081833826056238,0.768652343492041,12.8606483442411,145.2683,0.88823035297313,0.919687384827356,0.115874881630063,0.761643364723306,0.54574549196466,0.215897872758646,9.65518810419902,15.7482,3.20546024004205,129.5201,0.880130998644161,0.754723396871263,0.911301188637745,0.812239651797683,0.125407601772898,0.0990615368400624,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2672,38188,1594:1510,Pancreas,HuP-T3,SIDM00533,907285,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.765751081704019,0.081833826056238,0.768652343492041,12.8606483442411,145.2683,0.88823035297313,0.919687384827356,0.0907249516169217,0.588596363483359,0.43565071799378,0.152945645489579,9.8920618607475,18.5583,2.96858648349357,126.71,0.680163353591517,0.578772119762648,0.704251609761088,0.63506616945663,0.101391233828869,0.0691854403044581,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2673,38188,1564:1510,Pancreas,HuP-T3,SIDM00533,907285,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.565105416630516,0.081833826056238,0.768652343492041,12.8606483442411,145.2683,0.88823035297313,0.919687384827356,0.0514914667781098,0.434369602813092,0.375983874228756,0.0583857285843362,11.2094037621474,46.2484,1.65124458209364,99.0199,0.501943783680751,0.458451950462294,0.519720322772692,0.495100513407661,0.0434918332184566,0.024619809365031,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2674,38188,1558:1510,Pancreas,HuP-T3,SIDM00533,907285,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.870522801603978,0.081833826056238,0.768652343492041,12.8606483442411,145.2683,0.88823035297313,0.919687384827356,0.120702844471789,0.669129391516154,0.405503689118806,0.263625702397348,8.55967138584602,7.3697,4.30097695839505,137.8986,0.773224775339859,0.596989373460434,0.800608838839745,0.670650767933275,0.176235401879425,0.12995807090647,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2675,38188,1079:1510,Pancreas,HuP-T3,SIDM00533,907285,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.75807484976857,0.081833826056238,0.768652343492041,12.8606483442411,145.2683,0.88823035297313,0.919687384827356,0.0860962441322813,0.582696009816988,0.283459003341771,0.299237006475217,7.34271903755137,3.1704,5.51792930668971,142.0979,0.67334509138999,0.474839451358213,0.697191876087047,0.535853908989259,0.198505640031777,0.161337967097788,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2676,38189,1510:1558,Pancreas,HuP-T3,SIDM00533,907285,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.801996264058835,0.0616397873368808,0.852716847250472,14.6462679938296,500.8366,0.958065053462458,0.95123866124152,0.0820581160927481,0.683875725794907,0.327429841967349,0.356445883827558,7.80671829489272,4.3731,6.83954969893685,496.4635,0.768364593602219,0.547635675173064,0.762889852544027,0.587143631843143,0.220728918429155,0.175746220700883,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2677,38189,1085:1558,Pancreas,HuP-T3,SIDM00533,907285,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.966413730419275,0.0616397873368808,0.852716847250472,14.6462679938296,500.8366,0.958065053462458,0.95123866124152,0.0773451116053409,0.824077269342692,0.807090783366455,0.0169864859762365,14.2168097343491,371.8915,0.429458259480516,128.9451,0.925887222300996,0.952417129871746,0.919290103129454,0.913157395110423,-0.0265299075707492,0.0061327080190316,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2678,38189,1564:1558,Pancreas,HuP-T3,SIDM00533,907285,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.729172318973331,0.0616397873368808,0.852716847250472,14.6462679938296,500.8366,0.958065053462458,0.95123866124152,0.0884749221748772,0.621777520937255,0.447023713329936,0.174753807607319,10.4796027270801,27.8872,4.1666652667495,472.9494,0.698594516760529,0.580387655219017,0.693616900514566,0.620964289780559,0.118206861541512,0.0726526107340073,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2679,38189,1079:1558,Pancreas,HuP-T3,SIDM00533,907285,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.524324494648694,0.0616397873368808,0.852716847250472,14.6462679938296,500.8366,0.958065053462458,0.95123866124152,0.075805841284472,0.447100330013031,0.369962812332834,0.0771375176801968,11.8104939328339,70.1525,2.83577406099569,430.6841,0.502336974997277,0.425230388290193,0.49875773034576,0.468645358398222,0.0771065867070836,0.0301123719475381,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2680,38189,1372:1561,Pancreas,HuP-T3,SIDM00533,907285,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.599088921529863,0.0701740646566855,0.578496038932255,10.0179674445374,20.2506,0.806622988384361,0.834300975442121,0.0826656721663856,0.346570568073222,0.196597486554313,0.149973081518909,6.6961985830772,2.0253,3.32176886146018,18.2253,0.483238896192381,0.35667855103232,0.499820471608933,0.40128623682663,0.126560345160061,0.0985342347823027,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2681,38189,1564:1561,Pancreas,HuP-T3,SIDM00533,907285,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.669962225229147,0.0701740646566855,0.578496038932255,10.0179674445374,20.2506,0.806622988384361,0.834300975442121,0.084040740044454,0.387570493529301,0.178309725190697,0.209260768338604,5.7388965618761,1.0431,4.27907088266128,19.2075,0.540406932218971,0.361712628151442,0.558950138018052,0.409802522952466,0.178694304067528,0.149147615065586,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2682,38189,1079:1561,Pancreas,HuP-T3,SIDM00533,907285,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.746778889402067,0.0701740646566855,0.578496038932255,10.0179674445374,20.2506,0.806622988384361,0.834300975442121,0.0852773176281875,0.432008629477325,0.217646668703265,0.21436196077406,6.14365183849836,1.3809,3.87431560603902,18.8697,0.602369019431849,0.4306479899527,0.623038355867729,0.475462395404234,0.17172102947915,0.147575960463495,True,0.508548675357491,0.0864014437630406,0.610791230747544,77.424247392967
2683,38376,1053:1564,Pancreas,HuP-T3,SIDM00533,907285,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.90109958876536,0.106189246903609,0.533573274085053,9.43244131255644,13.4952,0.757028192942927,0.810324890055215,0.139615381933629,0.480802657854229,0.289886233415946,0.190916424438282,6.6015336798635,1.8967,2.83090763269294,11.5985,0.682157793344655,0.537423553737318,0.73018342519509,0.598546084880676,0.144734239607337,0.131637340314413,True,,,,
2684,38376,1085:1594,Pancreas,HuP-T3,SIDM00533,907285,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.755304466896886,0.0606146507043674,0.785382973153137,13.1712420137231,72.0658,0.923618518231979,0.926218404524185,0.0601414164456424,0.593203267847322,0.389222875810647,0.203980392036675,9.19708377452983,4.5855,3.97415823919324,67.4803,0.697613192529297,0.60579684424891,0.699576898259224,0.604279362265399,0.0918163482803865,0.0952975359938256,True,,,,
2685,38376,1083:1594,Pancreas,HuP-T3,SIDM00533,907285,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.958840805345512,0.0606146507043674,0.785382973153137,13.1712420137231,72.0658,0.923618518231979,0.926218404524185,0.0720001321121529,0.753057242482807,0.639129929045528,0.113927313437278,11.2271981953832,18.729,1.9440438183399,53.3368,0.885603123853579,0.80252123657564,0.888096000919805,0.840592835968988,0.0830818872779387,0.0475031649508166,True,,,,
2686,38376,1079:1594,Pancreas,HuP-T3,SIDM00533,907285,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.747824768885415,0.0606146507043674,0.785382973153137,13.1712420137231,72.0658,0.923618518231979,0.926218404524185,0.0707064494860809,0.587328840384785,0.385783036553395,0.20154580383139,9.20422091067359,4.6083,3.96702110304947,67.4575,0.690704804935119,0.553289711294135,0.692649064300716,0.598532329097697,0.137415093640984,0.0941167352030191,True,,,,
2687,38376,1510:1594,Pancreas,HuP-T3,SIDM00533,907285,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.780997489880607,0.0606146507043674,0.785382973153137,13.1712420137231,72.0658,0.923618518231979,0.926218404524185,0.0249320729954181,0.613382130627568,0.521086892505457,0.0922952381221117,11.2364852342172,18.8499,1.93475677950588,53.2159,0.721343744346421,0.689377263240786,0.723374249014609,0.68490765648075,0.0319664811056352,0.0384665925338589,True,,,,
2688,38377,1564:2265,Pancreas,HuP-T3,SIDM00533,907285,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,2265,Galunisertib,TGFBR1,RTK signaling,Targeted,Early clinical trials,10.0,0.663582589001484,0.0575914711615875,0.899504965726094,16.0470573816142,1322.439,0.955905967800844,0.967544634411322,0.0706158533278477,0.596895833976212,0.555466692869053,0.0414291411071599,14.2621516342756,383.7651,1.78490574733862,938.6739,0.634322556955253,0.563207573800514,0.642045773477159,0.627481471268727,0.0711149831547385,0.0145643022084326,True,,,,
2689,38377,1558:2265,Pancreas,HuP-T3,SIDM00533,907285,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,2265,Galunisertib,TGFBR1,RTK signaling,Targeted,Early clinical trials,10.0,0.825266491274669,0.0575914711615875,0.899504965726094,16.0470573816142,1322.439,0.955905967800844,0.967544634411322,0.0751098585665372,0.742331306948915,0.219452686063868,0.522878620885047,5.7350834526695,1.0403,10.3119739289447,1321.3987,0.788877164035519,0.453617963664339,0.798482165592264,0.504602551067425,0.33525920037118,0.293879614524839,True,,,,
2690,37886,1168:1011,Pancreas,CAPAN-2,SIDM00943,910915,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.872142439114171,0.192623287409083,0.158270200766938,3.30407677226994,0.1929,0.45684509634346,0.456583189809767,0.165063311131338,0.138034158935967,0.0765937092393384,0.0614404496966288,1.02264111411228,0.0397,2.28143565815766,0.1532,0.398433996622333,0.214487906619109,0.398205576819219,0.279819240317628,0.183946090003224,0.118386336501591,True,0.411093680747564,0.0492537045884628,0.820640084551085,58.7632737527589
2691,38052,1372:1053,Pancreas,CAPAN-2,SIDM00943,910915,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.583745404890408,0.0701419759231678,0.782116034331276,13.3560404510761,204.7853,0.904211473087605,0.921251547271985,0.0749391736015789,0.456556641131991,0.321865375351522,0.134691265780468,9.70296657312844,16.2785,3.65307387794763,188.5068,0.527829292464077,0.419751358755501,0.5377763574682,0.473725732435417,0.108077933708575,0.0640506250327829,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2692,38052,1011:1053,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.235107879155805,0.0701419759231678,0.782116034331276,13.3560404510761,204.7853,0.904211473087605,0.921251547271985,0.0636524024569497,0.183881642085375,0.172597612345113,0.0112840297402619,12.4616546198941,110.1696,0.894385831182001,94.6157,0.212587241745973,0.153157160878545,0.21659349744812,0.211868987770366,0.0594300808674279,0.0047245096777545,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2693,38052,1558:1053,Pancreas,CAPAN-2,SIDM00943,910915,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.885874061235011,0.0701419759231678,0.782116034331276,13.3560404510761,204.7853,0.904211473087605,0.921251547271985,0.0415776699739201,0.692856307690069,0.638664930499594,0.0541913771904747,12.2350425625507,94.1553,1.12099788852538,110.63,0.801017489879409,0.777349487133007,0.816112849600871,0.793234060553007,0.0236680027464018,0.0228787890478637,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2694,38053,1564:1057,Pancreas,CAPAN-2,SIDM00943,910915,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.586937048707826,0.0675789333621805,0.755229522566594,12.8402180977691,1.4323,0.897122148755536,0.910140709573396,0.0210822721919765,0.443272187072257,0.473295467946622,-0.0300232808743642,13.8626269311573,2.9094,-1.02240883338817,-1.4771,0.526554226320998,0.545311197666426,0.534195301985856,0.546425277771082,-0.018756971345428,-0.0122299757852267,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2695,38053,1011:1057,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.255129041264921,0.0675789333621805,0.755229522566594,12.8402180977691,1.4323,0.897122148755536,0.910140709573396,0.062709653591482,0.192680984027379,0.138506154041175,0.0541748299862044,9.58613548031724,0.1501,3.25408261745189,1.2822,0.228881913709526,0.153387459471444,0.232203326649635,0.205820193275177,0.0754944542380817,0.0263831333744578,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2696,38054,1561:1079,Pancreas,CAPAN-2,SIDM00943,910915,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.742658141131024,0.151808152676888,0.21809542527502,4.64818746451381,0.0979,0.510862991737512,0.540450026909902,0.0927396518793005,0.161970343123927,0.0706341268408077,0.0913362162831192,1.32167992405086,0.0098,3.32650754046295,0.0881,0.379396559816415,0.223584523374795,0.401369612359119,0.250771942817468,0.15581203644162,0.150597669541652,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2697,38054,1372:1079,Pancreas,CAPAN-2,SIDM00943,910915,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.583840223118664,0.151808152676888,0.21809542527502,4.64818746451381,0.0979,0.510862991737512,0.540450026909902,0.0581804131100235,0.127332881753728,0.0523385254147637,0.0749943563389641,1.09947775532492,0.0084,3.54870970918889,0.0895,0.298262363079097,0.14564270784692,0.315536464295565,0.189823210151552,0.152619655232177,0.125713254144013,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2698,38054,1011:1079,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.249703748648142,0.151808152676888,0.21809542527502,4.64818746451381,0.0979,0.510862991737512,0.540450026909902,0.056559059493546,0.0544592452541832,0.03917732351248,0.0152819217417032,3.26877375883538,0.0376,1.37941370567843,0.0603,0.127564404082461,0.0558103414827274,0.134952397676391,0.113463075108361,0.071754062599734,0.0214893225680306,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2699,38054,1372:1080,Pancreas,CAPAN-2,SIDM00943,910915,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.59931138923281,0.0887491139900502,0.732505132963034,12.4334940777888,1.0804,0.865120196302792,0.900458908168942,0.0720670944929413,0.438998668856241,0.340416189705044,0.0985824791511963,9.93302755045972,0.1909,2.50046652732907,0.8895,0.518476386699588,0.474500955532259,0.539655279201788,0.491874857138484,0.0439754311673285,0.0477804220633044,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2700,38054,1011:1080,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.249703748648142,0.0887491139900502,0.732505132963034,12.4334940777888,1.0804,0.865120196302792,0.900458908168942,0.0462135087536445,0.182909277604875,0.0769785721460027,0.105930705458872,6.24543814210872,0.0148,6.18805593568007,1.0656,0.216023756048023,0.129267699922948,0.224847964873397,0.159147699039964,0.0867560561250756,0.0657002658334337,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2701,38054,1564:1080,Pancreas,CAPAN-2,SIDM00943,910915,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.570957278403313,0.0887491139900502,0.732505132963034,12.4334940777888,1.0804,0.865120196302792,0.900458908168942,0.0455350878239564,0.418229137133031,0.362716519325279,0.0555126178077523,10.891397938215,0.371,1.54209613957384,0.7094,0.493946672772782,0.500998235616666,0.514123567522158,0.488520351107874,-0.0070515628438841,0.0256032164142834,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2702,38054,1079:1080,Pancreas,CAPAN-2,SIDM00943,910915,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.433118494290849,0.0887491139900502,0.732505132963034,12.4334940777888,1.0804,0.865120196302792,0.900458908168942,0.0727424335230566,0.317261520249268,0.223032070112399,0.0942294501368686,9.20380914791459,0.1152,3.2296849298742,0.9652,0.374699556803269,0.312092970871795,0.390005406476914,0.342358254774259,0.0626065859314743,0.0476471517026555,True,0.487097206065485,0.0579019911434073,0.666678122567989,72.0514840054505
2703,37891,1564:1085,Pancreas,CAPAN-2,SIDM00943,910915,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.646834999643719,0.0758566502242867,0.755243000549854,12.8404666068729,143.2503,0.943641503128043,0.910146371074327,0.0565958152946446,0.488517605991587,0.468340218386382,0.0201773876052043,12.2878394421966,97.6649,0.552627164676279,45.5854,0.610380351339627,0.577242595828326,0.588714527609595,0.580071759271626,0.0331377555113009,0.008642768337969,True,0.411093680747564,0.0492537045884628,0.820640084551085,58.7632737527589
2704,38547,1510:1168,Pancreas,CAPAN-2,SIDM00943,910915,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.830613385827341,0.0569617348992077,0.734573519403136,12.469562250161,110.7751,0.875396797623901,0.901351616578647,0.0483369934237862,0.610146598090545,0.419169096733746,0.1909775013568,9.06339843933366,10.4492,3.40616381082732,100.3259,0.727116298016801,0.6252353723601,0.748674718067337,0.651408244253372,0.101880925656701,0.0972664738139659,True,0.475553980886618,0.0499030077870783,0.691430343278734,69.6610259149328
2705,38547,1011:1168,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.368921351006564,0.0569617348992077,0.734573519403136,12.469562250161,110.7751,0.875396797623901,0.901351616578647,0.0397469935325674,0.270999855191851,0.177981467426563,0.0930183877652883,8.76046215769712,8.4702,3.70910009246386,102.3049,0.322952569246229,0.252809121355296,0.332527856120145,0.284244836573313,0.0701434478909335,0.0482830195468312,True,0.475553980886618,0.0499030077870783,0.691430343278734,69.6610259149328
2706,38547,1079:1168,Pancreas,CAPAN-2,SIDM00943,910915,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.478346540355731,0.0569617348992077,0.734573519403136,12.469562250161,110.7751,0.875396797623901,0.901351616578647,0.0391470553751208,0.351380701643424,0.203980818381808,0.147399883261616,7.98963508803184,4.9642,4.47992716212915,105.8109,0.418743029581879,0.321377391305847,0.431158427434441,0.350652630084229,0.097365638276032,0.0805057973502121,True,0.475553980886618,0.0499030077870783,0.691430343278734,69.6610259149328
2707,38548,1011:1372,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.334867324700111,0.0873868286695571,0.43110879653122,8.05475986456966,0.5193,0.700514603743842,0.736340661612594,0.0658055126920049,0.144364249349094,0.0913217125083293,0.0530425368407645,5.65667208634017,0.0985,2.39808777822949,0.4208,0.234579451269058,0.156100774594589,0.246576427422119,0.201705393363696,0.0784786766744696,0.0448710340584228,True,0.475553980886618,0.0499030077870783,0.691430343278734,69.6610259149328
2708,38548,1079:1372,Pancreas,CAPAN-2,SIDM00943,910915,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.545385039423304,0.0873868286695571,0.43110879653122,8.05475986456966,0.5193,0.700514603743842,0.736340661612594,0.0702374285416198,0.235120287991912,0.229242452408787,0.0058778355831257,7.90450363291127,0.468,0.150256231658396,0.0513,0.382050184779435,0.343547303590265,0.401589180762566,0.397431692743084,0.0385028811891704,0.0041574880194819,True,0.475553980886618,0.0499030077870783,0.691430343278734,69.6610259149328
2709,38549,1011:1510,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.749788988607496,0.0729658999705047,0.800565983575264,13.737079886854,266.6878,0.888831909370037,0.928671687314774,0.0389169994271611,0.600255559138463,0.341582068950648,0.258673490187815,8.39267459581786,6.5641,5.34440529103615,260.1237,0.66643637836863,0.532444102809098,0.696307805180161,0.564617683104073,0.133992275559532,0.131690122076088,True,0.475553980886618,0.0499030077870783,0.691430343278734,69.6610259149328
2710,38360,1053:1558,Pancreas,CAPAN-2,SIDM00943,910915,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.88686858022915,0.0601003429642921,0.876581626631775,15.6819471421159,1026.7543,0.95163490987141,0.95764585278633,0.0479800660245949,0.777412702665881,0.664245537639029,0.113167165026853,12.7259392414639,132.3182,2.95600790065195,894.4361,0.843975101414153,0.839205981655854,0.849306017822947,0.804837460798535,0.0047691197582981,0.0444685570244119,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2711,38360,1083:1558,Pancreas,CAPAN-2,SIDM00943,910915,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.97723837244546,0.0601003429642921,0.876581626631775,15.6819471421159,1026.7543,0.95163490987141,0.95764585278633,0.0442652661871971,0.85662920212523,0.774430794661668,0.082198407463562,13.5667809481674,236.9944,2.11516619394851,789.7599,0.929974150485018,0.907644505320049,0.935848274556058,0.904370602473636,0.0223296451649695,0.0314776720824218,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2712,38360,1011:1558,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.368032469532004,0.0601003429642921,0.876581626631775,15.6819471421159,1026.7543,0.95163490987141,0.95764585278633,0.0594568448916754,0.322610500795673,0.13877396100183,0.183836539793843,7.28898308598474,3.0544,8.39296405613113,1023.6999,0.350232545972841,0.228228053983288,0.352444768138035,0.256252670612866,0.122004491989553,0.0961920975251692,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2713,38360,1079:1558,Pancreas,CAPAN-2,SIDM00943,910915,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.55005864642151,0.0601003429642921,0.876581626631775,15.6819471421159,1026.7543,0.95163490987141,0.95764585278633,0.0362603858223564,0.48217130302304,0.237910182817907,0.244261120205132,8.07433423645828,5.2644,7.60761290565758,1021.4899,0.523455010411323,0.392158002912802,0.526761381534822,0.405571893885308,0.131297007498521,0.121189487649513,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2714,38360,1011:1561,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.368032469532004,0.0801894679679063,0.644076052043713,11.0215059830004,40.6007,0.8366914889925,0.859925826044467,0.0805562385691393,0.237040900000071,0.0517723137086166,0.185268586291454,2.83183191885303,0.1391,8.18967406414734,40.4616,0.307929634930319,0.0851937127569809,0.316480625373494,0.157297135937892,0.222735922173338,0.159183489435601,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2715,38360,1558:1561,Pancreas,CAPAN-2,SIDM00943,910915,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.883690187076523,0.0801894679679063,0.644076052043713,11.0215059830004,40.6007,0.8366914889925,0.859925826044467,0.0723556044704645,0.569163686922017,0.372575286109607,0.19658840081241,7.92242437715933,4.7382,3.09908160584104,35.8625,0.739376058433117,0.605825150130298,0.759908014089168,0.644769633929762,0.133550908302819,0.115138380159406,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2716,38360,1079:1561,Pancreas,CAPAN-2,SIDM00943,910915,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.547518591642632,0.0801894679679063,0.644076052043713,11.0215059830004,40.6007,0.8366914889925,0.859925826044467,0.045530683717326,0.35264361292572,0.211823667956607,0.140819944969113,7.43061872331346,3.3695,3.59088725968691,37.2312,0.45810414569255,0.346722939289569,0.470825377192993,0.385403002625728,0.111381206402981,0.085422374567265,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2717,38361,1053:1564,Pancreas,CAPAN-2,SIDM00943,910915,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.915928454459922,0.0963145670797863,0.538873194416972,9.53104931790944,14.4498,0.758044551829844,0.804438613398577,0.0719773251899291,0.493569292112219,0.363286216508767,0.130283075603452,7.57011927349725,3.7116,1.9609300444122,10.7382,0.694314574769273,0.603977333995304,0.736808215878041,0.651526898418259,0.0903372407739694,0.0852813174597825,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2718,38361,1011:1564,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.372148958432059,0.0963145670797863,0.538873194416972,9.53104931790944,14.4498,0.758044551829844,0.804438613398577,0.0534489621173691,0.200541098029233,0.0619723060854493,0.138568791943783,3.51096845268518,0.2227,6.02008086522426,14.2271,0.282105490408573,0.121464440320031,0.29937099209881,0.174708286193052,0.160641050088543,0.124662705905758,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2719,38361,1079:1564,Pancreas,CAPAN-2,SIDM00943,910915,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.450218130167591,0.0963145670797863,0.538873194416972,9.53104931790944,14.4498,0.758044551829844,0.804438613398577,0.0771721060437521,0.242610481987846,0.136168942703252,0.106441539284594,6.15178070156588,1.3887,3.37926861634357,13.0611,0.341285400708562,0.233018207746185,0.362172848358917,0.284470832338747,0.108267192962377,0.0777020160201705,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2720,38361,1011:1594,Pancreas,CAPAN-2,SIDM00943,910915,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.372148958432059,0.0615219497495646,0.698302447863416,11.8604008345325,29.0487,0.877447990645377,0.885347714435022,0.0409379700064609,0.259872528642927,0.115406408322564,0.144466120320363,6.2746162426299,0.6048,5.58578459190255,28.4439,0.32654135579698,0.210053583208377,0.329481229777197,0.237822460572179,0.116487772588603,0.0916587692050186,True,0.535434602085843,0.0541472024283103,0.572908322133138,83.0448350476454
2721,38646,1080:1011,Pancreas,HuP-T4,SIDM00531,907286,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.885671480431001,0.131111962200327,0.538790244529662,9.28456394053124,12.1804,0.917026307043128,0.887471417015899,0.0912992300576459,0.477191153514366,0.184569222037097,0.292621931477269,6.55721981270384,1.8393,2.7273441278274,10.3411,0.81218404695306,0.659054867029263,0.786008123748669,0.634027807564697,0.153129179923797,0.151980316183972,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2722,38646,1085:1011,Pancreas,HuP-T4,SIDM00531,907286,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.499058241836179,0.131111962200327,0.538790244529662,9.28456394053124,12.1804,0.917026307043128,0.887471417015899,0.0762950714150841,0.268887712153458,0.0547606976928441,0.214127014460614,5.16821395654921,0.7023,4.11634998398202,11.4781,0.457649536510467,0.270711597560828,0.442899925055817,0.300301473095473,0.186937938949639,0.142598451960344,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2723,38646,1372:1011,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.803062869362685,0.131111962200327,0.538790244529662,9.28456394053124,12.1804,0.917026307043128,0.887471417015899,0.0561276979677466,0.432682439756613,0.160519613515774,0.272162826240838,6.46133220687643,1.721,2.8232317336548,10.4594,0.736429777415121,0.545041692585807,0.712695342626156,0.568887194042753,0.191388084829314,0.143808148583403,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2724,38646,1564:1011,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.794035042427753,0.131111962200327,0.538790244529662,9.28456394053124,12.1804,0.917026307043128,0.887471417015899,0.0558022725670691,0.427818334674769,0.144332283159833,0.283486051514937,6.24649304819422,1.4829,3.03807089233702,10.6975,0.728151022620356,0.559423754449486,0.704683404263638,0.54898803631719,0.16872726817087,0.155695367946448,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2725,38646,1558:1011,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.8815025563275,0.131111962200327,0.538790244529662,9.28456394053124,12.1804,0.917026307043128,0.887471417015899,0.0874585707204145,0.474944977877216,0.274917752964591,0.200027224912625,7.55154579522178,3.6641,1.73301814530945,8.5163,0.808361033878084,0.687224519610502,0.782308322767104,0.695015820196582,0.121136514267582,0.0872925025705222,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2726,38648,1080:1053,Pancreas,HuP-T4,SIDM00531,907286,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.962276915112573,0.0504477815559968,0.870549442305802,12.4882445044029,112.219,0.959452985154622,0.974741650169047,0.0688309484467067,0.837709631794997,0.790883437761033,0.0468261940339643,11.7988836209397,69.5902,0.689360883463189,42.6288,0.923259458750139,0.884548890011411,0.937971388156409,0.927891176997217,0.0387105687387274,0.0100802111591922,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2727,38648,1564:1053,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.838858617034129,0.0504477815559968,0.870549442305802,12.4882445044029,112.219,0.959452985154622,0.974741650169047,0.0636509676847243,0.730267901232477,0.200704006839565,0.529563894392912,6.88279433467826,2.3049,5.60545016972464,109.9141,0.804845404236073,0.590689668894543,0.817670432626372,0.621323874111365,0.21415573534153,0.196346558515007,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2728,38648,1168:1053,Pancreas,HuP-T4,SIDM00531,907286,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.772453540301281,0.0504477815559968,0.870549442305802,12.4882445044029,112.219,0.959452985154622,0.974741650169047,0.109241245480875,0.672458998716422,0.362166684980376,0.310292313736047,8.77166562670907,8.5362,3.71657887769383,103.6828,0.74113285513532,0.581073030197325,0.752942638552193,0.666038031940778,0.160059824937995,0.0869046066114152,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2729,38648,1372:1053,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.695904605835117,0.0504477815559968,0.870549442305802,12.4882445044029,112.219,0.959452985154622,0.974741650169047,0.0357536713396773,0.605819366507799,0.158573421576622,0.447245944931177,6.76629982000845,2.1261,5.72194468439445,110.0929,0.667687751451353,0.490041102721671,0.678327203851962,0.509338581973249,0.177646648729682,0.168988621878713,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2730,38648,1558:1053,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.899795328880927,0.0504477815559968,0.870549442305802,12.4882445044029,112.219,0.959452985154622,0.974741650169047,0.0238242294947412,0.783316321746656,0.727973755903188,0.0553425658434678,11.6426116659264,62.4461,0.845632838476499,49.7729,0.86331131432299,0.857097126107739,0.877067983687795,0.86506178250143,0.0062141882152511,0.0120062011863653,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2731,38648,1564:1054,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,0.763078032791117,0.0491304672992038,0.885097496995696,12.7367786776818,106.6528,0.967149241239814,0.977760424221552,0.114919761482823,0.675398456835817,0.482496085777966,0.192902371057852,9.99222182344964,15.914,2.74455685423218,90.7388,0.738010340420699,0.604699799559253,0.74610750105599,0.699400403174962,0.133310540861446,0.046707097881028,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2732,38648,1558:1054,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,0.802141285093712,0.0491304672992038,0.885097496995696,12.7367786776818,106.6528,0.967149241239814,0.977760424221552,0.137504752301366,0.709973243673356,0.324982219735832,0.384991023937523,8.29701699140381,4.9144,4.43976168627801,101.7384,0.775790335245513,0.709815423146515,0.784302003198849,0.670401369812207,0.0659749120989984,0.113900633386642,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2733,38649,1053:1057,Pancreas,HuP-T4,SIDM00531,907286,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.864231788659424,0.0616633073438199,0.808767829375,11.6393449760504,0.623,0.930480583531728,0.961336294415254,0.0601134275511458,0.698962867790956,0.602053511469095,0.0969093563218613,10.5215731867957,0.2871,1.11777178925468,0.3359,0.804150899018489,0.810341851457357,0.830817385225717,0.807341927277002,-0.0061909524388674,0.0234754579487144,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2734,38649,1564:1057,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.848991206316662,0.0616633073438199,0.808767829375,11.6393449760504,0.623,0.930480583531728,0.961336294415254,0.0518486469970277,0.68663677509119,0.381406486811872,0.305230288279318,8.62713942629713,0.0772,3.01220554975328,0.5458,0.789969833066833,0.699854265288977,0.816166060271596,0.725454968238014,0.0901155677778563,0.0907110920335821,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2735,38649,1372:1057,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.683909405587634,0.0616633073438199,0.808767829375,11.6393449760504,0.623,0.930480583531728,0.961336294415254,0.0554825011421906,0.553123925446257,0.357117881378245,0.196006044068012,9.16242778812252,0.1119,2.47691718792789,0.5111,0.636364422794019,0.597312938922735,0.657466933683355,0.603059421946731,0.0390514838712831,0.0544075117366232,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2736,38650,1594:1079,Pancreas,HuP-T4,SIDM00531,907286,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.855191779268931,0.113607110615518,0.681668670862423,10.3936885007826,5.255,0.843785080375076,0.930222459273161,0.178406038399388,0.582957443506723,0.376390727084775,0.206566716421948,8.55952324403155,1.4738,1.83416525675107,3.7812,0.721598064206539,0.578177993595085,0.795518600061735,0.727572633162164,0.143420070611454,0.0679459668995703,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2737,38650,1372:1079,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.814786018007514,0.113607110615518,0.681668670862423,10.3936885007826,5.255,0.843785080375076,0.930222459273161,0.12727714704588,0.555414101932468,0.327930219541968,0.2274838823905,8.27672309732258,1.2114,2.11696540346005,4.0436,0.687504285692959,0.600715089507926,0.757932253452335,0.679993860235777,0.0867891961850326,0.0779383932165585,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2738,38650,1510:1079,Pancreas,HuP-T4,SIDM00531,907286,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.912725297874353,0.113607110615518,0.681668670862423,10.3936885007826,5.255,0.843785080375076,0.930222459273161,0.120702214635837,0.622176240664519,0.415176810008449,0.206999430656071,8.66873553917971,1.5897,1.72495296160292,3.6653,0.770143988827277,0.684126181265967,0.849037571229509,0.781976040651144,0.0860178075613097,0.0670615305783648,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2739,38650,1564:1079,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.804468696509997,0.113607110615518,0.681668670862423,10.3936885007826,5.255,0.843785080375076,0.930222459273161,0.0972557556722491,0.548381107100396,0.480377151785124,0.0680039553152721,9.72030882280623,3.2951,0.673379677976392,1.9599,0.678798683743921,0.660916705421183,0.748334849275803,0.728969395891828,0.0178819783227383,0.0193654533839752,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2740,38650,1011:1080,Pancreas,HuP-T4,SIDM00531,907286,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.921377351700254,0.0541489661399064,0.644270558368113,10.0871073425174,0.2124,0.908993388047017,0.919960880306707,0.0586217397058065,0.593616300847656,0.248074423614713,0.345541877232943,7.17250038137844,0.0282,2.91460696113894,0.1842,0.837525920591802,0.697751432127661,0.847631119564828,0.702026438162143,0.139774488464141,0.145604681402685,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2741,38650,1168:1080,Pancreas,HuP-T4,SIDM00531,907286,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.778365063566846,0.0541489661399064,0.644270558368113,10.0871073425174,0.2124,0.908993388047017,0.919960880306707,0.112551052296617,0.501477694118444,0.337795247373881,0.163682446744563,8.51381758295668,0.0714,1.5732897595607,0.141,0.707528696269059,0.590867759334076,0.716065409078942,0.660227253864847,0.116660936934984,0.0558381552140944,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2742,38650,1372:1080,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.814786018007514,0.0541489661399064,0.644270558368113,10.0871073425174,0.2124,0.908993388047017,0.919960880306707,0.0673979439759736,0.524942642772232,0.263372588821339,0.261570053950893,7.64755896768802,0.0392,2.43954837482936,0.1732,0.740635103041987,0.62721225585606,0.749571262387788,0.647681805553891,0.113422847185927,0.101889456833897,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2743,38650,1053:1080,Pancreas,HuP-T4,SIDM00531,907286,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.945945198338723,0.0541489661399064,0.644270558368113,10.0871073425174,0.2124,0.908993388047017,0.919960880306707,0.0876316336883917,0.609444641119324,0.523905745859432,0.0855388952598921,9.39573600783306,0.1316,0.691371334684321,0.0808,0.859857930744723,0.802823762383938,0.870232577385593,0.844233415252349,0.0570341683607843,0.0259991621332439,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2744,38650,1558:1080,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.825112334554287,0.0541489661399064,0.644270558368113,10.0871073425174,0.2124,0.908993388047017,0.919960880306707,0.0909670050027177,0.531595584499708,0.248294174616692,0.283301409883016,7.457211317233,0.0343,2.62989602528438,0.1781,0.750021656505885,0.605614243085627,0.759071069648484,0.645230349219364,0.144407413420258,0.11384072042912,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2745,38651,1011:1083,Pancreas,HuP-T4,SIDM00531,907286,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.936802763380383,0.0635205456317232,0.712023174578595,10.6568490001988,25.2262,0.915254904057771,0.938148080759859,0.0343901078443477,0.667025277536101,0.461545347254566,0.205479930281535,8.94641544699611,7.7083,1.71043355320273,17.5179,0.857413323318767,0.825937041565102,0.878859714515839,0.816171670612244,0.0314762817536655,0.0626880439035952,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2746,38651,1168:1083,Pancreas,HuP-T4,SIDM00531,907286,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.875007863662665,0.0635205456317232,0.712023174578595,10.6568490001988,25.2262,0.915254904057771,0.938148080759859,0.124772620673051,0.623025876866325,0.448097785844348,0.174928091021977,9.08865652344664,8.507,1.5681924767522,16.7192,0.800855238306367,0.676082485873554,0.820886947944914,0.768475286092028,0.124772752432813,0.0524116618528859,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2747,38651,1564:1083,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.821883434662697,0.0635205456317232,0.712023174578595,10.6568490001988,25.2262,0.915254904057771,0.938148080759859,0.0224310903994998,0.585200052282093,0.336936497607107,0.248263554674986,8.33350311293085,5.0403,2.32334588726799,20.1859,0.752232844138878,0.69340968340835,0.77104836683713,0.688659402458063,0.0588231607305274,0.0823889643790675,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2748,38651,1558:1083,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.831241167920075,0.0635205456317232,0.712023174578595,10.6568490001988,25.2262,0.915254904057771,0.938148080759859,0.0877298387962,0.591862975222871,0.173220629654264,0.418642345568607,6.55714499893374,1.4714,4.0997040012651,23.7548,0.760797555393558,0.60715385364795,0.779827306332802,0.595057822361955,0.153643701745608,0.184769483970847,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2749,38651,1372:1083,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.813056691203641,0.0635205456317232,0.712023174578595,10.6568490001988,25.2262,0.915254904057771,0.938148080759859,0.0321165303661292,0.578915206383185,0.321382628129064,0.257532578254121,8.22178373510983,4.6647,2.43506526508901,20.5615,0.744154123901117,0.658625234315691,0.762767574401657,0.675893805096429,0.085528889585426,0.0868737693052283,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2750,38651,1011:1085,Pancreas,HuP-T4,SIDM00531,907286,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.936802763380383,0.0798193300404809,0.527327684480335,9.20027170981311,11.4891,0.902511106707787,0.883566672996709,0.169404373648017,0.494002032028157,0.26787893514324,0.226123096884917,7.32502254656949,3.1317,1.87524916324363,8.3574,0.845474898745343,0.778603175798661,0.827727700894129,0.723946231027285,0.0668717229466816,0.103781469866844,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2751,38651,1372:1085,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.813056691203641,0.0798193300404809,0.527327684480335,9.20027170981311,11.4891,0.902511106707787,0.883566672996709,0.0495425772081206,0.428747302323659,0.53550138600299,-0.106754083679331,10.202846677,23.0193,-1.00257496718687,-11.5302,0.733792694194369,0.774192855269093,0.718389795604514,0.7512387991545,-0.0404001610747237,-0.0328490035499864,True,0.625139915971695,0.0673467344938681,0.426618586379464,109.970546077841
2752,38391,1083:1168,Pancreas,HuP-T4,SIDM00531,907286,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.877918520467101,0.0966879849359462,0.790670197792766,11.4324220393601,53.9799,0.890899595396753,0.957216068195629,0.0534116688660888,0.694144010223654,0.467874276171315,0.22626973405234,9.24148064311547,11.8221,2.19094139624463,42.1578,0.782137254675456,0.740895902994138,0.840357714357642,0.777385897226817,0.0412413516813177,0.0629718171308251,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2753,38391,1372:1168,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.879090228471469,0.0966879849359462,0.790670197792766,11.4324220393601,53.9799,0.890899595396753,0.957216068195629,0.109475452263771,0.695070444823224,0.486864959331819,0.208205485491405,9.39562153672616,13.1551,2.03680050263394,40.8248,0.783181128862471,0.697271980614654,0.841479292086657,0.784562501630733,0.0859091482478166,0.0569167904559236,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2754,38391,1011:1168,Pancreas,HuP-T4,SIDM00531,907286,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.833134607163292,0.0966879849359462,0.790670197792766,11.4324220393601,53.9799,0.890899595396753,0.957216068195629,0.0806434348820044,0.658734704633798,0.624372505015193,0.0343621996186049,11.0051953985952,40.1443,0.427226640764896,13.8356,0.74223928443281,0.756996404351007,0.797489832946556,0.78936535030779,-0.0147571199181976,0.0081244826387659,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2755,38391,1080:1168,Pancreas,HuP-T4,SIDM00531,907286,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.901160641615618,0.0966879849359462,0.790670197792766,11.4324220393601,53.9799,0.890899595396753,0.957216068195629,0.0713443751523815,0.712520862749277,0.266974864126586,0.445545998622691,7.41644200279974,3.3366,4.01598003656036,50.6433,0.802843651002833,0.667508660685665,0.862605446179952,0.702158679633767,0.135334990317168,0.160446766546186,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2756,38391,1561:1168,Pancreas,HuP-T4,SIDM00531,907286,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.8378461067177,0.0966879849359462,0.790670197792766,11.4324220393601,53.9799,0.890899595396753,0.957216068195629,0.0342355347670893,0.662459946918382,0.449881626004864,0.212578320913518,9.27101474310498,12.0666,2.16140729625512,41.9133,0.746436757479544,0.760587381040185,0.801999756025332,0.743043974341281,-0.0141506235606412,0.0589557816840505,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2757,38391,1510:1168,Pancreas,HuP-T4,SIDM00531,907286,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,2.5,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.899976599842783,0.0966879849359462,0.790670197792766,11.4324220393601,53.9799,0.890899595396753,0.957216068195629,0.0501859386207012,0.711584676206554,0.517947756360854,0.1936369198457,9.55710546402187,14.7131,1.87531657533823,39.2668,0.801788788666481,0.811747419877645,0.86147206236958,0.809482061317438,-0.0099586312111642,0.0519900010521415,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2758,38391,1594:1168,Pancreas,HuP-T4,SIDM00531,907286,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.914451142666462,0.0966879849359462,0.790670197792766,11.4324220393601,53.9799,0.890899595396753,0.957216068195629,0.116841497188077,0.723029265843912,0.484175001673131,0.23885426417078,9.21601133010482,11.6152,2.21641070925528,42.3647,0.814684153011649,0.712618272029764,0.875327327340191,0.808651909940878,0.102065880981885,0.0666754173993127,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2759,38391,1053:1168,Pancreas,HuP-T4,SIDM00531,907286,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.964475176513537,0.0966879849359462,0.790670197792766,11.4324220393601,53.9799,0.890899595396753,0.957216068195629,0.104805803941005,0.762581778580171,0.423206283916381,0.33937549466379,8.54964131857266,7.3186,2.88278072078744,46.6613,0.859250544526122,0.751213717005237,0.923211136334573,0.820018693270208,0.108036827520885,0.103192443064366,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2760,38392,1080:1372,Pancreas,HuP-T4,SIDM00531,907286,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.980580270969739,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.136013488188211,0.738093971607434,0.590556311097037,0.147537660510397,9.75931505350498,1.6927,1.27804636952998,2.4122,0.858723290212273,0.783380762540485,0.9298455939241,0.890073240580961,0.0753425276717874,0.0397723533431388,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2761,38392,1558:1372,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.876419569599528,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.187649532151744,0.659691021807389,0.446214576851777,0.213476444955612,9.06687596593813,1.0474,1.97048545709683,3.0575,0.76750666793311,0.630463691002966,0.831074109226216,0.768788666853766,0.137042976930144,0.06228544237245,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2762,38392,1079:1372,Pancreas,HuP-T4,SIDM00531,907286,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.909969469355302,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.188827947294251,0.68494441461049,0.511118351520468,0.173826063090022,9.45393968828769,1.3698,1.58342173474727,2.7351,0.796887312391802,0.699799952294991,0.862888155855616,0.814450419301091,0.097087360096811,0.0484377365545253,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2763,38392,1053:1372,Pancreas,HuP-T4,SIDM00531,907286,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.98873102392635,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.170013084088101,0.744229136467916,0.0652063815473477,0.679022754920568,4.14851663408228,0.0346,6.88884478895268,4.0703,0.865861146850655,0.48624362802963,0.937574631462631,0.507253069770704,0.379617518821026,0.430321561691928,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2764,38392,1510:1372,Pancreas,HuP-T4,SIDM00531,907286,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.876419569599528,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.135918028439354,0.659691021807389,0.250216815897377,0.409474205910012,7.32097509841647,0.3123,3.71638632461849,3.7926,0.76750666793311,0.580954690779506,0.831074109226216,0.677033408959743,0.186551977153604,0.154040700266472,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2765,38392,1011:1372,Pancreas,HuP-T4,SIDM00531,907286,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.928014528030339,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.145172887203042,0.69852713641273,0.496526668409236,0.202000468003494,9.25697101524357,1.195,1.78039040779139,2.9099,0.812689906647729,0.699195638096965,0.879999573245741,0.822409893663212,0.113494268550763,0.0575896795825294,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2766,38392,1083:1372,Pancreas,HuP-T4,SIDM00531,907286,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.809196809285784,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.184671337177474,0.609091682200732,0.328406267431828,0.280685414768904,8.30232338639129,0.6166,2.73503803664367,3.4883,0.708637698586336,0.546118695078487,0.767329417088636,0.676550752582924,0.162519003507849,0.0907786645057121,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2767,38392,1057:1372,Pancreas,HuP-T4,SIDM00531,907286,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.89258700784977,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.145361196892444,0.671860437266908,0.358246056232709,0.313614381034199,8.26821779919386,0.6022,2.7691436238411,3.5027,0.781664974172355,0.642677872148252,0.846405053226507,0.74447474037283,0.138987102024103,0.101930312853677,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2768,38392,1594:1372,Pancreas,HuP-T4,SIDM00531,907286,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.886524681291795,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.169898144783726,0.667297254813796,0.0898348889938088,0.577462365819988,5.00537119471951,0.0627,6.03199022831545,4.0422,0.776356014607977,0.476242831076307,0.840656388067981,0.521041630824491,0.30011318353167,0.31961475724349,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2769,38392,1561:1372,Pancreas,HuP-T4,SIDM00531,907286,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.828752288836719,0.105682558004385,0.752711423489583,11.037361423035,4.1049,0.875729724159189,0.948260556990948,0.13364814793009,0.623811315050537,0.270393677816943,0.353417637233595,7.67280378011632,0.3985,3.36455764291864,3.7064,0.725763013299277,0.571900849069822,0.785873107019831,0.660178193565993,0.153862164229455,0.125694913453838,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2770,38393,1080:1510,Pancreas,HuP-T4,SIDM00531,907286,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.842969687600373,0.0833521681417942,0.887877569285563,12.7873475136099,138.0719,0.932517071925158,0.978331675675186,0.0575970718588569,0.74845387720803,0.497390073363792,0.251063803844238,9.66650883328046,15.8723,3.12083868032948,122.1996,0.786083624802766,0.719930185122369,0.824703947013462,0.762027071787954,0.0661534396803964,0.0626768752255077,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2771,38393,1085:1510,Pancreas,HuP-T4,SIDM00531,907286,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.549969726624061,0.0833521681417942,0.887877569285563,12.7873475136099,138.0719,0.932517071925158,0.978331675675186,0.131876314583663,0.488305784055617,0.250063013434561,0.238242770621056,8.66732621569988,7.9406,4.12002129791006,130.1313,0.512856159118949,0.356102636800538,0.538052804218742,0.471143877522185,0.156753522318411,0.0669089266965566,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2772,38393,1372:1510,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.875762717969808,0.0833521681417942,0.887877569285563,12.7873475136099,138.0719,0.932517071925158,0.978331675675186,0.0825063576014825,0.777570073301951,0.468971993713728,0.308598079588223,9.26035043710418,11.9777,3.52699707650576,126.0942,0.816663685462423,0.738158245555052,0.856786407365258,0.776240601715568,0.0785054399073714,0.0805458056496894,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2773,38393,1594:1510,Pancreas,HuP-T4,SIDM00531,907286,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.905922219787411,0.0833521681417942,0.887877569285563,12.7873475136099,138.0719,0.932517071925158,0.978331675675186,0.10921946240958,0.804348018466628,0.509997733810348,0.29435028465628,9.46340204068366,13.7879,3.32394547292628,124.284,0.844787935788096,0.711920385674104,0.886292403316002,0.811200371953132,0.132867550113992,0.07509203136287,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2774,38393,1564:1510,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.851712359402157,0.0833521681417942,0.887877569285563,12.7873475136099,138.0719,0.932517071925158,0.978331675675186,0.0858795930988692,0.756216299396459,0.367722058009783,0.388494241386676,8.49714623529732,7.0571,4.29020127831262,131.0148,0.794236315512168,0.657552561905076,0.833257179767179,0.721644678726448,0.136683753607091,0.111612501040732,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2775,38393,1558:1510,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.912377232980419,0.0833521681417942,0.887877569285563,12.7873475136099,138.0719,0.932517071925158,0.978331675675186,0.0969986976662123,0.810079279890143,0.235608450464627,0.574470829425516,7.06873699475278,2.622,5.71861051885716,135.4499,0.850807345790079,0.617788024831073,0.892607547189623,0.688309193662883,0.233019320959006,0.20429835352674,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2776,38393,1079:1510,Pancreas,HuP-T4,SIDM00531,907286,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.93370801576557,0.0833521681417942,0.887877569285563,12.7873475136099,138.0719,0.932517071925158,0.978331675675186,0.111584741371888,0.82901840346038,0.575437336900168,0.253581066560213,9.86727517798989,18.2421,2.92007233562005,119.8298,0.870698664894759,0.753116206537368,0.913476127655283,0.851438452957884,0.117582458357391,0.0620376746973996,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2777,38394,1510:1558,Pancreas,HuP-T4,SIDM00531,907286,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.830373301688304,0.0775025170681428,0.820451762464094,11.7809879250977,68.7323,0.924040904470562,0.96394789786618,0.0795005662451379,0.681281238873298,0.408697274945268,0.27258396392803,8.94277988966139,9.6111,2.83820803543627,59.1212,0.767298896740267,0.692837445325129,0.80043659860664,0.723295102506697,0.0744614514151376,0.0771414960999428,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2778,38394,1053:1558,Pancreas,HuP-T4,SIDM00531,907286,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.953459601910771,0.0775025170681428,0.820451762464094,11.7809879250977,68.7323,0.924040904470562,0.96394789786618,0.0700342645342253,0.782267610826006,0.619690130316543,0.162577480509463,10.1325368268695,21.9244,1.64845109822817,46.8079,0.881035672925771,0.830041158860451,0.919085378962213,0.878664103919033,0.0509945140653199,0.0404212750431806,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2779,38394,1083:1558,Pancreas,HuP-T4,SIDM00531,907286,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.943790913793549,0.0775025170681428,0.820451762464094,11.7809879250977,68.7323,0.924040904470562,0.96394789786618,0.114516925454874,0.774334918619515,0.838663630327955,-0.0643287117084399,12.8008833861202,139.3734,-1.01989546102256,-70.6411,0.872101409612889,0.850719920291168,0.909765267376493,0.923482632719099,0.0213814893217208,-0.0137173653426059,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2780,38394,1080:1558,Pancreas,HuP-T4,SIDM00531,907286,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.903708908644165,0.0775025170681428,0.820451762464094,11.7809879250977,68.7323,0.924040904470562,0.96394789786618,0.0449081849962487,0.741449566851609,0.82865244155492,-0.0872028747033113,13.3955905796374,210.477,-1.61460265453979,-141.7447,0.835063997321659,0.877955632175122,0.871128302770483,0.889430587109722,-0.042891634853463,-0.0183022843392392,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2781,38394,1011:1558,Pancreas,HuP-T4,SIDM00531,907286,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.868306841865582,0.0775025170681428,0.820451762464094,11.7809879250977,68.7323,0.924040904470562,0.96394789786618,0.118386170121178,0.712403878768248,0.460667831205008,0.25173604756324,9.22383774639387,11.6784,2.55715017870379,57.0539,0.802351039515449,0.699578913554014,0.837002554919149,0.768163217769316,0.102772125961435,0.0688393371498331,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2782,38394,1594:1558,Pancreas,HuP-T4,SIDM00531,907286,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.897855898650078,0.0775025170681428,0.820451762464094,11.7809879250977,68.7323,0.924040904470562,0.96394789786618,0.100033740514327,0.73664745448624,0.387514838266945,0.349132616219294,8.49607071934426,7.0518,3.28491720575339,61.6805,0.829655576672847,0.710708904466229,0.865486306090493,0.760687147389964,0.118946672206618,0.104799158700529,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2783,38394,1080:1561,Pancreas,HuP-T4,SIDM00531,907286,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.868146316275026,0.107417628288952,0.830487379597341,11.9085129397834,75.0844,0.899475784101901,0.966161698169495,0.108061017174107,0.720984559310331,0.402689688807201,0.31829487050313,8.73487527051514,8.3213,3.17363766926824,66.7631,0.780876588546656,0.660744057930334,0.838769719191871,0.74685885670606,0.120132530616322,0.0919108624858113,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2784,38394,1372:1561,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.880284628862328,0.107417628288952,0.830487379597341,11.9085129397834,75.0844,0.899475784101901,0.966161698169495,0.159050896610807,0.731065274723692,0.47573995338499,0.255325321338702,9.29670951280785,12.2834,2.61180342697553,62.801,0.791794706778793,0.645389167787617,0.85049729189413,0.781715818550576,0.146405538991176,0.0687814733435542,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2785,38394,1168:1561,Pancreas,HuP-T4,SIDM00531,907286,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.855155983245548,0.107417628288952,0.830487379597341,11.9085129397834,75.0844,0.899475784101901,0.966161698169495,0.089162714716843,0.710196251672582,0.737295170816964,-0.0270989191443816,12.3558372210395,102.3782,-0.447324281256115,-27.2938,0.769192098559221,0.783833228549664,0.826218956972322,0.832050810371025,-0.0146411299904426,-0.0058318533987028,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2786,38394,1083:1561,Pancreas,HuP-T4,SIDM00531,907286,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.943790913793549,0.107417628288952,0.830487379597341,11.9085129397834,75.0844,0.899475784101901,0.966161698169495,0.0810875759373373,0.783806442884184,0.736170504311156,0.0476359385730281,11.3167107503045,49.8195,0.591802189478909,25.2649,0.848917072212702,0.833018886901876,0.911854631987715,0.901080594956977,0.0158981853108257,0.010774037030738,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2787,38394,1594:1561,Pancreas,HuP-T4,SIDM00531,907286,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.897855898650078,0.107417628288952,0.830487379597341,11.9085129397834,75.0844,0.899475784101901,0.966161698169495,0.179803520531274,0.745657992525919,0.436066406090585,0.309591586435333,8.89509671865817,9.2987,3.01341622112521,65.7857,0.807599638448796,0.632710733164349,0.867473979751257,0.779906550820342,0.174888905284447,0.0875674289309153,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2788,38394,1564:1561,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.874406814306677,0.107417628288952,0.830487379597341,11.9085129397834,75.0844,0.899475784101901,0.966161698169495,0.141261096102064,0.726183823915611,0.19888995014336,0.52729387377225,6.76203604104184,2.1199,5.14647689874154,72.9645,0.786507754922543,0.554256937811111,0.844818372601517,0.639703223309051,0.232250817111432,0.205115149292466,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2789,38394,1558:1561,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.82681704245139,0.107417628288952,0.830487379597341,11.9085129397834,75.0844,0.899475784101901,0.966161698169495,0.116989741387102,0.686661118991878,0.379675173353479,0.306985945638399,8.7006353851303,8.1261,3.20787755465308,66.9583,0.743701907567779,0.616198206551282,0.798838957810314,0.709793137130462,0.127503701016496,0.0890458206798527,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2790,38394,1079:1561,Pancreas,HuP-T4,SIDM00531,907286,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.825816952857871,0.107417628288952,0.830487379597341,11.9085129397834,75.0844,0.899475784101901,0.966161698169495,0.0841054771586069,0.685830557205994,0.465672717667344,0.22015783953865,9.47034929617666,13.8544,2.43816364360672,61.23,0.742802351196476,0.678438917258451,0.797872709550318,0.739719380956781,0.064363433938025,0.0581533285935367,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2791,38395,1510:1564,Pancreas,HuP-T4,SIDM00531,907286,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.97505180731897,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.132182419818084,0.765478651684835,0.303299247735692,0.462179403949144,7.54459510928597,3.6465,3.82643576317066,48.0846,0.854420381280088,0.67369985282895,0.932072317768403,0.768313863111426,0.180720528451138,0.163758454656977,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2792,38395,1168:1564,Pancreas,HuP-T4,SIDM00531,907286,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.847917048872199,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.100123469747676,0.665669654103771,0.739672110002414,-0.0740024558986435,12.5175016594799,114.5179,-1.14647078702324,-62.7868,0.743014476516192,0.770576336513053,0.810541555931004,0.826817424015958,-0.0275618599968611,-0.0162758680849542,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2793,38395,1594:1564,Pancreas,HuP-T4,SIDM00531,907286,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.923140646162574,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.135235909954545,0.724725037003935,0.337563283909521,0.387161753094414,7.99178436690285,4.9716,3.37924650555378,46.7595,0.808931563378302,0.708383508614201,0.882449358317529,0.754396769092335,0.100548054764101,0.128052589225193,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2794,38395,1053:1564,Pancreas,HuP-T4,SIDM00531,907286,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.986150200393721,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.0980613409775425,0.774191607143159,0.0954601211948194,0.67873148594834,4.91239898144509,0.5882,6.45863189101153,51.1429,0.864145703741259,0.530057011988963,0.942681502715336,0.571675134285332,0.334088691752296,0.371006368430004,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2795,38395,1558:1564,Pancreas,HuP-T4,SIDM00531,907286,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.926756314441946,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.128490504154658,0.727563570155362,0.189288328436678,0.538275241718685,6.51087259973036,1.7811,4.86015827272627,49.95,0.812099908533559,0.58529911825161,0.885905650883872,0.660099145336327,0.226800790281949,0.225806505547545,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2796,38395,1083:1564,Pancreas,HuP-T4,SIDM00531,907286,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.929673274297195,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.070903981088416,0.729853572061163,0.828079933522257,-0.0982263614610946,12.8402236771106,143.2262,-1.46919280465401,-91.4951,0.814655988049532,0.868042165563591,0.888694033524375,0.910070370543485,-0.0533861775140592,-0.0213763370191105,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2797,38395,1561:1564,Pancreas,HuP-T4,SIDM00531,907286,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.910114535506823,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.05942316479217,0.714498698724661,0.288570511576671,0.42592818714799,7.59566585987924,3.7779,3.77536501257739,47.9532,0.797517016633666,0.672845683309584,0.869997428010566,0.720290719474789,0.124671333324083,0.149706708535777,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2798,38395,1054:1564,Pancreas,HuP-T4,SIDM00531,907286,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.999187932403477,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.154967738443907,0.784427068936003,0.634314460108206,0.150112608827797,10.0121487401831,20.1691,1.35888213227355,31.562,0.875570434069623,0.788809364248222,0.955144542116484,0.916532039427283,0.0867610698214011,0.0386125026892004,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2799,38395,1057:1564,Pancreas,HuP-T4,SIDM00531,907286,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.940097628839657,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.0779488919356986,0.738037363732489,0.485444351661001,0.252593012071488,9.11993916723164,10.8669,2.25109170522499,40.8642,0.823790662654422,0.783436965204275,0.898658891008562,0.827057170412044,0.0403536974501468,0.0716017205965176,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2800,38395,1011:1564,Pancreas,HuP-T4,SIDM00531,907286,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.798051246020678,0.106993286607326,0.785064594454337,11.3710308724566,51.7311,0.876282034315106,0.955920814434728,0.0728730414877986,0.626521777811002,0.470911193306717,0.155610584504285,9.66674608950831,15.8749,1.70428478294832,35.8562,0.699317969350705,0.656267821821488,0.762873797056737,0.721429440787196,0.0430501475292174,0.0414443562695404,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2801,38395,1079:1594,Pancreas,HuP-T4,SIDM00531,907286,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.903151917274018,0.0661664246281247,0.886574072055805,12.7635026776403,54.3234,0.966551933708476,0.978064054019351,0.0709024906589377,0.800711072982633,0.591839514549503,0.208871558433131,10.175859401174,9.0371,2.58764327646638,45.2863,0.87294323207372,0.787132983933005,0.883340425604375,0.833653240562173,0.0858102481407148,0.049687185042202,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2802,38395,1564:1594,Pancreas,HuP-T4,SIDM00531,907286,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.831009405978786,0.0661664246281247,0.886574072055805,12.7635026776403,54.3234,0.966551933708476,0.978064054019351,0.0543090945870276,0.736751392975288,0.411977896237917,0.324773496737371,8.96892794898195,3.9148,3.7945747286584,50.4086,0.803213748278728,0.68648043689592,0.812780428539824,0.724939352017061,0.116733311382807,0.0878410765227634,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2803,38395,1510:1594,Pancreas,HuP-T4,SIDM00531,907286,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.917877599982146,0.0661664246281247,0.886574072055805,12.7635026776403,54.3234,0.966551933708476,0.978064054019351,0.106134470776811,0.81376648146498,0.633091306225458,0.180675175239522,10.4621870531634,11.021,2.30131562447697,43.3024,0.887176369170438,0.802064395189531,0.89774308653209,0.855794208149404,0.0851119739809066,0.0419488783826858,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2804,38395,1561:1594,Pancreas,HuP-T4,SIDM00531,907286,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.910114535506823,0.0661664246281247,0.886574072055805,12.7635026776403,54.3234,0.966551933708476,0.978064054019351,0.161638183032547,0.806883949781461,0.51137568343381,0.295508266347651,9.4553762117436,5.4846,3.30812646589674,48.8388,0.879672964190311,0.669824131268291,0.890150312219742,0.814637119509844,0.209848832922021,0.0755131927098973,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2805,38395,1372:1594,Pancreas,HuP-T4,SIDM00531,907286,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.898340676715958,0.0661664246281247,0.886574072055805,12.7635026776403,54.3234,0.966551933708476,0.978064054019351,0.0993507472811647,0.796445551849435,0.374991841903968,0.421453709945467,8.38987844981217,2.6206,4.37362422782818,51.7028,0.868292918208791,0.686224767107811,0.878634724159297,0.755662318996067,0.18206815110098,0.122972405163231,True,0.972411985879737,0.103493972181074,0.0021042604173185,1830.03291845184
2806,38275,1080:1011,Pancreas,KP-2,SIDM00582,1298218,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.679374287000219,0.160078765377244,0.278246957261764,6.0484913724105,1.2927,0.685399098108375,0.634143150447756,0.0821736433623715,0.189033828199691,0.0557515599198697,0.133282268279821,1.52305296893412,0.0561,4.52543840347637,1.2366,0.46564252358797,0.180139100898138,0.430820550691517,0.230503762740593,0.285503422689832,0.200316787950924,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2807,38275,1083:1011,Pancreas,KP-2,SIDM00582,1298218,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.944664855033092,0.160078765377244,0.278246957261764,6.0484913724105,1.2927,0.685399098108375,0.634143150447756,0.152300949089329,0.262850121545083,0.172210374912373,0.0906397466327096,4.35259014292834,0.399,1.69590122948216,0.8937,0.64747243965436,0.504575527298779,0.599052747287958,0.494573238830749,0.142896912355581,0.104479508457209,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2808,38275,1558:1011,Pancreas,KP-2,SIDM00582,1298218,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.947989730827394,0.160078765377244,0.278246957261764,6.0484913724105,1.2927,0.685399098108375,0.634143150447756,0.158391579749807,0.263775258118121,0.113928298323601,0.14984695979452,2.83566921289453,0.1394,3.21282215951597,1.1533,0.649751306525097,0.375051418965883,0.601161194499004,0.400726960018055,0.274699887559214,0.200434234480949,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2809,38277,1510:1053,Pancreas,KP-2,SIDM00582,1298218,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.861732029648267,0.0514750166321865,0.833343764548147,13.9838661820636,316.4413,0.952566212231635,0.945989225616332,0.0647408514636258,0.718119013618802,0.47956126447483,0.238557749143972,9.70291953004686,16.278,4.2809466520167,300.1633,0.820856815440729,0.669437018369001,0.815189215415754,0.713633243874552,0.151419797071727,0.101555971541202,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2810,38277,1083:1053,Pancreas,KP-2,SIDM00582,1298218,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.943165310929416,0.0514750166321865,0.833343764548147,13.9838661820636,316.4413,0.952566212231635,0.945989225616332,0.028882465541789,0.785980930801143,0.819938790923762,-0.0339578601226193,14.8685142722517,584.2501,-0.88464809018817,-267.8088,0.898427407740306,0.910592866857987,0.892224222114305,0.904006668356487,-0.0121654591176813,-0.0117824462421821,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2811,38277,1564:1053,Pancreas,KP-2,SIDM00582,1298218,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.683552680602199,0.0514750166321865,0.833343764548147,13.9838661820636,316.4413,0.952566212231635,0.945989225616332,0.0589081321617133,0.569634364120013,0.467776020841987,0.101858343278027,11.3959079536942,52.6308,2.58795822836937,263.8105,0.651129187822017,0.600573509152322,0.646633470990842,0.607095636351824,0.0505556786696955,0.0395378346390179,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2812,38277,1011:1053,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.339016504489181,0.0514750166321865,0.833343764548147,13.9838661820636,316.4413,0.952566212231635,0.945989225616332,0.0633785203707857,0.282517290094968,0.120920165590621,0.161597124504347,7.17366130381493,2.8198,6.81020487824864,313.6215,0.322935667565268,0.183226108004754,0.320705960552876,0.238032718705506,0.139709559560514,0.08267324184737,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2813,38277,1558:1053,Pancreas,KP-2,SIDM00582,1298218,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.959359999280435,0.0514750166321865,0.833343764548147,13.9838661820636,316.4413,0.952566212231635,0.945989225616332,0.0543819984525246,0.799476673357265,0.800087094219663,-0.0006104208623973,13.9980743605435,319.5732,-0.0142081784799171,-3.13189999999997,0.913853920681108,0.912738806357267,0.907544222806583,0.907760273945146,0.0011151143238403,-0.0002160511385633,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2814,38278,1011:1057,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.319814354305644,0.0491662232240595,0.779373613402588,12.9078515373126,1.501,0.926474170354902,0.926265126678389,0.0651211225550535,0.249254868933205,0.11429729272684,0.134957576206365,7.18319908942887,0.0284,5.7246524478837,1.4726,0.29629973857291,0.169112249874388,0.296232883404484,0.22472619662246,0.127187488698522,0.0715066867820244,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2815,38279,1083:1079,Pancreas,KP-2,SIDM00582,1298218,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.950582348862571,0.12447558949443,0.451167592643772,8.39322654485794,1.3133,0.700057617168295,0.768105050527827,0.147572137111582,0.428871949945988,0.345525300240376,0.083346649705612,7.26516139576235,0.6009,1.12806514909559,0.7124,0.665462414066973,0.583593527756614,0.730147103103946,0.672424062852092,0.081868886310359,0.057723040251854,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2816,38279,1561:1079,Pancreas,KP-2,SIDM00582,1298218,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.762636406631906,0.12447558949443,0.451167592643772,8.39322654485794,1.3133,0.700057617168295,0.768105050527827,0.102522442182469,0.344076831642613,0.151810756272459,0.192266075370154,4.68911650750318,0.1008,3.70411003735477,1.2125,0.533889425592523,0.376949564618361,0.58578487565036,0.416351485512662,0.156939860974162,0.169433390137698,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2817,38279,1372:1079,Pancreas,KP-2,SIDM00582,1298218,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.685413191496073,0.12447558949443,0.451167592643772,8.39322654485794,1.3133,0.700057617168295,0.768105050527827,0.112664884559389,0.309236219573568,0.12373437928962,0.185501840283948,4.31562786629652,0.0778,4.07759867856143,1.2355,0.479828725614457,0.315697337864368,0.52646933408653,0.357153742894359,0.164131387750089,0.169315591192171,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2818,38279,1011:1079,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.250244059441894,0.12447558949443,0.451167592643772,8.39322654485794,1.3133,0.700057617168295,0.768105050527827,0.0667417531899265,0.112902009871804,0.0340820320014776,0.0788199778703267,3.27995535776652,0.0379,5.11327118709143,1.2754,0.175185259963414,0.0525363139304016,0.192213725921905,0.113113139732518,0.122648946033012,0.0791005861893867,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2819,38279,1011:1080,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.250244059441894,0.0841379886486043,0.543193760340033,9.53633574946389,0.145,0.78369117489859,0.821162459647859,0.0616777803009913,0.135931011650997,0.04130902756706,0.0946219840839373,3.98074301532897,0.0031,5.55559273413492,0.1419,0.196114060955411,0.0751805401220716,0.205491027363571,0.124800060967011,0.120933520833339,0.0806909663965606,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2820,38280,1011:1083,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.57690180770115,0.103269753448356,0.544417525578595,9.55161058694399,11.7258,0.851368539534568,0.821810202033471,0.0815643223685095,0.314075454650478,0.105001228307373,0.209074226343105,4.34658281040077,0.3179,5.20502777654322,11.4079,0.491156049477381,0.293574750082946,0.474103791140357,0.30180210667507,0.197581299394435,0.172301684465287,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2821,38280,1558:1083,Pancreas,KP-2,SIDM00582,1298218,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.942977138387859,0.103269753448356,0.544417525578595,9.55161058694399,11.7258,0.851368539534568,0.821810202033471,0.194049545571756,0.513373280358302,0.282048111423515,0.231325168934787,6.36311239375529,1.2862,3.1884981931887,10.4396,0.802821069123759,0.678126825005991,0.774948232611471,0.616449821087738,0.124694244117767,0.158498411523734,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2822,38280,1011:1085,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.57690180770115,0.106820265205206,0.601237671326421,10.2715018468154,24.1413,0.875071953333668,0.850484256422923,0.104526413535539,0.346855099446242,0.19237405408614,0.154481045360103,6.85543978024741,2.2616,3.41606206656802,21.8797,0.50483059174677,0.397831057931796,0.490645904951753,0.394317620218342,0.106999533814974,0.0963282847334105,True,0.497357260224694,0.0809960593036928,0.636588578772835,74.7292218614352
2823,38562,1510:1168,Pancreas,KP-2,SIDM00582,1298218,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.783209073726784,0.060071335563793,0.89261904458202,15.5577086196015,942.0349,0.943704969606246,0.966295979136726,0.0341083433799671,0.699107335097971,0.439176152263762,0.259931182834209,9.75605284317044,16.8886,5.80165577643109,925.1463,0.739118295116671,0.652540988099244,0.756811778765591,0.65031595038262,0.0865773070174271,0.106495828382971,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2824,38562,1083:1168,Pancreas,KP-2,SIDM00582,1298218,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.912045755718612,0.060071335563793,0.89261904458202,15.5577086196015,942.0349,0.943704969606246,0.966295979136726,0.0667956803802062,0.814109411084634,0.710087390607583,0.104022020477052,12.8933185839982,148.5955,2.66439003560335,793.4394,0.860702112179939,0.819614284264404,0.881306146539612,0.844517928523388,0.0410878279155351,0.0367882180162239,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2825,38562,1564:1168,Pancreas,KP-2,SIDM00582,1298218,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.423251778924287,0.060071335563793,0.89261904458202,15.5577086196015,942.0349,0.943704969606246,0.966295979136726,0.0288377950578344,0.377802598521038,0.237328649155852,0.140473949365186,9.75589598192498,16.8868,5.80181263767655,925.1481,0.399424807165534,0.340986588669276,0.408986492137005,0.351432668930214,0.0584382184962586,0.0575538232067918,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2826,38562,1372:1168,Pancreas,KP-2,SIDM00582,1298218,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.399250639699417,0.060071335563793,0.89261904458202,15.5577086196015,942.0349,0.943704969606246,0.966295979136726,0.0535240100516277,0.356378724557254,0.186301280470578,0.170077444086675,8.58603052148181,7.5056,6.97167809811972,934.5293,0.376774812802812,0.276697737468985,0.385794287809312,0.310488443212364,0.100077075333827,0.0753058445969478,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2827,38562,1011:1168,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.30327000022816,0.060071335563793,0.89261904458202,15.5577086196015,942.0349,0.943704969606246,0.966295979136726,0.048041824807701,0.270704577854049,0.16508259110457,0.105621986749479,9.5506673941275,14.6476,6.00704122547403,927.3873,0.286197406347802,0.225580811928503,0.293048581813265,0.2492182646651,0.0606165944192991,0.0438303171481642,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2828,38563,1561:1372,Pancreas,KP-2,SIDM00582,1298218,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.646458429519887,0.117118896013493,0.17801128029679,4.26271868291386,0.0375,0.491022525588952,0.517547254915527,0.0832701118656099,0.115076892697487,0.0585031524420514,0.056573740255436,1.85459566325644,0.0071,2.40812301965742,0.0304,0.317425650751122,0.212162909281022,0.33457278561502,0.232584336752863,0.1052627414701,0.101988448862157,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2829,38564,1011:1507,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1507,Ruxolitinib,"JAK1, JAK2","Other, kinases",Targeted,Advanced clinical trials,10.0,0.289418523027554,0.0496479107134307,0.874189869733856,15.0026497017447,641.1765,0.961542412575694,0.960123903440706,0.0707442065112431,0.253006740944023,0.123383880490124,0.129622860453899,8.08065991047996,5.2875,6.92198979126475,635.889,0.278288184876009,0.180172601098511,0.277877642057259,0.21766249158286,0.098115583777498,0.0602151504743996,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2830,38564,1085:1510,Pancreas,KP-2,SIDM00582,1298218,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.633977078004103,0.0626922846142445,0.743991020860054,12.303403173301,98.7242,0.90431662733152,0.912616961494132,0.118280360875136,0.471673253466146,0.200995208259753,0.270678045206393,6.62369576249908,1.926,5.67970741080193,96.7982,0.573316012986162,0.352062874072406,0.578578234585033,0.424530380002392,0.221253138913756,0.15404785458264,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2831,38564,1372:1510,Pancreas,KP-2,SIDM00582,1298218,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.377959460315338,0.0626922846142445,0.743991020860054,12.303403173301,98.7242,0.90431662733152,0.912616961494132,0.0679143954325617,0.281198444723723,0.208953001954597,0.0722454427691266,9.6569931200856,15.7679,2.64641005321541,82.9563,0.341795024420408,0.277470527228777,0.344932214240946,0.312283135691354,0.0643244971916313,0.0326490785495915,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2832,38564,1011:1510,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.289418523027554,0.0626922846142445,0.743991020860054,12.303403173301,98.7242,0.90431662733152,0.912616961494132,0.0672457619930923,0.215324782403079,0.0805272400893298,0.134797542313749,6.04835374380593,1.2926,6.25504942949508,97.4316,0.261725982631548,0.132582432275521,0.264128253085526,0.183530269941397,0.129143550356026,0.0805979831441287,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2833,38564,1594:1510,Pancreas,KP-2,SIDM00582,1298218,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.521042925303392,0.0626922846142445,0.743991020860054,12.303403173301,98.7242,0.90431662733152,0.912616961494132,0.130304471549596,0.387651257908379,0.238538218649983,0.149113039258396,8.47617755137244,6.9553,3.82722562192857,91.7689,0.471187780905313,0.31265057458929,0.475512611298396,0.402377444586617,0.158537206316023,0.0731351667117787,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2834,38564,1564:1510,Pancreas,KP-2,SIDM00582,1298218,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.468875372533013,0.0626922846142445,0.743991020860054,12.303403173301,98.7242,0.90431662733152,0.912616961494132,0.080794018504451,0.348839067066974,0.145038758522999,0.203800308543975,6.51276866031509,1.7835,5.79063451298592,96.9407,0.424011795527865,0.24799392951517,0.427903617800508,0.310816438859399,0.176017866012694,0.117087178941109,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2835,38564,1558:1510,Pancreas,KP-2,SIDM00582,1298218,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.769245354552908,0.0626922846142445,0.743991020860054,12.303403173301,98.7242,0.90431662733152,0.912616961494132,0.0878073671396342,0.572311636625672,0.316362220684669,0.255949415941003,7.88914009773904,4.6302,4.41426307556197,94.094,0.695641364619725,0.515365214301045,0.702026358115551,0.57072940219931,0.180276150318679,0.131296955916241,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2836,38564,1079:1510,Pancreas,KP-2,SIDM00582,1298218,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.587004051681368,0.0626922846142445,0.743991020860054,12.303403173301,98.7242,0.90431662733152,0.912616961494132,0.0656783698729875,0.436725743659409,0.253112560244645,0.183613183414764,8.14232437281467,5.5184,4.16107880048634,93.2058,0.530837524246432,0.400588993606683,0.535709854030195,0.443353563317351,0.13024853063975,0.0923562907128443,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2837,38565,1510:1558,Pancreas,KP-2,SIDM00582,1298218,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.81169817680968,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.0633611144142257,0.645015709143607,0.286685669381893,0.358330039761714,7.12650353010202,2.7291,6.06363857958214,179.8111,0.735303486736495,0.557545088481429,0.756483719800943,0.567703085392684,0.177758398255066,0.188780634408259,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2838,38565,1053:1558,Pancreas,KP-2,SIDM00582,1298218,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.77546403591005,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.0568150631040001,0.616222260106374,0.505721248330151,0.110501011776223,10.9462057035129,38.536,2.24393640617127,144.0042,0.702479598616999,0.693677008584239,0.722714347792151,0.677833728139902,0.0088025900327599,0.0448806196522497,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2839,38565,1083:1558,Pancreas,KP-2,SIDM00582,1298218,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.883436849924583,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.0740251521302049,0.70202282389912,0.608221863632806,0.0938009602663145,11.4554892400842,54.8499,1.73465286959998,127.6903,0.800290322955059,0.801453453057012,0.823342485586085,0.786179434370176,-0.0011631301019534,0.0371630512159091,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2840,38565,1085:1558,Pancreas,KP-2,SIDM00582,1298218,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.922264427218133,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.0457064371826277,0.732877146377412,0.649622207742888,0.0832549386345233,11.6884809431982,64.4634,1.50166116648593,118.0768,0.835463560718992,0.86413159560834,0.859528879668341,0.826890445429162,-0.028668034889348,0.0326384342391781,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2841,38565,1054:1558,Pancreas,KP-2,SIDM00582,1298218,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.761195550495547,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.17230261069175,0.604883812514667,0.403458401691492,0.201425410823174,9.37243188814862,12.9453,3.81771022153553,169.5949,0.689554021874953,0.667192424968842,0.709416453044238,0.619696275205403,0.0223615969061112,0.0897201778388343,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2842,38565,1564:1558,Pancreas,KP-2,SIDM00582,1298218,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.387664524112988,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.0431531295293862,0.308057496092155,0.232233719669859,0.0758237764222964,10.2433821309554,23.6753,2.94675997872874,158.8649,0.351178657792107,0.330050631718679,0.361294271213593,0.329294703099323,0.0211280260734276,0.0319995681142696,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2843,38565,1507:1558,Pancreas,KP-2,SIDM00582,1298218,1507,Ruxolitinib,"JAK1, JAK2","Other, kinases",Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.980441246975815,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.116112304112573,0.779107338490458,0.53370518991011,0.245402148580348,9.55079300081144,14.6489,3.63934910887272,167.8913,0.888164946082698,0.735668517813562,0.913748315258867,0.805702667542637,0.152496428269136,0.108045647716231,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2844,38565,1372:1558,Pancreas,KP-2,SIDM00582,1298218,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.404414485251751,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.0603559306590723,0.321367847612855,0.20213613076179,0.119231716851064,8.99782205329309,9.9849,4.19232005639107,172.5553,0.366352160924074,0.299394067041868,0.376904843308969,0.322433772593652,0.0669580938822069,0.0544710707153176,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2845,38565,1011:1558,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.300123574951546,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.0481207553535722,0.23849310748603,0.0784483123063421,0.160044795179688,5.7834317736198,1.0758,7.40671033606436,181.4644,0.271876810147668,0.164396330693121,0.279708153678084,0.185282314402609,0.107480479454547,0.0944258392754752,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2846,38565,1079:1558,Pancreas,KP-2,SIDM00582,1298218,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.473574132751998,0.0914799716265331,0.79464969562799,13.1901421096842,182.5402,0.905882885713199,0.931976615709852,0.0693069836225316,0.376325540448664,0.257532464042919,0.118793076405746,9.543977042221,14.5799,3.64616506746316,167.9603,0.429002701976505,0.346725918819445,0.441360017529935,0.389034851276711,0.0822767831570603,0.0523251662532243,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2847,38565,1085:1561,Pancreas,KP-2,SIDM00582,1298218,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.666784589838234,0.0709496106471092,0.33316437859511,6.85131126809506,2.2552,0.656231855833758,0.683264117214437,0.10386517008798,0.22214887353025,0.10378029421718,0.118368579313071,3.76377439672431,0.2653,3.08753687137075,1.9899,0.437565288830895,0.293799258348741,0.455589984148011,0.32287126233853,0.143766030482154,0.132718721809481,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2848,38565,1011:1561,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.300123574951546,0.0709496106471092,0.33316437859511,6.85131126809506,2.2552,0.656231855833758,0.683264117214437,0.0620419698038728,0.0999904843504749,0.0318510631090509,0.0681394212414239,2.40155532028191,0.1032,4.44975594781315,2.152,0.196950650569915,0.0637170589615018,0.205063669494509,0.118399961757599,0.133233591608413,0.08666370773691,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2849,38565,1079:1561,Pancreas,KP-2,SIDM00582,1298218,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.627253302953126,0.0709496106471092,0.33316437859511,6.85131126809506,2.2552,0.656231855833758,0.683264117214437,0.0565137080236168,0.208978456900109,0.0685402986606166,0.140438158239492,2.50286828131507,0.1107,4.34844298677999,2.1445,0.411623599074785,0.226940145634529,0.428579674312108,0.251555027520457,0.184683453440256,0.177024646791651,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2850,38566,1510:1564,Pancreas,KP-2,SIDM00582,1298218,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.786375186612539,0.0956411476731056,0.255409860419541,5.68684927216785,1.0061,0.582800593984107,0.611176045019078,0.0499842712761412,0.200847976650099,0.0949994759645502,0.105848500685549,2.85401833293084,0.1412,2.83283093923702,0.8649,0.458299925852151,0.317257461524029,0.480613676454991,0.333356138649347,0.141042464328122,0.147257537805644,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2851,38566,1561:1564,Pancreas,KP-2,SIDM00582,1298218,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.534064077166151,0.0956411476731056,0.255409860419541,5.68684927216785,1.0061,0.582800593984107,0.611176045019078,0.0638075622509301,0.136405231404098,0.0460618418260922,0.0903433895780056,1.69120897411165,0.0631,3.99564029805621,0.943,0.311252861398007,0.164831666816549,0.326407170469172,0.186722333699962,0.146421194581458,0.139684836769209,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2852,38566,1168:1564,Pancreas,KP-2,SIDM00582,1298218,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.785813197418244,0.0956411476731056,0.255409860419541,5.68684927216785,1.0061,0.582800593984107,0.611176045019078,0.0966199020715922,0.200704439068427,0.0864304016613263,0.114274037407101,2.52564406369636,0.1125,3.1612052084715,0.8936,0.457972398215903,0.291191080365124,0.480270202121878,0.316302406080843,0.166781317850779,0.163967796041035,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2853,38566,1558:1564,Pancreas,KP-2,SIDM00582,1298218,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.946938805241325,0.0956411476731056,0.255409860419541,5.68684927216785,1.0061,0.582800593984107,0.611176045019078,0.124896512920692,0.241857508072534,0.145555651728668,0.0963018563438663,3.71804046951927,0.257,1.96880880264858,0.7491,0.551876498161245,0.4280960558537,0.578746313862484,0.455637198588113,0.123780442307544,0.12310911527437,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2854,38566,1011:1594,Pancreas,KP-2,SIDM00582,1298218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.263559944978968,0.0786212790084488,0.445332186810112,8.3201655598725,2.4969,0.7778697353429,0.764413315209058,0.0427954378883544,0.117371726653037,0.049664308605136,0.0677074180479006,4.47847723401235,0.1742,3.84168832586015,2.3227,0.20501530464778,0.121313317295601,0.20146873129769,0.140196343212462,0.0837019873521782,0.0612723880852276,True,0.373937954989178,0.0600076390214254,0.923000315258153,52.7487959891857
2855,38533,1083:1011,Pancreas,PANC-08-13,SIDM01136,925347,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,1.0,0.197169249579175,0.513399972470711,9.21435843855769,11.6019,0.747246505592608,0.763359738277921,0.102254364755988,0.513399972470711,0.370131266926645,0.143268705544066,6.87430213682472,2.2914,2.34005630173297,9.3105,0.747246505592608,0.660204340752728,0.763359738277921,0.654838727058736,0.0870421648398798,0.108521011219185,True,,,,
2856,38533,1564:1011,Pancreas,PANC-08-13,SIDM01136,925347,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.916532808297372,0.197169249579175,0.513399972470711,9.21435843855769,11.6019,0.747246505592608,0.763359738277921,0.0865027675161292,0.470547918548374,0.236629807092483,0.233918111455891,4.78000760804342,0.5366,4.43435083051426,11.0653,0.68487593826119,0.48828332861245,0.69964424466501,0.497841330371325,0.19659260964874,0.201802914293684,True,,,,
2857,38533,1561:1011,Pancreas,PANC-08-13,SIDM01136,925347,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.865452737441689,0.197169249579175,0.513399972470711,9.21435843855769,11.6019,0.747246505592608,0.763359738277921,0.12902474442996,0.444323411577264,0.272009057577741,0.172314353999523,5.88091775842414,1.151,3.33344068013354,10.4509,0.646706533808859,0.545319002933977,0.660651775145398,0.521897758043084,0.101387530874882,0.138754017102314,True,,,,
2858,38533,1080:1011,Pancreas,PANC-08-13,SIDM01136,925347,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.98750575217046,0.197169249579175,0.513399972470711,9.21435843855769,11.6019,0.747246505592608,0.763359738277921,0.086546707652555,0.506985425978983,0.305736509476057,0.201248916502925,5.79351287664509,1.0833,3.4208455619126,10.5186,0.737910222561976,0.577322800041504,0.753822132524784,0.590883116588652,0.160587422520471,0.162939015936132,True,,,,
2859,38533,1558:1011,Pancreas,PANC-08-13,SIDM01136,925347,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.855732749049534,0.197169249579175,0.513399972470711,9.21435843855769,11.6019,0.747246505592608,0.763359738277921,0.178145371881609,0.439333169804316,0.265641987496687,0.173691182307629,5.8088691650517,1.0949,3.40548927350599,10.507,0.63944330644842,0.553163054087182,0.653231927350298,0.512739428808651,0.0862802523612384,0.140492498541647,True,,,,
2860,38533,1510:1011,Pancreas,PANC-08-13,SIDM01136,925347,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,2.5,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.879273992834972,0.197169249579175,0.513399972470711,9.21435843855769,11.6019,0.747246505592608,0.763359738277921,0.184060779481651,0.451419243715686,0.283262427399844,0.168156816315842,6.02573788487559,1.2725,3.1886205536821,10.3294,0.657034418604392,0.586569947485689,0.671202365045087,0.537011190838359,0.070464471118703,0.134191174206728,True,,,,
2861,38537,1564:1079,Pancreas,PANC-08-13,SIDM01136,925347,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.896830887508024,0.0432688118085759,0.942948302952642,20.2153762974546,4755.4834,0.982861512570195,0.978491276002105,0.0618480537503436,0.845665163411203,0.496020954159305,0.349644209251898,9.85215574028993,3.6104,10.3632205571647,4751.873,0.881460562615808,0.686547013140635,0.877541199475827,0.707468009830008,0.194913549475172,0.170073189645819,True,,,,
2862,38537,1372:1079,Pancreas,PANC-08-13,SIDM01136,925347,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.899966026465805,0.0432688118085759,0.942948302952642,20.2153762974546,4755.4834,0.982861512570195,0.978491276002105,0.114690757924244,0.848621437370964,0.44768422157524,0.400937215795723,8.95914831766111,1.9442,11.2562279797935,4753.5392,0.88454197003397,0.602817766613366,0.88060890559507,0.677344603226646,0.281724203420604,0.203264302368424,True,,,,
2863,38537,1011:1079,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.468719408905337,0.0432688118085759,0.942948302952642,20.2153762974546,4755.4834,0.982861512570195,0.978491276002105,0.107153491561502,0.441978171188253,0.199045020934125,0.242933150254128,7.78578690153641,0.862,12.4295893959182,4754.6214,0.460686267207708,0.237214226115551,0.458637852506736,0.327952501634084,0.223472041092157,0.130685350872652,True,,,,
2864,38537,1011:1080,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.468719408905337,0.0734778863585961,0.77140484676238,13.8629452716567,2.91,0.908427169504218,0.905827054050894,0.0725252337399146,0.361572423801175,0.197377787940264,0.164194635860911,7.72751285011312,0.0414,6.13543242154358,2.8686,0.425797445923565,0.284835896260277,0.424578721345198,0.326651038334432,0.140961549663289,0.0979276830107664,True,,,,
2865,38538,1168:1083,Pancreas,PANC-08-13,SIDM01136,925347,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.718426581594696,0.103919720130677,0.746275200809737,13.3135160624885,159.0698,0.911079016024969,0.893979934423472,0.0996750216663825,0.536143941446635,0.323833508229871,0.212310433216764,8.20983879246837,4.6262,5.10367727002012,154.4436,0.654543383045478,0.541684550265278,0.642258948302106,0.516893514702558,0.1128588327802,0.125365433599548,True,,,,
2866,38538,1372:1083,Pancreas,PANC-08-13,SIDM01136,925347,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.83112713573177,0.103919720130677,0.746275200809737,13.3135160624885,159.0698,0.911079016024969,0.893979934423472,0.117925817772323,0.620249570116648,0.488304045121563,0.131945524995085,10.414284732952,21.3222,2.89923132953652,137.7476,0.757222493014152,0.730073844662023,0.743010982299056,0.672990857494688,0.0271486483521285,0.0700201248043684,True,,,,
2867,38538,1011:1083,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.465207296831373,0.103919720130677,0.746275200809737,13.3135160624885,159.0698,0.911079016024969,0.893979934423472,0.0842338789429073,0.347172668860988,0.155020893851903,0.192151775009085,6.22674232823772,1.1702,7.08677373425077,157.8996,0.423840606244763,0.277154008498963,0.415885988714631,0.28906255266918,0.1466865977458,0.126823436045452,True,,,,
2868,38538,1558:1083,Pancreas,PANC-08-13,SIDM01136,925347,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.938359880045905,0.103919720130677,0.746275200809737,13.3135160624885,159.0698,0.911079016024969,0.893979934423472,0.121602267160503,0.700274707913058,0.608553094694289,0.0917216132187687,11.4492521250473,43.6906,1.86426393744117,115.3792,0.854919996189531,0.857789200112191,0.838874904029055,0.792200099278941,-0.0028692039226599,0.0466748047501144,True,,,,
2869,38538,1011:1085,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.626767252881764,0.0887364162432035,0.763507805489027,13.6860110603617,257.4127,0.937977026802464,0.902141757362471,0.0655722643450329,0.478541689800142,0.364000679889873,0.114541009910269,10.3029965049839,24.6741,3.38301455537785,232.7386,0.587893284355186,0.512907016080784,0.565432910972004,0.50499800740972,0.0749862682744015,0.0604349035622835,True,,,,
2870,38380,1011:1168,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.472158050861937,0.0663950888716233,0.77435946301962,13.9302451188039,304.896,0.907714208734268,0.907197193712159,0.0466848169148693,0.36562005472584,0.209755067028115,0.155864987697725,8.10462255750701,5.3761,5.82562256129687,299.5199,0.428584571535658,0.315575279902442,0.428340458730552,0.337420200360995,0.113009291633216,0.0909202583695576,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2871,38381,1011:1372,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.4884308941569,0.0514244580071547,0.832564707583012,15.412889447924,85.2064,0.921685125333148,0.933273315010327,0.0558778910926179,0.406650324568249,0.272882857731514,0.133767466836735,9.94302845886141,1.9226,5.46986098906258,83.2838,0.450179489897584,0.333029633628625,0.455839519743268,0.386998626728204,0.11714985626896,0.0688408930150643,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2872,38381,1079:1372,Pancreas,PANC-08-13,SIDM01136,925347,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1.0,0.0514244580071547,0.832564707583012,15.412889447924,85.2064,0.921685125333148,0.933273315010327,0.0610626725581825,0.832564707583012,0.599787468466431,0.232777239116581,10.6176207212742,3.0687,4.79526872664982,82.1377,0.921685125333148,0.764073921864981,0.933273315010327,0.816914409719783,0.157611203468167,0.116358905290544,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2873,38382,1011:1510,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.622927618866799,0.0730032588053585,0.82018231001944,15.0677149849786,670.7555,0.909484255320779,0.927866597560061,0.041589168302788,0.51091421341708,0.401420604443948,0.109493608973132,11.3771965297284,51.9526,3.69051845525021,618.8029,0.566542861563817,0.497511372971421,0.577993730244127,0.524505654052954,0.0690314885923954,0.0534880761911732,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2874,38383,1011:1558,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.459021256663304,0.0621457187968456,0.865025766927369,16.4274974229868,1721.4702,0.949899225715345,0.947109688947901,0.0596770656330462,0.397065214581139,0.191247262974594,0.205817951606544,7.65427591275286,3.9346,8.77322151023391,1717.5356,0.436023936291357,0.305479662590675,0.434743479618856,0.318282155447952,0.130544273700682,0.116461324170904,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2875,38383,1011:1561,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.459021256663304,0.082806546584653,0.655552000797986,11.5730279971348,59.5057,0.815202412288408,0.848027029231857,0.0540893872574477,0.300912303214435,0.12613911378357,0.174773189430865,5.12006127745286,0.6792,6.45296671968194,58.8265,0.374195235723582,0.209850278810501,0.389262432642455,0.257905391384684,0.164344956913081,0.131357041257771,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2876,38383,1079:1561,Pancreas,PANC-08-13,SIDM01136,925347,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.992976524199589,0.082806546584653,0.655552000797986,11.5730279971348,59.5057,0.815202412288408,0.848027029231857,0.0539338314875277,0.650947747184471,0.442123276920742,0.208824470263729,8.12086051755482,5.4369,3.45216747957998,54.0688,0.809476857873264,0.672840127147355,0.842070931913953,0.7103603438068,0.136636730725909,0.131710588107152,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2877,38384,1011:1564,Pancreas,PANC-08-13,SIDM01136,925347,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.429182036199018,0.0581710776087791,0.800794241394271,14.5626634327803,472.6379,0.902014775794896,0.919251229963442,0.0507955557884529,0.343686503098041,0.196534736713306,0.147151766384734,8.3255534414226,6.2657,6.23710999135769,466.3722,0.387128538157254,0.265449497354231,0.394526114654162,0.311052525947298,0.121679040803023,0.0834735887068638,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2878,38384,1083:1594,Pancreas,PANC-08-13,SIDM01136,925347,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.975363632783914,0.0752356364184072,0.790358518310242,14.3060622808842,158.2501,0.894495292528862,0.914535948717509,0.0850612632694017,0.770886955620789,0.818738996050041,-0.0478520404292514,15.6128002878533,391.4815,-1.3067380069691,-233.2314,0.87245817802906,0.878744521706114,0.892005105252593,0.913169737105413,-0.0062863436770535,-0.0211646318528198,True,0.588885004130016,0.0604990811819972,0.47660528781524,98.2207557140039
2879,38232,1080:1011,Pancreas,AsPC-1,SIDM00899,910702,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.941675842878267,0.0638199482951413,0.670338176189072,12.2439646727761,94.7394,0.851918868781521,0.841722142515375,0.0788949461045693,0.631241267076324,0.424678933104044,0.206562333972281,8.10090794620048,5.3622,4.14305672657566,89.3772,0.802231418823739,0.645898098249562,0.792629408022467,0.654010638481061,0.156333320574176,0.138618769541405,True,0.629507771316861,0.0776243047830664,0.431301911570614,110.594754115149
2880,38232,1083:1011,Pancreas,AsPC-1,SIDM00899,910702,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.98182544211747,0.0638199482951413,0.670338176189072,12.2439646727761,94.7394,0.851918868781521,0.841722142515375,0.0439630575770739,0.658155076205054,0.552574818526035,0.105580257679019,10.1543457079057,22.2583,2.08961896487039,72.4811,0.836435619989632,0.738371603435038,0.826424214715222,0.761350999009186,0.0980640165545941,0.065073215706036,True,0.629507771316861,0.0776243047830664,0.431301911570614,110.594754115149
2881,38232,1564:1011,Pancreas,AsPC-1,SIDM00899,910702,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.699307146034535,0.0638199482951413,0.670338176189072,12.2439646727761,94.7394,0.851918868781521,0.841722142515375,0.0841262143934465,0.468772276868775,0.327862498536903,0.140909778331872,8.42953889805473,6.734,3.8144257747214,88.0054,0.595752952780575,0.483923799400093,0.588622309236501,0.495418221839479,0.111829153380482,0.0932040873970224,True,0.629507771316861,0.0776243047830664,0.431301911570614,110.594754115149
2882,38232,1561:1011,Pancreas,AsPC-1,SIDM00899,910702,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.846609545790012,0.0638199482951413,0.670338176189072,12.2439646727761,94.7394,0.851918868781521,0.841722142515375,0.118001518957465,0.567514698869135,0.369141393972653,0.198373304896482,7.82385241177964,4.4253,4.42011226099649,90.3141,0.721242646549065,0.590148999363411,0.712610000756338,0.577826422116547,0.131093647185654,0.13478357863979,True,0.629507771316861,0.0776243047830664,0.431301911570614,110.594754115149
2883,38232,1510:1011,Pancreas,AsPC-1,SIDM00899,910702,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.859174930320436,0.0638199482951413,0.670338176189072,12.2439646727761,94.7394,0.851918868781521,0.841722142515375,0.110214122621349,0.575937755818374,0.438759940300985,0.137177815517389,9.19521945594157,11.449,3.04874521683457,83.2904,0.731947334724029,0.639391911316011,0.723186563144816,0.63535332376716,0.0925554234080179,0.0878332393776555,True,0.629507771316861,0.0776243047830664,0.431301911570614,110.594754115149
2884,38237,1011:1083,Pancreas,AsPC-1,SIDM00899,910702,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.630071824642988,0.0677275460533691,0.748887137550786,13.9944474396892,255.0166,0.889133860099575,0.884702932537925,0.0720358579855247,0.471852685208288,0.366981142185011,0.104871543023277,10.5212154265476,22.9626,3.47323201314157,232.054,0.560218193584802,0.50030495645432,0.557426390971172,0.496678430586164,0.0599132371304818,0.0607479603850081,True,0.629507771316861,0.0776243047830664,0.431301911570614,110.594754115149
2885,38237,1558:1085,Pancreas,AsPC-1,SIDM00899,910702,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,10.0,0.807863707168898,0.0993355897904792,0.665507988235927,12.1444248690491,88.4232,0.863342564177517,0.83894244867726,0.101947629143298,0.537639750526792,0.401672770625961,0.135966979900831,8.94887294832807,9.6518,3.19555192072107,78.7714,0.697463124453151,0.604455067569962,0.677751156689764,0.589515752972703,0.0930080568831887,0.0882354037170611,True,0.629507771316861,0.0776243047830664,0.431301911570614,110.594754115149
2886,38172,1011:1510,Pancreas,AsPC-1,SIDM00899,910702,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.830168180853232,0.0912204591185029,0.724626088416039,13.4223668001583,214.4199,0.835578156339913,0.871853781589987,0.0515781644859484,0.601561521619136,0.433411736830946,0.16814978478819,9.40390127400136,13.2308,4.01846552615698,201.1891,0.693670398009403,0.584161922426881,0.723785267832571,0.620634405653122,0.109508475582522,0.103150862179448,True,0.755325171644131,0.10494938592446,0.247564959615334,183.06104131339
2887,38172,1594:1510,Pancreas,AsPC-1,SIDM00899,910702,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.744077118354605,0.0912204591185029,0.724626088416039,13.4223668001583,214.4199,0.835578156339913,0.871853781589987,0.0583259920425191,0.539177691753176,0.426063387653972,0.113114304099204,10.3369294039464,25.2613,3.08543739621192,189.1586,0.621734586729457,0.529318581593979,0.648726449432043,0.58179427683806,0.0924160051354773,0.066932172593984,True,0.755325171644131,0.10494938592446,0.247564959615334,183.06104131339
2888,38173,1011:1558,Pancreas,AsPC-1,SIDM00899,910702,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.786719022647423,0.0772376609344118,0.808885595059627,15.5946818178296,966.4893,0.903376906806629,0.915009549605099,0.099267951321596,0.636365684778889,0.420545822176112,0.215819862602777,9.63281343306701,15.5059,5.9618683847626,950.9834,0.710703797205163,0.585182321026015,0.719855418578382,0.595006891495652,0.125521476179148,0.12484852708273,True,0.755325171644131,0.10494938592446,0.247564959615334,183.06104131339
2889,38173,1011:1561,Pancreas,AsPC-1,SIDM00899,910702,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.803863626761055,0.0916912200485974,0.674784141236369,12.3362433202588,100.9972,0.797674775089179,0.844265866962737,0.0861790425437961,0.542434427055112,0.295887898873771,0.246546528181341,6.52969780898017,1.8045,5.80654551127865,99.1927,0.641221737678997,0.46512094892368,0.678674621767232,0.501341361937836,0.176100788755316,0.177333259829396,True,0.755325171644131,0.10494938592446,0.247564959615334,183.06104131339
2890,38174,1011:1564,Pancreas,AsPC-1,SIDM00899,910702,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.726878296910615,0.0775543963007828,0.559072331219939,10.0850986625552,21.2152,0.774471782305108,0.772962865269563,0.053299848750014,0.406377543966997,0.267142743809022,0.139234800157975,6.51865796234676,1.7908,3.56644070020846,19.4244,0.562946730127266,0.414448800655459,0.561849931082289,0.452950717184699,0.148497929471807,0.10889921389759,True,0.755325171644131,0.10494938592446,0.247564959615334,183.06104131339
2891,38174,1558:1564,Pancreas,AsPC-1,SIDM00899,910702,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.896818985158079,0.0775543963007828,0.559072331219939,10.0850986625552,21.2152,0.774471782305108,0.772962865269563,0.0713222458035359,0.501386680714628,0.425518077921161,0.0758686027934666,8.53291310675374,7.2342,1.55218555580147,13.981,0.694560997840436,0.602492549014842,0.693207772395931,0.639207158971922,0.0920684488255946,0.0540006134240085,True,0.755325171644131,0.10494938592446,0.247564959615334,183.06104131339
2892,38100,1080:1011,Pancreas,PA-TU-8988T,SIDM00453,1240201,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.541387052607002,0.120638774590335,0.514525360601347,9.15036988510574,11.0985,0.835629143016785,0.833136923396405,0.0618741383396252,0.278557368467518,0.0524775592800687,0.22607980918745,3.22561942654589,0.1827,5.92475045855984,10.9158,0.452398798810372,0.209579924186822,0.451049543375645,0.239477374333117,0.24281887462355,0.211572169042528,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2893,38100,1083:1011,Pancreas,PA-TU-8988T,SIDM00453,1240201,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.9641299569139,0.120638774590335,0.514525360601347,9.15036988510574,11.0985,0.835629143016785,0.833136923396405,0.111857993655595,0.496069313747686,0.358174540037228,0.137894773710458,7.63961837516205,3.8948,1.51075150994369,7.2037,0.805655089652772,0.700273974997751,0.803252266057555,0.725814594316415,0.105381114655021,0.0774376717411407,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2894,38102,1564:1053,Pancreas,PA-TU-8988T,SIDM00453,1240201,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.715676359647663,0.0708401396156546,0.738402151315211,11.6848205661478,64.3001,0.903153324121721,0.923449357760262,0.0379402306674936,0.528456963609273,0.370267400917673,0.158189562691601,9.17980994720605,11.3273,2.50501061894178,52.9728,0.646365483211119,0.589640181102195,0.660890874680837,0.597235640918045,0.0567253021089242,0.0636552337627916,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2895,38102,1372:1053,Pancreas,PA-TU-8988T,SIDM00453,1240201,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.772188194815354,0.0708401396156546,0.738402151315211,11.6848205661478,64.3001,0.903153324121721,0.923449357760262,0.0838295655853908,0.570185424271867,0.268810843424388,0.301374580847479,7.37688505902524,3.2463,4.30793550712258,61.0538,0.697404334995038,0.517502661223939,0.713076692572295,0.569058069157939,0.179901673771099,0.144018623414356,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2896,38102,1558:1053,Pancreas,PA-TU-8988T,SIDM00453,1240201,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.9385182058358,0.0708401396156546,0.738402151315211,11.6848205661478,64.3001,0.903153324121721,0.923449357760262,0.0605408589768795,0.693003862237647,0.678788135140587,0.0142157270970604,11.4855598477925,56.0052,0.199260718355326,8.2949,0.847625837349357,0.813035757101687,0.866674034425383,0.861784374256335,0.0345900802476696,0.0048896601690483,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2897,38102,1594:1054,Pancreas,PA-TU-8988T,SIDM00453,1240201,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,0.589532711243357,0.0652380357925456,0.856758057681267,13.6277504324316,197.7797,0.957586940489657,0.960905193531037,0.112256298719576,0.505086900624429,0.403795642416428,0.101291258208002,11.0092601693192,32.2061,2.61849026311236,165.5736,0.564528825278099,0.432037075664174,0.566485043990175,0.533275282764906,0.132491749613925,0.033209761225269,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2898,38104,1510:1079,Pancreas,PA-TU-8988T,SIDM00453,1240201,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.863368017185439,0.0998449063591103,0.436829841003109,8.34271979040965,1.2681,0.750193640033429,0.792614116743306,0.0886247078526577,0.377144913674285,0.162998229347487,0.214146684326798,5.22801224369939,0.1464,3.11470754671026,1.1217,0.647693195500789,0.475880136754291,0.684317678365856,0.510233679233258,0.171813058746497,0.174083999132599,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2899,38104,1083:1079,Pancreas,PA-TU-8988T,SIDM00453,1240201,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.953060485604559,0.0998449063591103,0.436829841003109,8.34271979040965,1.2681,0.750193640033429,0.792614116743306,0.0834851115788028,0.416325260392986,0.313806633257678,0.102518627135308,7.1590512720246,0.5583,1.18366851838505,0.7098,0.714979914867712,0.663222584526421,0.755409195000404,0.689437011779974,0.0517573303412906,0.0659721832204303,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2900,38104,1011:1080,Pancreas,PA-TU-8988T,SIDM00453,1240201,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.79130604578643,0.0862397093469784,0.39169105809949,7.8610330667785,0.0454,0.778190276439948,0.765783515063358,0.171653490737913,0.30994750235461,0.109555747275612,0.200391755078998,4.26976681427194,0.0038,3.59126625250656,0.0416,0.615786670519144,0.418955883404037,0.605969125233218,0.41159378636108,0.196830787115107,0.194375338872138,True,0.221295631603729,0.0355503362207888,1.42320343631463,34.5934987899097
2901,38316,1372:1083,Pancreas,PA-TU-8988T,SIDM00453,1240201,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.803555958848501,0.0622145153689683,0.822180047482851,12.9616875066748,124.6455,0.936121651579826,0.950511570207643,0.115571607881532,0.660667676401188,0.36272967415132,0.297938002249868,8.49548879164325,5.6392,4.46619871503153,119.0063,0.752226131334069,0.561510305633259,0.763789236194797,0.643419896008234,0.19071582570081,0.120369340186563,True,0.222681557994576,0.0464644075464695,1.37103537802547,35.6037734061434
2902,38316,1011:1083,Pancreas,PA-TU-8988T,SIDM00453,1240201,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.804195793157073,0.0622145153689683,0.822180047482851,12.9616875066748,124.6455,0.936121651579826,0.950511570207643,0.0964465511192552,0.661193735403391,0.309115081191878,0.352078654211513,7.78134928004075,3.4375,5.18033822663403,121.208,0.752825094083747,0.633491665347564,0.76439740610811,0.612123386294938,0.119333428736183,0.152274019813172,True,0.222681557994576,0.0464644075464695,1.37103537802547,35.6037734061434
2903,38316,1558:1083,Pancreas,PA-TU-8988T,SIDM00453,1240201,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.954032605466266,0.0622145153689683,0.822180047482851,12.9616875066748,124.6455,0.936121651579826,0.950511570207643,0.0569506148394578,0.784386572862442,0.743417896235862,0.0409686766265801,12.2632120893066,76.8095,0.698475417368201,47.836,0.893090578290085,0.910904414289207,0.90681902985103,0.893922679079814,-0.0178138359991215,0.0128963507712155,True,0.222681557994576,0.0464644075464695,1.37103537802547,35.6037734061434
2904,38316,1079:1083,Pancreas,PA-TU-8988T,SIDM00453,1240201,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.684433473462041,0.0622145153689683,0.822180047482851,12.9616875066748,124.6455,0.936121651579826,0.950511570207643,0.0521335871478891,0.562727545709874,0.200607216991926,0.362120328717948,6.72217459961484,1.6497,6.23951290705993,122.9958,0.640712993573803,0.476612290814666,0.650561935563076,0.475840918531579,0.164100702759137,0.174721017031497,True,0.222681557994576,0.0464644075464695,1.37103537802547,35.6037734061434
2905,38219,1594:1168,Pancreas,PA-TU-8988T,SIDM00453,1240201,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,0.520787192296951,0.0772504208526097,0.87357692640017,14.0012100250527,320.2685,0.939140141090485,0.965813637663314,0.0450390542652364,0.454947674755345,0.301714106700548,0.153233568054797,9.82813819778204,17.7539,4.17307182727071,302.5146,0.489092157251877,0.429077411200833,0.502983372640782,0.44927070818523,0.060014746051044,0.0537126644555525,True,0.26756550262373,0.0538701661393178,1.24271970070205,39.4976191203835
2906,38221,1085:1510,Pancreas,PA-TU-8988T,SIDM00453,1240201,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.495706557891861,0.100252593893762,0.846021834140709,13.4081221111992,212.3132,0.901670977600112,0.957722513029723,0.048244621156895,0.419378571303249,0.350777829478407,0.0686007418248425,11.2869688910107,48.803,2.12115322018843,163.5102,0.44696421665714,0.417358321589054,0.474749330349506,0.452457846039982,0.0296058950680864,0.0222914843095247,True,0.26756550262373,0.0538701661393178,1.24271970070205,39.4976191203835
2907,38221,1594:1510,Pancreas,PA-TU-8988T,SIDM00453,1240201,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.505788235286502,0.100252593893762,0.846021834140709,13.4081221111992,212.3132,0.901670977600112,0.957722513029723,0.0553780741293774,0.427907890503879,0.314541731990159,0.11336615851372,10.2873350191006,24.4077,3.12078709209862,187.9055,0.456054572569416,0.392466221019235,0.484404779759457,0.445285069979465,0.0635883515501802,0.0391197097799924,True,0.26756550262373,0.0538701661393178,1.24271970070205,39.4976191203835
2908,38221,1079:1510,Pancreas,PA-TU-8988T,SIDM00453,1240201,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.80999488691952,0.100252593893762,0.846021834140709,13.4081221111992,212.3132,0.901670977600112,0.957722513029723,0.0899603566695409,0.685273359876248,0.462608372787003,0.222664987089245,9.74112193839001,16.7148,3.66700017280917,195.5984,0.730348881539815,0.627284931608604,0.775750338641789,0.695876899319212,0.103063949931211,0.0798734393225764,True,0.26756550262373,0.0538701661393178,1.24271970070205,39.4976191203835
2909,38222,1053:1558,Pancreas,PA-TU-8988T,SIDM00453,1240201,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,5.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.851715867821191,0.0621842148120596,0.833152116365705,13.1607717618656,178.8616,0.94084370993294,0.953855049719174,0.166685075608091,0.709608877817478,0.433970011298597,0.275638866518881,9.09858290478911,10.7072,4.06218885707649,168.1544,0.801331516889642,0.695920941758682,0.812413481447191,0.707529984084239,0.10541057513096,0.104883497362953,True,0.26756550262373,0.0538701661393178,1.24271970070205,39.4976191203835
2910,36179,1080:1011,Pancreas,SU8686,SIDM01188,1240218,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.778886985083362,0.160552905809208,0.451620886758423,8.03220166942416,5.1129,0.726023295982463,0.679141790677557,0.139341304438083,0.351761630887943,0.221307874981663,0.13045375590628,4.39317835357227,0.4104,3.63902331585188,4.7025,0.565490096108066,0.379859387847693,0.528974701784959,0.403624737227524,0.185630708260373,0.125349964557435,True,0.34929585216241,0.0353686353370659,1.01539368805041,48.5343226239962
2911,36183,1011:1080,Pancreas,SU8686,SIDM01188,1240218,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.516132713941942,0.0839300596394449,0.720054283311192,13.709927772712,2.6172,0.864985411926726,0.861682847836239,0.0875858652178083,0.371643571430926,0.263589262346584,0.108054309084342,9.21342173998026,0.1159,4.49650603273169,2.5013,0.44644726817793,0.37399427779185,0.444742706810939,0.374423684444027,0.0724529903860799,0.0703190223669122,True,0.34929585216241,0.0353686353370659,1.01539368805041,48.5343226239962
2912,37955,1564:1561,Pancreas,SU8686,SIDM01188,1240218,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.69224597420078,0.0582030916737794,0.632331693199528,11.7032859944862,65.1284,0.822354012745376,0.809047785339349,0.0546832651109721,0.437729068976936,0.356547317804277,0.0811817511726585,9.3003898318125,12.3148,2.40289616267369,52.8136,0.569271254690843,0.459500469367155,0.560060072337221,0.504433863970763,0.109770785323688,0.055626208366458,True,0.42323727711311,0.0507922310872659,0.796100381365245,60.5981007744114
2913,36545,1168:1564,Pancreas,SU8686,SIDM01188,1240218,1168,Erlotinib,EGFR,EGFR signaling,Targeted,FDA approved in pancreas,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.684811860635692,0.112485146368219,0.547786421401963,9.95586861514871,19.3975,0.700743353267232,0.7524500612583,0.0704378558777227,0.375130638471245,0.264487356131583,0.110643282339662,6.69056267131734,2.0174,3.26530594383137,17.3801,0.479877359579027,0.370972446680056,0.515286726485737,0.426167896514313,0.108904912898971,0.0891188299714233,True,0.497578854780933,0.0576856789646371,0.666463313851374,73.146771367176
2914,36545,1564:1594,Pancreas,SU8686,SIDM01188,1240218,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.759598223315511,0.0785469845991207,0.828137834783506,16.8395863120267,916.2429,0.915466743606612,0.919716124761157,0.0481787862944242,0.629052027961905,0.412774043505873,0.216277984456032,9.86788247397758,7.2999,6.97170383804916,908.943,0.695386911948019,0.533279940177873,0.698614734323201,0.569196253855577,0.162106971770146,0.129418480467624,True,0.497578854780933,0.0576856789646371,0.666463313851374,73.146771367176
2915,35357,1372:1011,Pancreas,PA-TU-8902,SIDM00455,1298526,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.603576877696417,0.0946292137003454,0.677148070696391,11.441417354303,54.3175,0.901709094690747,0.878974104460089,0.0936334778224408,0.408710918249081,0.193049906665822,0.215661011583258,6.51310711360285,1.7839,4.92831024070012,52.5336,0.544250759963904,0.411355945518557,0.530528445546025,0.396179383667394,0.132894814445347,0.134349061878631,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2916,35357,1564:1011,Pancreas,PA-TU-8902,SIDM00455,1298526,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.60679177351202,0.0946292137003454,0.677148070696391,11.441417354303,54.3175,0.901709094690747,0.878974104460089,0.0974908658663773,0.410887878748106,0.148667297383727,0.262220581364379,5.29045686873521,0.7644,6.15096048556775,53.5531,0.547149660759316,0.353245127722225,0.533354255716477,0.353148366485061,0.19390453303709,0.180205889231416,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2917,35357,1561:1011,Pancreas,PA-TU-8902,SIDM00455,1298526,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.578273756512442,0.0946292137003454,0.677148070696391,11.441417354303,54.3175,0.901709094690747,0.878974104460089,0.0750981719420454,0.391576958556755,0.208286747350718,0.183290211206037,7.10621183326183,2.691,4.33520552104114,51.6265,0.521434705468252,0.412780165377259,0.508287657263296,0.399276562567686,0.108654540090992,0.10901109469561,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2918,35357,1080:1011,Pancreas,PA-TU-8902,SIDM00455,1298526,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.85141802897111,0.0946292137003454,0.677148070696391,11.441417354303,54.3175,0.901709094690747,0.878974104460089,0.0837788975425356,0.576536075673912,0.28843166410789,0.288104411566021,6.79556962873688,2.1697,4.64584772556608,52.1478,0.76773138010692,0.567325250207086,0.748374399536056,0.572841682502048,0.200406129899834,0.175532717034008,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2919,35357,1558:1011,Pancreas,PA-TU-8902,SIDM00455,1298526,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.917437781698189,0.0946292137003454,0.677148070696391,11.441417354303,54.3175,0.901709094690747,0.878974104460089,0.139993953608839,0.621241223860906,0.326898655118418,0.294342568742488,7.0507266616784,2.5895,4.39069069262457,51.728,0.827261991570161,0.622561572921232,0.806404052566017,0.630593998748969,0.204700418648929,0.175810053817048,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2920,35357,1079:1011,Pancreas,PA-TU-8902,SIDM00455,1298526,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.881210908279952,0.0946292137003454,0.677148070696391,11.441417354303,54.3175,0.901709094690747,0.878974104460089,0.1103067662097,0.596710266418385,0.392204628861542,0.204505637556842,8.27290538517269,6.0412,3.16851196913027,48.2763,0.794595890336726,0.678086816010963,0.774561568945833,0.663008798790475,0.116509074325764,0.111552770155358,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2921,35357,1083:1011,Pancreas,PA-TU-8902,SIDM00455,1298526,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.681095790395239,0.0946292137003454,0.677148070696391,11.441417354303,54.3175,0.901709094690747,0.878974104460089,0.141576411948725,0.46120270042557,0.240655491761659,0.22054720866391,7.00780207263487,2.5136,4.43361528166809,51.8039,0.614150268554969,0.502630830077784,0.598665562414192,0.466495142557789,0.111519438477185,0.132170419856403,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2922,35357,1085:1011,Pancreas,PA-TU-8902,SIDM00455,1298526,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,1.25,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.936252276556295,0.0946292137003454,0.677148070696391,11.441417354303,54.3175,0.901709094690747,0.878974104460089,0.0740181585378867,0.633981422755199,0.602108287168608,0.0318731355865914,10.9409658455119,38.3963,0.500451508791022,15.9212,0.844227192695727,0.828717292406497,0.822941506334789,0.808156195203594,0.0155099002892302,0.0147853111311951,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2923,35359,1510:1053,Pancreas,PA-TU-8902,SIDM00455,1298526,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.7656456982809,0.0581041088671147,0.825899595500216,14.1315220584253,350.5436,0.937501321247647,0.940278533870043,0.0715448083850541,0.632346472506675,0.390450835024867,0.241895637481808,9.13137158493785,10.9533,5.00015047348748,339.5903,0.717793853745921,0.549053237471839,0.71992021464347,0.607108022602626,0.168740616274082,0.112812192040843,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2924,35359,1564:1053,Pancreas,PA-TU-8902,SIDM00455,1298526,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.611805575523325,0.0581041088671147,0.825899595500216,14.1315220584253,350.5436,0.937501321247647,0.940278533870043,0.0695708670874359,0.505289977349491,0.350704604292392,0.154585373057099,9.97247522256259,19.622,4.15904683586274,330.9216,0.573568535399794,0.46602472322646,0.57526764956659,0.506688276906038,0.107543812173334,0.0685793726605521,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2925,35359,1558:1053,Pancreas,PA-TU-8902,SIDM00455,1298526,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.88199300437338,0.0581041088671147,0.825899595500216,14.1315220584253,350.5436,0.937501321247647,0.940278533870043,0.166320384793811,0.728437665545995,0.360011505032658,0.368426160513337,7.77550715254233,4.2795,6.356014905883,346.2641,0.826869606931225,0.706600398419443,0.829319089035836,0.641108680140915,0.120269208511782,0.188210408894921,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2926,35359,1372:1053,Pancreas,PA-TU-8902,SIDM00455,1298526,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.623412143814921,0.0581041088671147,0.825899595500216,14.1315220584253,350.5436,0.937501321247647,0.940278533870043,0.0601530756268061,0.514875837406665,0.291420836596224,0.223455000810441,8.57038351090621,7.4246,5.56113854751912,343.119,0.584449708508316,0.436498379877024,0.586181056583074,0.47812272817564,0.147951328631293,0.108058328407434,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2927,35361,1510:1079,Pancreas,PA-TU-8902,SIDM00455,1298526,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.572627350280541,0.111037326017164,0.769620664739877,12.9756728191084,31.4649,0.881018715232178,0.918403624554785,0.0648361855957069,0.440705841971145,0.239008761600107,0.201697080371038,7.90075272893708,0.9335,5.07492009017133,30.5314,0.504495412450969,0.381870599477984,0.525903034016852,0.419986890811322,0.122624812972985,0.10591614320553,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2928,35361,1053:1079,Pancreas,PA-TU-8902,SIDM00455,1298526,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.90000190956399,0.111037326017164,0.769620664739877,12.9756728191084,31.4649,0.881018715232178,0.918403624554785,0.059579074854853,0.692660067905797,0.374273607330476,0.318386460575321,7.87998965233115,0.9202,5.09568316677727,30.5447,0.792918526070573,0.632997265748941,0.826565015849796,0.659123805247711,0.159921260321633,0.167441210602085,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2929,35361,1083:1079,Pancreas,PA-TU-8902,SIDM00455,1298526,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.954313483995737,0.111037326017164,0.769620664739877,12.9756728191084,31.4649,0.881018715232178,0.918403624554785,0.0960582036041204,0.734459377923028,0.655120962372389,0.0793384155506388,11.5832703779752,11.9859,1.39240244113325,19.479,0.840768039598668,0.818882257883513,0.87644496266319,0.842826635490537,0.0218857817151556,0.0336183271726526,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2930,35361,1561:1079,Pancreas,PA-TU-8902,SIDM00455,1298526,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.466038460876373,0.111037326017164,0.769620664739877,12.9756728191084,31.4649,0.881018715232178,0.918403624554785,0.0894607987523662,0.358672830054024,0.262557338318483,0.0961154917355409,9.84016653671954,3.5805,3.13550628238888,27.8844,0.410588606050084,0.31559409216647,0.428011411650795,0.383521762339969,0.0949945138836141,0.0444896493108256,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2931,35361,1564:1079,Pancreas,PA-TU-8902,SIDM00455,1298526,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.659128680061396,0.111037326017164,0.769620664739877,12.9756728191084,31.4649,0.881018715232178,0.918403624554785,0.0755271865013919,0.507279052897969,0.370894746894934,0.136384306003036,9.83110107498769,3.5581,3.14457174412072,27.9068,0.580704702880372,0.486225750536254,0.605346168816397,0.542183876387026,0.0944789523441188,0.0631622924293707,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2932,35361,1372:1079,Pancreas,PA-TU-8902,SIDM00455,1298526,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.64373808345058,0.111037326017164,0.769620664739877,12.9756728191084,31.4649,0.881018715232178,0.918403624554785,0.0903167462333575,0.49543413170361,0.343590394121864,0.151843737581746,9.44555382462966,2.7237,3.53011899447875,28.7412,0.567145299227655,0.451160455206191,0.591211389104964,0.519259044693441,0.115984844021464,0.0719523444115221,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2933,35361,1011:1079,Pancreas,PA-TU-8902,SIDM00455,1298526,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.91188801413717,0.111037326017164,0.769620664739877,12.9756728191084,31.4649,0.881018715232178,0.918403624554785,0.1189815291312,0.701807859608576,0.278166339292231,0.423641520316345,6.2860126227055,0.3048,6.68966019640291,31.1601,0.803390406650752,0.545062182646691,0.837481257371642,0.586295474662078,0.25832822400406,0.251185782709564,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2934,35361,1011:1080,Pancreas,PA-TU-8902,SIDM00455,1298526,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.1,0.91188801413717,0.0803762167578484,0.547242381372085,9.62472818115423,0.1542,0.805977796003819,0.814159661039821,0.139341014566849,0.499023768401086,0.241401621864557,0.257622146536529,5.63288544596941,0.0097,3.99184273518482,0.1445,0.734961491836576,0.56475114195219,0.742422436496194,0.550126882301162,0.170210349884386,0.192295554195031,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2935,35362,1011:1083,Pancreas,PA-TU-8902,SIDM00455,1298526,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,8.0,0.869353917197566,0.101643397298935,0.625793077849309,10.6948964535209,25.9003,0.887123192664744,0.854851675655487,0.145604049882494,0.544035663583418,0.308403625206591,0.235632038376827,7.02819046935266,2.0395,3.66670598416825,23.8608,0.771224022579907,0.644940178656983,0.743168652854001,0.596438488164695,0.126283843922924,0.146730164689306,True,0.374242121883825,0.0428499725745735,0.937328452010777,52.2796229438163
2936,35571,1011:1372,Pancreas,PA-TU-8902,SIDM00455,1298526,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.822611775058768,0.094355145881642,0.62300983561648,10.6557793546096,3.1509,0.809531905162388,0.853492507461272,0.081689530304027,0.512495226755544,0.202917168183634,0.30957805857191,5.32012547861337,0.078,5.33565387599624,3.0729,0.665930477472338,0.476539263394454,0.702092986562076,0.480280631294054,0.189391214077884,0.221812355268021,True,,,,
2937,35571,1053:1372,Pancreas,PA-TU-8902,SIDM00455,1298526,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.916387593461884,0.094355145881642,0.62300983561648,10.6557793546096,3.1509,0.809531905162388,0.853492507461272,0.0814728851280979,0.57091848396367,0.372855707661537,0.198062776302134,7.7577057947057,0.4227,2.89807355990391,2.7282,0.741844994402375,0.617892407243863,0.782129944950184,0.665249818798699,0.123952587158512,0.116880126151485,True,,,,
2938,35571,1561:1372,Pancreas,PA-TU-8902,SIDM00455,1298526,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.5,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.708764624245169,0.094355145881642,0.62300983561648,10.6557793546096,3.1509,0.809531905162388,0.853492507461272,0.0934849428088825,0.441567332041759,0.261377626538199,0.18018970550356,7.22847909217689,0.2929,3.42730026243272,2.858,0.573767576576896,0.427283874244109,0.604925296346855,0.494212055673708,0.146483702332787,0.110713240673148,True,,,,
2939,35572,1079:1510,Pancreas,PA-TU-8902,SIDM00455,1298526,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.839713535278136,0.0755002011473173,0.670197134744994,11.3371963839825,50.532,0.864913141574764,0.875810594560888,0.0946316905687252,0.562773605349996,0.323692410419114,0.239081194930881,7.46284513079148,3.4456,3.87435125319106,47.0864,0.726279271820264,0.530911485867167,0.735430010592769,0.596329949824853,0.195367785953097,0.139100060767916,True,,,,
2940,35573,1054:1558,Pancreas,PA-TU-8902,SIDM00455,1298526,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.922191641440155,0.0675048053504763,0.856493695008241,14.8883981283357,592.3583,0.931116533845658,0.951587810118946,0.0942420839197941,0.789851326482793,0.510797448002575,0.279053878480218,9.71334867632322,16.3961,5.17504945201252,575.9622,0.858667884719195,0.738910736066434,0.877546324588033,0.754175256221417,0.119757148652761,0.123371068366616,True,,,,
2941,35574,1053:1564,Pancreas,PA-TU-8902,SIDM00455,1298526,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.937396898198336,0.12519407614591,0.653483497480519,11.0910099098824,42.6046,0.815463142112774,0.868077248981755,0.114560227121205,0.612573403562039,0.37380783839942,0.238765565162618,7.64667088449114,3.9139,3.44433902539129,38.6907,0.764412620011584,0.606801963928614,0.813732920592042,0.674979021696213,0.157610656082969,0.138753898895829,True,,,,
2942,35574,1011:1564,Pancreas,PA-TU-8902,SIDM00455,1298526,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.805129919145847,0.12519407614591,0.653483497480519,11.0910099098824,42.6046,0.815463142112774,0.868077248981755,0.0533079718897848,0.526139115489635,0.118739858516278,0.407399256973357,3.21693556542902,0.1816,7.87407434445341,42.423,0.656553773675676,0.335555956457381,0.69891496528503,0.362315756129014,0.320997817218295,0.336599209156015,True,,,,
2943,37926,1510:1558,Pancreas,BxPC-3,SIDM00132,906693,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.818444476597861,0.060104390119906,0.690602728777741,11.2126728755224,46.3533,0.89731358785253,0.901244103390999,0.0724192454580744,0.565219988891553,0.291181359850627,0.274038629040926,7.36378273445735,3.217,3.84889014106501,43.1363,0.734401349754112,0.575059459591647,0.737618258486754,0.595947341459258,0.159341890162465,0.141670917027496,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2944,37926,1053:1558,Pancreas,BxPC-3,SIDM00132,906693,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.917918219370984,0.060104390119906,0.690602728777741,11.2126728755224,46.3533,0.89731358785253,0.901244103390999,0.039409950826614,0.633916827092407,0.459314746318574,0.174602080773833,9.00427068406108,10.0296,2.20840219146127,36.3237,0.823660490778983,0.727788985190635,0.827268382603265,0.749398435232342,0.0958715055883487,0.077869947370923,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2945,37926,1083:1558,Pancreas,BxPC-3,SIDM00132,906693,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.946059217082431,0.060104390119906,0.690602728777741,11.2126728755224,46.3533,0.89731358785253,0.901244103390999,0.0416930665632827,0.65335107690246,0.714008231481212,-0.0606571545787519,12.0972551262913,85.5789,-0.884582250768959,-39.2256,0.848911790401192,0.872227428811318,0.852630290854246,0.87493310756913,-0.0233156384101263,-0.022302816714884,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2946,37926,1080:1558,Pancreas,BxPC-3,SIDM00132,906693,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.0025,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.863679349830753,0.060104390119906,0.690602728777741,11.2126728755224,46.3533,0.89731358785253,0.901244103390999,0.0309931838444106,0.596459315782103,0.563840826593473,0.0326184891886301,10.7403132166829,33.4108,0.472359658839501,12.9425,0.774991216150773,0.764857728605694,0.778385921255538,0.765523198291708,0.010133487545079,0.0128627229638301,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2947,37926,1564:1558,Pancreas,BxPC-3,SIDM00132,906693,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.680890167779696,0.060104390119906,0.690602728777741,11.2126728755224,46.3533,0.89731358785253,0.901244103390999,0.0541366914376653,0.470224607866592,0.218062827015149,0.252161780851443,6.92612651332006,2.3752,4.2865463622023,43.9781,0.61097199938391,0.461635844900072,0.613648248768359,0.4775318510105,0.149336154483838,0.136116397757859,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2948,37926,1372:1558,Pancreas,BxPC-3,SIDM00132,906693,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.628056938718532,0.060104390119906,0.690602728777741,11.2126728755224,46.3533,0.89731358785253,0.901244103390999,0.0293083794549783,0.433737835706813,0.209679065117939,0.224058770588874,7.09633050753513,2.6726,4.11634236798723,43.6807,0.563564025057203,0.439756435155277,0.566032612613879,0.447118114251964,0.123807589901926,0.118914498361915,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2949,37926,1079:1558,Pancreas,BxPC-3,SIDM00132,906693,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.5,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.60567339510865,0.060104390119906,0.690602728777741,11.2126728755224,46.3533,0.89731358785253,0.901244103390999,0.0453766343382437,0.418279699410113,0.234372167071744,0.183907532338369,7.73208462005871,4.1526,3.48058825546364,42.2007,0.543478967231766,0.470870926813164,0.545859575922478,0.454083311052947,0.0726080404186019,0.0917762648695309,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2950,37926,1080:1561,Pancreas,BxPC-3,SIDM00132,906693,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.635511614968729,0.0889143686199498,0.516408386282288,9.18093255030291,11.3362,0.771838021165552,0.824653387828577,0.109722014619731,0.328183527549652,0.164023246463138,0.164160281086514,6.09027458199785,1.3307,3.09065796830506,10.0055,0.490512027325188,0.348163443060263,0.524076806288372,0.41119183550151,0.142348584264925,0.112884970786862,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2951,37926,1372:1561,Pancreas,BxPC-3,SIDM00132,906693,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.653543344956114,0.0889143686199498,0.516408386282288,9.18093255030291,11.3362,0.771838021165552,0.824653387828577,0.0567747811526318,0.337495264134316,0.0627485436343371,0.274746720499978,2.82076021290572,0.138,6.3601723373972,11.1982,0.504429602116843,0.240477197001037,0.53894673351088,0.271705019301267,0.263952405115806,0.267241714209612,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2952,37926,1564:1561,Pancreas,BxPC-3,SIDM00132,906693,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.633033227838428,0.0889143686199498,0.516408386282288,9.18093255030291,11.3362,0.771838021165552,0.824653387828577,0.0624217929889355,0.32690366765111,0.0595961695300447,0.267307498121066,2.76089637237474,0.1324,6.42003617792817,11.2038,0.488599113906854,0.227893365233145,0.522032995945019,0.260513245828761,0.260705748673709,0.261519750116257,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2953,37926,1079:1561,Pancreas,BxPC-3,SIDM00132,906693,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,0.05,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.868799318528723,0.0889143686199498,0.516408386282288,9.18093255030291,11.3362,0.771838021165552,0.824653387828577,0.105703277176375,0.448655254084569,0.202096142709951,0.246559111374619,5.71077044698828,1.0229,3.47016210331463,10.3133,0.67057234680319,0.486317263191788,0.71645830136787,0.539741571066571,0.184255083611402,0.176716730301299,True,0.344306806381711,0.0480511788203858,0.981404205445745,49.3427750444841
2954,38327,1080:1011,Pancreas,HPAC,SIDM00670,1298136,1080,Paclitaxel,Microtubule stabiliser,Mitosis,Chemotherapeutic,FDA approved in pancreas,0.025,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.442234844804716,0.102122567068023,0.537081120909752,9.36206561045506,12.8526,0.897242091214819,0.851983801960898,0.0451223433471274,0.237515986153067,0.0570466592948404,0.180469326858226,4.34651396370652,0.3973,5.01555164674854,12.4553,0.396791716960644,0.201336556339174,0.376776924436309,0.232944367406729,0.19545516062147,0.143832557029581,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2955,38327,1085:1011,Pancreas,HPAC,SIDM00670,1298136,1085,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Targeted,FDA approved,5.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.621600135655225,0.102122567068023,0.537081120909752,9.36206561045506,12.8526,0.897242091214819,0.851983801960898,0.093858026544023,0.333849697615362,0.102014279421414,0.231835418193949,5.03348429134649,0.6397,4.32858131910857,12.2129,0.55772580561471,0.320894356723252,0.529593246874949,0.360115062066876,0.236831448891458,0.169478184808073,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2956,38327,1372:1011,Pancreas,HPAC,SIDM00670,1298136,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.339383855350662,0.102122567068023,0.537081120909752,9.36206561045506,12.8526,0.897242091214819,0.851983801960898,0.0509036056110055,0.182276661450407,0.0630867129372505,0.119189948513156,5.40128856945874,0.8254,3.96077704099632,12.0272,0.304509480099375,0.176584105839063,0.289149547405804,0.206014238995898,0.127925374260312,0.0831353084099064,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2957,38327,1083:1011,Pancreas,HPAC,SIDM00670,1298136,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.924987853453748,0.102122567068023,0.537081120909752,9.36206561045506,12.8526,0.897242091214819,0.851983801960898,0.0886822777000518,0.496793513160844,0.337494034341643,0.159299478819201,7.64937367062799,3.9212,1.71269193982707,8.9314,0.829938035981148,0.676885317425176,0.788074668153174,0.704137642361,0.153052718555972,0.0839370257921742,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2958,38327,1564:1011,Pancreas,HPAC,SIDM00670,1298136,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,10.0,0.307234932687248,0.102122567068023,0.537081120909752,9.36206561045506,12.8526,0.897242091214819,0.851983801960898,0.0533439328700771,0.1650100820303,0.0314821220749413,0.133527959955358,3.71246732149354,0.256,5.64959828896152,12.5966,0.275664113498551,0.0962218898656097,0.261759186046083,0.146798026606715,0.179442223632941,0.114961159439368,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2959,38329,1054:1053,Pancreas,HPAC,SIDM00670,1298136,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.948487706590057,0.0727864054106414,0.789889944974144,12.2266383055509,93.6084,0.930716586520306,0.943598315172697,0.115157189922403,0.749200902367071,0.501476731169346,0.247724171197725,9.28014068308008,12.1431,2.94649762247081,81.4653,0.882773240633971,0.728047960778898,0.894991401900393,0.804577368034085,0.154725279855073,0.0904140338663081,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2960,38329,1564:1053,Pancreas,HPAC,SIDM00670,1298136,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.325101233433373,0.0727864054106414,0.789889944974144,12.2266383055509,93.6084,0.930716586520306,0.943598315172697,0.0649587110985375,0.256794195387713,0.0396838097485734,0.21711038563914,4.19265285840251,0.3571,8.03398544714839,93.2513,0.30257711025465,0.115802755576932,0.306764976128296,0.167386736574785,0.186774354677718,0.139378239553511,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2961,38329,1057:1053,Pancreas,HPAC,SIDM00670,1298136,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.0125,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.896187906847987,0.0727864054106414,0.789889944974144,12.2266383055509,93.6084,0.930716586520306,0.943598315172697,0.0970129587594045,0.707889816426649,0.586213425611556,0.121676390815093,10.5525584626638,29.3337,1.67407984288706,64.2747,0.834096949542336,0.759504308373828,0.845641398979907,0.805398322394149,0.0745926411685084,0.0402430765857578,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2962,38329,1372:1053,Pancreas,HPAC,SIDM00670,1298136,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.342451148220258,0.0727864054106414,0.789889944974144,12.2266383055509,93.6084,0.930716586520306,0.943598315172697,0.0769455544734767,0.270498718624032,0.059576289533387,0.210922429090645,5.20446307091749,0.7202,7.02217523463341,92.8882,0.318724963721518,0.158357456455672,0.323136326489591,0.202820150757983,0.160367507265846,0.120316175731608,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2963,38329,1558:1053,Pancreas,HPAC,SIDM00670,1298136,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,10.0,0.966655566156062,0.0727864054106414,0.789889944974144,12.2266383055509,93.6084,0.930716586520306,0.943598315172697,0.0495314368847023,0.763551511959962,0.763336656731694,0.0002148552282679,12.2233764212435,93.397,0.0032618843074292,0.211399999999998,0.899682368873624,0.917763704490461,0.91213456357717,0.912069657448239,-0.0180813356168372,6.49061289308417e-05,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2964,38329,1558:1054,Pancreas,HPAC,SIDM00670,1298136,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,8.0,0.860835774276415,0.0940408727279878,0.74940106479656,11.6690529228496,50.8809,0.892997455457068,0.931051025029968,0.0819685377782057,0.645111245857717,0.344906981214889,0.300204264642828,8.0188137101494,4.0525,3.65023921270022,46.8284,0.768724155995254,0.622489196279001,0.801482030022523,0.674109950166363,0.146234959716253,0.12737207985616,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2965,38330,1372:1057,Pancreas,HPAC,SIDM00670,1298136,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.307072846904987,0.0771227491919428,0.607408375193094,10.0633893268994,0.209,0.881656223270141,0.881109911196816,0.0475779438047422,0.186518619004476,0.092668162099561,0.0938504569049152,6.95611897717615,0.0243,3.1072703497233,0.1847,0.270732686471061,0.194019588176891,0.270564928867407,0.220237789293262,0.0767130982941706,0.0503271395741448,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2966,38330,1053:1057,Pancreas,HPAC,SIDM00670,1298136,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.966303686283077,0.0771227491919428,0.607408375193094,10.0633893268994,0.209,0.881656223270141,0.881109911196816,0.0996351448178218,0.586940952028301,0.372571851389684,0.214369100638618,7.86457035108415,0.0455,2.1988189758153,0.1635,0.851947658580353,0.735053898114927,0.851419755210039,0.748025355909751,0.116893760465425,0.103394399300287,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2967,38330,1564:1057,Pancreas,HPAC,SIDM00670,1298136,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.1,0.321132900543364,0.0771227491919428,0.607408375193094,10.0633893268994,0.209,0.881656223270141,0.881109911196816,0.0426032210202845,0.19505881334009,0.101160707037014,0.0938981063030758,7.10730623230584,0.0269,2.95608309459361,0.1821,0.283128820260848,0.228626539395963,0.282953381480139,0.23350650728825,0.0545022808648847,0.049446874191889,True,0.295135354184212,0.051198586310322,1.13105437860429,43.0883414409707
2968,38555,1510:1079,Pancreas,HPAC,SIDM00670,1298136,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.677773448918596,0.136378234323515,0.712742367668849,11.214196780622,9.2805,0.839417733809161,0.919104975932028,0.0977646921108304,0.483077852725322,0.350852541202949,0.132225311522373,9.17213718002082,2.2535,2.0420596006012,7.027,0.568935052527267,0.511440419235058,0.622944949455694,0.571555633654674,0.0574946332922096,0.0513893158010191,True,0.296161441710273,0.0493520129543105,1.13025045069769,43.146089012471
2969,38555,1053:1079,Pancreas,HPAC,SIDM00670,1298136,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.941214533066424,0.136378234323515,0.712742367668849,11.214196780622,9.2805,0.839417733809161,0.919104975932028,0.100542788162633,0.670843474782093,0.325473353832717,0.345370120949376,7.44658347914085,0.6814,3.76761330148117,8.5991,0.790072170374865,0.658586918691274,0.86507496076089,0.70473977372135,0.131485251683591,0.16033518703954,True,0.296161441710273,0.0493520129543105,1.13025045069769,43.146089012471
2970,38555,1083:1079,Pancreas,HPAC,SIDM00670,1298136,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.824000989813329,0.136378234323515,0.712742367668849,11.214196780622,9.2805,0.839417733809161,0.919104975932028,0.0924151799971034,0.587300416441027,0.612086536802412,-0.0247861203613855,11.5844325405209,11.9956,-0.370235759898852,-2.7151,0.69168104352561,0.711285902574223,0.757343409910346,0.765455677536617,-0.0196048590486126,-0.0081122676262709,True,0.296161441710273,0.0493520129543105,1.13025045069769,43.146089012471
2971,38555,1564:1079,Pancreas,HPAC,SIDM00670,1298136,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.30257752868735,0.136378234323515,0.712742367668849,11.214196780622,9.2805,0.839417733809161,0.919104975932028,0.0324960420821669,0.215659824200011,0.0798644386835909,0.13579538551642,6.50118152179122,0.3538,4.7130152588308,8.9267,0.253988943432312,0.196220216464997,0.278100512221759,0.207693040892247,0.0577687269673147,0.0704074713295122,True,0.296161441710273,0.0493520129543105,1.13025045069769,43.146089012471
2972,38555,1372:1079,Pancreas,HPAC,SIDM00670,1298136,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.324520783482585,0.136378234323515,0.712742367668849,11.214196780622,9.2805,0.839417733809161,0.919104975932028,0.0623798412738564,0.231299711577127,0.0437172301944406,0.187582481382687,4.46821862914423,0.0865,6.74597815147779,9.194,0.272408500644925,0.136066842622986,0.298268666892204,0.173980890031347,0.136341658021938,0.124287776860857,True,0.296161441710273,0.0493520129543105,1.13025045069769,43.146089012471
2973,38555,1594:1079,Pancreas,HPAC,SIDM00670,1298136,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1079,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Targeted,FDA approved,2.0,0.494740719437506,0.136378234323515,0.712742367668849,11.214196780622,9.2805,0.839417733809161,0.919104975932028,0.0585473227671889,0.352622671754078,0.310775767844903,0.0418469039091753,10.2775503696047,4.8485,0.936646411017353,4.432,0.415294133533346,0.418939228011717,0.454718657031204,0.439863210687594,-0.0036450944783713,0.0148554463436096,True,0.296161441710273,0.0493520129543105,1.13025045069769,43.146089012471
2974,39378,1510:1372,Pancreas,HPAC,SIDM00670,1298136,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,0.71601480921523,0.0983644702500028,0.194828648501708,5.54268687403068,0.091,0.594293807179646,0.617545077381759,0.0715023521044971,0.139500197586611,0.0448971686367257,0.0946030289498857,2.41016568764525,0.0104,3.13252118638543,0.0806,0.425523166965527,0.244513914377963,0.442171420763305,0.271344022588895,0.181009252587564,0.170827398174409,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2975,39381,1564:1507,Pancreas,HPAC,SIDM00670,1298136,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1507,Ruxolitinib,"JAK1, JAK2","Other, kinases",Targeted,Advanced clinical trials,10.0,0.339173202936316,0.048190653388822,0.954311035809669,16.4050160271298,1694.8526,0.974509550048887,0.988797743679639,0.0810893438577376,0.323676730613039,0.200412730912533,0.123263999700506,9.89575011171927,18.6058,6.50926591541055,1676.2468,0.330527525382109,0.227062903164188,0.335373697780025,0.296631880895025,0.103464622217921,0.0387418168850007,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2976,39381,1372:1510,Pancreas,HPAC,SIDM00670,1298136,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,0.25,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.355803933659043,0.0826585637535084,0.670072663819866,10.726333038215,33.0886,0.878919145821212,0.904419820455233,0.0409797227143684,0.238414489624502,0.0833593082715098,0.155055181352992,6.11444793297419,1.3532,4.61188510524076,31.7354,0.312722889451433,0.197664859186856,0.321796129797177,0.234546990027059,0.115058030264578,0.0872491397701182,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2977,39381,1564:1510,Pancreas,HPAC,SIDM00670,1298136,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.339173202936316,0.0826585637535084,0.670072663819866,10.726333038215,33.0886,0.878919145821212,0.904419820455233,0.0492639702091113,0.227270691587853,0.0442381333526203,0.183032558235233,4.37744463519015,0.4059,6.3488884030248,32.6827,0.298105821810231,0.133332313644274,0.306754967302889,0.179465728458873,0.164773508165957,0.127289238844016,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2978,39381,1057:1510,Pancreas,HPAC,SIDM00670,1298136,1057,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Advanced clinical trials,0.05,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.715408679975241,0.0826585637535084,0.670072663819866,10.726333038215,33.0886,0.878919145821212,0.904419820455233,0.0676721539125474,0.479375799910864,0.298742924924326,0.180632874986538,8.18935569799657,5.7013,2.53697734021838,27.3873,0.62878638591692,0.514766476105087,0.647029789895323,0.567152973440684,0.114019909811833,0.0798768164546388,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2979,39381,1054:1510,Pancreas,HPAC,SIDM00670,1298136,1054,Palbociclib,"CDK4, CDK6",Cell cycle,Targeted,FDA approved,2.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.899842913034487,0.0826585637535084,0.670072663819866,10.726333038215,33.0886,0.878919145821212,0.904419820455233,0.11201234338713,0.602960137756447,0.432161259404228,0.170798878352219,8.8075388341274,8.7511,1.91879420408756,24.3375,0.790889164497543,0.677601137409947,0.813835765844565,0.742920386128257,0.113288027087596,0.0709153797163075,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2980,39381,1594:1510,Pancreas,HPAC,SIDM00670,1298136,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,0.616801356489117,0.0826585637535084,0.670072663819866,10.726333038215,33.0886,0.878919145821212,0.904419820455233,0.117849308429206,0.41330172799037,0.192017469322296,0.221284258668074,7.0653890691046,2.6159,3.66094396911036,30.4727,0.54211852138678,0.368131431165844,0.557847372092432,0.446811486326356,0.173987090220936,0.111035885766076,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2981,39382,1083:1558,Pancreas,HPAC,SIDM00670,1298136,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,10.0,0.894805266315111,0.112966481296796,0.639498650237579,10.3966063700104,26.3282,0.918369033660447,0.893325141906912,0.117830832240152,0.572226760033991,0.416961094856282,0.155265665177709,8.66791756066747,7.9439,1.72868880934291,18.3843,0.821761447740087,0.71886851756079,0.799352041509999,0.73240421335726,0.102892930179297,0.0669478281527393,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2982,39382,1564:1561,Pancreas,HPAC,SIDM00670,1298136,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.345819904456978,0.0632467596678093,0.305722337715341,7.00155012381886,2.5027,0.708753618809895,0.720214295333383,0.0452708669347803,0.105724869619083,0.0233173561128861,0.082407513506197,2.59938043391844,0.1184,4.40216968990042,2.3843,0.245101108740375,0.0972269833509291,0.24906443880074,0.135916103063284,0.147874125389446,0.113148335737456,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2983,39382,1372:1561,Pancreas,HPAC,SIDM00670,1298136,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,10.0,0.3282070643214,0.0632467596678093,0.305722337715341,7.00155012381886,2.5027,0.708753618809895,0.720214295333383,0.044083123134512,0.100340230959028,0.0304713157677732,0.0698689151912547,3.44606518209135,0.2129,3.55548494172751,2.2898,0.232617944556764,0.117827584413271,0.236379419553675,0.150086831049858,0.114790360143493,0.0862925885038177,True,0.258578003967525,0.0391650501002069,1.2706433712277,38.6131626086359
2984,38249,1510:1564,Pancreas,HPAC,SIDM00670,1298136,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.769803010299451,0.108055684926245,0.167894230268126,5.09998740851483,0.6699,0.580229246500067,0.584372694157594,0.0794689644882486,0.129245483872312,0.0354743734376872,0.0937711104346252,1.61688072485669,0.0599,3.48310668365814,0.61,0.446662220619534,0.214664884900808,0.449851859099316,0.247723256344988,0.231997335718726,0.202128602754328,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
2985,38249,1053:1564,Pancreas,HPAC,SIDM00670,1298136,1053,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Targeted,Early clinical trials,1.25,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.886625018392476,0.108055684926245,0.167894230268126,5.09998740851483,0.6699,0.580229246500067,0.584372694157594,0.0964809516891829,0.148859224999468,0.0554663196905163,0.0933929053089513,2.40413507567334,0.1034,2.69585233284149,0.5665,0.514445766349974,0.309576079826864,0.518119450705537,0.335603904048976,0.20486968652311,0.182515546656561,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
2986,38249,1083:1564,Pancreas,HPAC,SIDM00670,1298136,1083,Crizotinib,"MET, ALK, ROS1",RTK signaling,Targeted,FDA approved,1.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.860693956911163,0.108055684926245,0.167894230268126,5.09998740851483,0.6699,0.580229246500067,0.584372694157594,0.127380817247787,0.144505549392027,0.129696075766108,0.0148094736259196,4.78666740283132,0.5391,0.313320005683504,0.1308,0.499399806085725,0.455578870455634,0.502966046445336,0.482455757243323,0.0438209356300913,0.0205102892020133,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
2987,38249,1561:1564,Pancreas,HPAC,SIDM00670,1298136,1561,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Targeted,Advanced clinical trials,2.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.653936747312017,0.108055684926245,0.167894230268126,5.09998740851483,0.6699,0.580229246500067,0.584372694157594,0.0725511131219406,0.109792206833993,0.0190176485454453,0.0907745582885476,0.452245998568458,0.0267,4.64774140994637,0.6432,0.379433226151556,0.126851472923091,0.382142778835377,0.160197276494721,0.252581753228465,0.221945502340656,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
2988,38249,1011:1564,Pancreas,HPAC,SIDM00670,1298136,1011,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Targeted,Advanced clinical trials,4.0,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.715953192782977,0.108055684926245,0.167894230268126,5.09998740851483,0.6699,0.580229246500067,0.584372694157594,0.0892354326951902,0.120204410210305,0.0393280897188031,0.0808763204915018,2.06756494297235,0.0819,3.03242246554248,0.588,0.415416981577784,0.223275442701447,0.418383496157319,0.253368059793878,0.192141538876337,0.165015436363441,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
2989,38249,1558:1564,Pancreas,HPAC,SIDM00670,1298136,1558,Lapatinib,"EGFR, ERBB2",EGFR signaling,Targeted,FDA approved,2.5,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,10.0,0.911148739574944,0.108055684926245,0.167894230268126,5.09998740851483,0.6699,0.580229246500067,0.584372694157594,0.113791118355391,0.152976616290708,0.0722125677549478,0.0807640485357604,3.0242975180957,0.1589,2.07568989041912,0.511,0.528675146613055,0.374825297455353,0.532450443723705,0.38728441082553,0.153849849157702,0.145166032898175,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
2990,38249,1372:1594,Pancreas,HPAC,SIDM00670,1298136,1372,Trametinib,"MEK1, MEK2",ERK MAPK signaling,Targeted,FDA approved,1.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.295411081470875,0.0647792513321114,0.498977532227118,8.99003478803803,3.9725,0.812415291546299,0.834616742645886,0.04489570471965,0.147403492424882,0.0712175433805871,0.0761859490442945,6.20582997319489,0.5767,2.78420481484314,3.3958,0.239996479879169,0.18640264623736,0.24655503455872,0.196658044201212,0.0535938336418082,0.0498969903575082,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
2991,38249,1564:1594,Pancreas,HPAC,SIDM00670,1298136,1564,SCH772984,"ERK1, ERK2",ERK MAPK signaling,Targeted,Experimental only,4.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.28724445351639,0.0647792513321114,0.498977532227118,8.99003478803803,3.9725,0.812415291546299,0.834616742645886,0.064000426791646,0.143328528561536,0.0288382908449731,0.114490237716562,3.6570513877349,0.0986,5.33298340030313,3.8739,0.233361786448575,0.11072225534823,0.239739030136947,0.136019215596047,0.122639531100345,0.1037198145409,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
2992,38249,1510:1594,Pancreas,HPAC,SIDM00670,1298136,1510,Linsitinib,IGF1R,IGF1R signaling,Targeted,Advanced clinical trials,10.0,1594,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Targeted,Early clinical trials,4.0,0.769803010299451,0.0647792513321114,0.498977532227118,8.99003478803803,3.9725,0.812415291546299,0.834616742645886,0.0818639848693374,0.384114406380227,0.225261650852495,0.158852755527733,6.84929803888797,0.9008,2.14073674915006,3.0717,0.625399737045647,0.52120015672568,0.642490480935126,0.546645230854916,0.104199580319967,0.0958452500802094,True,0.292515617713831,0.0454256397804089,1.13619206245154,42.8634315635585
